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 Abstract  
Introduction  
Autophagy is a cellular process whereby elements within cytoplasm become 
engulfed within membrane vesicles and trafficked to fuse with lysosomes. This is a 
common cellular response to starvation, allowing non-essential cytoplasmic 
contents to be recycled in times of energy deprivation. However, autophagy also 
plays an important role in immunity and inflammation, where it promotes host 
defence and down-regulates inflammation. A specialised bacterial virulence 
mechanism, the type III secretion system (T3SS) in Pseudomonas aeruginosa (PA), 
an extracellular bacterium, is responsible for the activation of the inflammasome and 
IL-1β production, a key cytokine in host defence. The relationship between 
inflammasome activation and induction of autophagy is not clear.  
Hypothesis and aims 
The central hypothesis is that induction of autophagy occurs following PA 
infection and that this process will influence inflammasome activation in 
macrophages. 
Our aims were to determine the role of the T3SS in the induction of 
autophagy in macrophages following infection with PA, and to investigate the effects 
of autophagy on inflammasome activation and other pro-inflammatory pathways 
following infection with these bacteria.  
 
 
 
 
Materials and methods 
Primary mouse bone marrow macrophages BMDMs were infected with PA, in 
vitro. Induction of autophagy was determined using five different methods: - electron 
microscopy, immunostaining of the autophagocytic marker LC3, FACS, RT-PCR 
assays for autophagy genes, and post-translational conjugation of phosphatidyl-
ethanoloamine (PE) to LC3 using Western blot. Inflammasome activation was 
measured by secretion of active IL-1β and caspase-1 using ELISA and Western 
blot. Functional requirements of proteins were determined using knockout animals 
or SiRNA mediated knockdown. 
 
Result and Conclusions  
PA induced autophagy that was not dependent on a functional T3SS but was 
dependent on TLR4 and the signaling molecule TRIF. PA infection also strongly 
induced activation of the inflammasome which was absolutely dependent on a 
functional T3SS. We found that inhibition of inflammasome activation increased 
autophagy, suggesting that the inflammasome normally inhibits this process. Further 
experiments showed that this inhibitory effect was due to the proteolytic action of 
caspase-1 on the signaling molecule TRIF. Using a construct of TRIF with a 
mutation in the proteolytic cleavage site, prevented caspase-1 cleavage and 
increased autophagy. TRIF is also involved in the production of interferon-β 
following infection. We also found that caspase-1 cleavage of TRIF down-regulated 
this pathway as well. 
Caspase-1 mediated inhibition of TRIF-mediated signaling is a novel pathway 
in the inflammatory response to infection. It is potentially amenable to therapeutic 
intervention.  
Recognition of a pathogen infection is a key function of the innate immune 
system that allows an appropriate defensive response to be initiated. One of the 
most important innate immune defences is provided by a multi-subunit cytoplasmic 
platform termed the inflammasome that results in production of the cytokine IL-1β.  
The human pathogen Pseudomonas aeruginosa activates the inflammasome 
following infection in a process that is dependent on a specialized bacterial 
virulence apparatus, the type III secretory system (T3SS). Here, we report the novel 
finding that this infection results in mitochondrial damage and release of 
mitochondrial DNA into the cytoplasm. This initiates activation of an inflammasome 
based on the protein NLRC4. Autophagy induced during infection removes 
damaged mitochondria and acts to down-regulate NLRC4 activation following 
infection. Our results highlight a new pathway in innate immune activation following 
infection with a pathogenic bacterium that could be exploited to improve outcomes 
following infection.  
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1    Introduction 
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1.1 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a Gram negative pathogen which can 
cause opportunistic infections in the host. It belongs to the family of 
Pseudomonadacae. It is a common environmental organism, widely found 
in the soil and water. Pseudomonas aeruginosa can survive in many 
different types of environmental conditions and metabolise a wide range of 
carbon containing sources for its nutritional requirements. This bacterium 
can survive in high temperature even up to 42˚C (Berthelot et al., 2001).   
1.1.1 Pseudomonas aeruginosa infections  
P. aeruginosa  can cause serious  infections in the healthy tissues 
but it more  typically causes acute and chronic infections in almost any 
immuno-deficient individual where it takes advantage of a deficient host 
immune system, such as a breach in mucosal continuity or skin injury 
(Lyczak et al., 2000). P. aeruginosa can cause urinary tract infections, 
respiratory system infections, dermatitis, soft tissue infections and a variety 
of systemic infections in severely immuno- compromised patients. Patients 
with cystic fibrosis are particularly at risk, and virtually all affected patients 
develop chronic pseudomonal respiratory infections (Lyczak et al., 2000) 
(Gaspar et al., 2013).  
 
P. aeruginosa pneumonia is a very common cause of healthcare-
associated infections responsible for almost 10 % of all hospital acquired 
infection in the USA: this number is much higher in developing countries. 
The natural properties of this pathogen are suitable for an opportunistic and 
nosocomial infection (Weber et al., 2007), as it shows resistance to high 
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concentrations of salts, dyes, weak antiseptics and many antibiotics. It has 
been successfully isolated in the hospital environment from disinfectants, 
respiratory equipment, food, sinks, taps, toilets, showers and mops (Sadikot 
et al., 2005).   
 
 In general, P. aeruginosa is resistant to а wide range of common 
аntimicrobiаl аgents which makes its treatment often difficult. Resistаnce 
mаy or mаy not be plаsmid-mediаted but can be explained by the 
permeability barrier afforded by its Gram-negative outer membrane and its 
tendency to form a biofilm layer on colonized surfaces, which results in 
resistance to therapeutic concentration of antibiotics. Due to its natural 
habitat of soil it has developed resistance to naturally occurring antibiotic 
from bacilli, actinomycetes and molds. In addition it possess several 
multidrug efflux pumps which also contributes to the resistance (Yoshihara 
and Eda, 2007). P. аeruginosа can also undergo horizontal gene transfer 
such as transduction and conjugation which enables transfer of antibiotic 
resistance plasmids. The antibiotics still effective against P. аeruginosа 
include agents such as Imipenem, Gentаmicin, and Fluoroquinolones 
(Poole and McKay, 2003). 
1.1.2 Pseudomonas aeruginosa virulence factors  
P. аeruginosа produces severаl extrаcellulаr products thаt аfter 
colonizаtion cаn cаuse extensive tissue dаmаge, bloodstreаm invаsion, аnd 
disseminаted systematic disease. P. аeruginosа has a wide array of 
virulence factors, which results in a multifactorial pathogenesis where 
normal host defences are altered or circumvented. This wide array of 
virulence factors contribute to the ability of P. аeruginosа to cause such a 
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wide variety of diseases throughout the body. P. аeruginosа has several 
cell- associated and secreted proteins which contribute to its virulence. 
Examples are elastase A, phospholipase C and other effector proteins 
translocated via the type III secretory system (T3SS), and considered 
further below (Travassos et al., 2005). Some P. аeruginosа strains have a 
single polar flagellum, which contributes to the motility of the bacterium, but 
it is also an important virulence factor (Soscia et al., 2007). All P. 
аeruginosа strains have multiple pili structure belonging to the type IVa pilin 
class (Woods et al., 1980). P. аeruginosа  has two isoform of LPS , smooth 
and rough (Pier and Ames, 1984). In addition, P. аeruginosа  has a wide 
range of other virulence factors such as iron acquisition proteins (Poole and 
McKay, 2003). Invasion of tissues by P. аeruginosа  is dependent on 
production of extracellular enzymes and toxins such as LasA protease, 
protease IV, elastase and alkaline protease and pyocyanin (Bejarano et al., 
1989). P. аeruginosа also produces exotoxin A (Allured et al., 1986). P. 
аeruginosа also produce haemolycin, phospholipase C (PlcHR) and 
Rhamnolipid, which results in degradation of host cell phospholipids 
(Terada et al., 1999) . Some strains of P. аeruginosа produces alignate, a 
mucoid exopolysacchadide which contributes to biofilm formation (Lau et al., 
2004).   
1.1.3 Pseudomonas aeruginosa type III secretion system 
The type III secretion system (T3SS) is exclusive to Gram-negative 
bacteria and is structurally related to the flagellum (Desvaux et al., 2006). 
T3SS are essential for the pathogenicity of many Gram-negative bacteria. It 
allows the bacteria to inject protein effectors into the host cell in one single 
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step altering the function of the host cell and promoting survival of the 
bacteria (Salmond and Reeves, 1993). The T3SS of P. аeruginosа is similar 
to that found in Yersinia species at both a structural and functional level 
(Keizer et al., 2001). The P. аeruginosа T3SS is encoded by 36 genes 
found in five operons that are clustered together into the exoenzyme S 
regulon (Frank, 1997). This regulon is divided into 5 parts: needle complex, 
translocated secreted proteins, regulated proteins, chaperone proteins, and 
effector proteins (Fig. 1-1) (Hauser, 2009). The T3SS of P. аeruginosа has 
been shown to enhance disease severity in an acute pneumonia model 
(Lee et al., 2005), bacteremia (Vance et al., 2005), keratitis (Lee et al., 
2003), burn infections (Holder et al., 2001) and ventilator-associated 
pneumonia (Hauser et al., 2002).   
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Figure 1.1; Pseudomonas aeruginosa T3SS 
 The components of T3SS are: the needle complex (Yellow, Brown), translocation apparatus 
(Blue), the effector proteins (Green), chaperon (White), and regulatory proteins (not presented 
in this figure). PM, plasma membrane; OM, outer membrane; PGN, peptidoglycan layer; IM, 
inner membrane. T, ExoT; S,ExoS; Y,ExoY; U,ExoU.  Figure adapted from (Hauser, 2009)  
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1.2 Autophagy 
            Autophagy, derived from the Greek words meaning “self-eating” was 
coined by Christian De Dove in 1963 (Klionsky, 2008). He used it to 
describe what had been called ‘cytolysosomes’, structures related to 
lysosome that contained a variety of cytoplasmic contents, including 
mitochondria, ER membranes, and ribosomes in an apparent state of 
decomposition. The essentials of an autophagocytic vacuole are the 
presence of diverse cytoplasmic contents contained within a double 
membrane vacuole (Fig. 1-2). Autophagy is an essential homeostatic 
process and the only system for the degradation of large cellular 
components and aggregates which cannot be degraded by the ubiquitin- 
proteasome pathway. This important lysosomal degradation pathway is 
activated as one of the adaptive responses to starvation, and subsequent 
studies have shown that it is a process found in virtually all eukaryotic cells 
that is essential for survival. 34 autophagy related (ATG) genes have been 
identified in yeast, with their orthologous well conserved throughout 
eukaryotes (Heath and Xavier, 2009b). It is also a pathway used to degrade 
microorganisms i.e. viruses, bacteria and protozoa that invade intracellularly 
(Deretic and Levine, 2009), (Virgin and Levine, 2009), . A large number of 
studies have shown that the Atg genes play an important role, not just in the 
response to nutrient deprivation, but also in inflammatory diseases, 
neurodegenerative disorders and cancer (Heath and Xavier, 2009a).  
              Three different forms of autophagy have been described; 
macroautophagy, microautophagy and chaperone-mediated autophagy. 
Macroautophagy is the main pathway, which encloses cytoplasmic contents 
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in a double membrane structure,  after which it is combined with a lysosome 
(Cesen et al., 2012). In Microautophagy, a lysosome directly surrounds the 
degraded structures (Cesen et al., 2012). In the chaperone mediated 
autophagy (CMA), proteins with a KFERQ-like motif of Hsp70 chaperones 
are recognized and led to the lysosome, where they pass through the 
lysosomal membrane-associated protein 2 (LAMP-2A) into the lysosome 
and are degraded (Bandyopadhyay et al., 2008). 
1.2.1 Autophagy pathway                
1.2.1.1 Induction                  
 The molecular mechanisms of autophagy were first described in 
yeast cells; these seem well conserved throughout higher eukaryotes. 
Autophagy induced by nutrient starvation is mediated by a protein kinase 
called target of rapamycin (Tor). Tor is a negative regulator of autophagy 
with two main effects: firstly it controls both general transcription and 
translation machinery; secondly it specifically acts to produce 
hyperphosphoryation of the Atg13 protein which results in this protein 
having a much lower affinity for the Atg1 kinase that results in inhibition of 
autophagy. Rapamycin, through inhibiting Tor, relieves this inhibition and is 
thus a potent inducer of autophagy. 
The subsequent steps of the process can be broken down into 
selection of cargo and packaging, nucleation of the autophagocytic vesicle, 
expansion and closure of the vesicle, retrieval of targeting proteins, 
targeting, docking and fusion with lysosomes, and finally vesicle breakdown. 
This is an extremely complex series of processes with many proteins being 
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involved at each step. A large number of these proteins have homologues 
with very similar functions in higher eukaryotes. I will highlight here some of 
the more important proteins involved. Atg8 is an ubiquitin-like protein which 
has essential role in the formation of the autophagocytic vacuole. It 
undergoes a complex processing pathway analogous to the ubiquitin 
conjugation system pathway. This pathway transfer ubiquitin initially to an 
ubiquitin-activating enzyme (E1). In turn the ubiquitin is then transferred to 
an ubiquitin carrier enzyme (E2). Finally, the action of an ubiquitin ligase 
(E3) binds to the E2-ubiquitin complex and transfers the ubiquitin to its 
target. The mechanism is as follows: 
1. Initially the C terminus of Atg8 is proteolytically cleaved by the Atg4 to 
reveal a terminal glycine. 
           2. This glycine is conjugated to the E1-like enzyme Atg7. 
3. The Atg8 is then transferred from Atg7 and conjugated to the E2-like 
enzyme Atg3. 
4. A complex of covalently joined Atg5-Atg12 together with Atg16 acts as an 
E3-like ligase, covalently linking the Atg8 to the lipid 
phosphatidylethanolamine. 
This lipid modification targets the Atg8 molecule to the 
autophagocytic vacuole membrane. Importantly, Atg8 is not retrieved from 
the membrane. Thus, the detection of lipid-modified Atg8 and its localization 
to the autophagocytic membrane are very useful markers of the 
autophagocytic process. Importantly, the proteins involved in this lipid 
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modification are highly conserved in higher eukaryotes. In mammals, the 
Atg8 gene family has expanded into three sub-families (Slobodkin and 
Elazar, 2013), of which microtubule-associated protein light chain 3 
(MAPLC3) is the functional analogue of Atg8 in yeast. Specifically, MAPLC3 
B (usually abbreviated LC3B) shows the closest functional relationship to 
yeast Atg8 and is a reliable marker of autophagosome in mammalian cells 
when lipidated. Levels of the Atg8 mRNA and protein are usually markedly 
upregulated in yeast following induction of autophagy (Kirisako et al., 1999). 
Mammalian LC3B also show transcriptional and translational upregulation 
following induction of autophagy (Polager et al., 2008).     
1.2.1.2 Autophagosome formation  
             There are several potential interconnections between the protein 
complexes involved in autophagosomal membrane formation which could 
be a potential source for membrane formation (Behrends et al., 2010). 
According to some studies membranes of mitochondria, ER, plasma 
membrane and the nuclear membrane could be sources for 
autophagosome membrane formation (Hailey et al., 2010, Ravikumar et al., 
2010) but the absence of specific protein markers for these structures on 
the autophagosomal membrane does not agree with the assumption that 
these membrane could be the source of autophagosome membrane. 
1.2.1.3 Docking and fusion with the lysosome  
      The mechanism of closure of the autophagosome and fusion with 
the lysosome  are  not as clear as the mechanisms of the early stages of 
autophagosome formation (Noda et al., 2009). As LC3 does not dissociate 
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from the autophagosome like the Atg16 complex, it may play an important 
role in the closure of autophagosome (Fujita et al., 2008). After closure,  the 
autophagosome is trafficked  to the peri-nuclear region of the cell for fusion 
with lysosomes with the help of microtubules and dynein (Kimura et al., 
2008). Upon closure, the Atg16 complex rapidly dissociates from the 
autophagosome while the modified LC3 remains attached. Dynein may be 
recruited to the phagosome through an interaction with LC3 after the 
dissociation of the Atg16 complex (Noda et al., 2009). The final step is 
maturation of the autophagosome in which there is fusion of the outer 
autophagic membrane with the lysosomal membrane resulting in the 
formation of the autolysosome (Fig. 1-2).   
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Figure 1.2; Autophagy pathway. 
 Schematic representation of Autophagy pathway steps; Induction, Autophagosome 
formation, Autophagosome fusion, and Autophagosome breakdown.   
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1.2.2 Mitophagy   
The autophagocytic process may also target specific organelles 
within the cell. One important organelle targeted in this fashion is the 
mitochondria, which I explore in some detail in the experimental work 
carried out in this thesis; this process is termed mitophagy (Kim et al., 2007). 
Mitochondria are removed by this process in cells such as reticulocytes as 
part of a developmental program (Zhang et al., 2009). However, 
mitochondria are also removed as part of a quality control process when 
they become depolarized (Wu et al., 2009). This process has increasingly 
been recognized as important in the pathophysiology of a number of 
important disease states. Genetic studies of familial forms of Parkinson’s 
diseases revealed two genes linked to the development of disease termed 
Parkin and PINK1. The protein products of these genes are now 
understood to be on the same pathway and linked to the mechanism 
whereby defective mitochondria are removed by mitophagy (Jin and Youle, 
2012). PINK1 has a mitochondrial-targeting signal that results in the protein 
being located within the inner mitochondrial membrane. Here it is 
processed from its full length 64 kDs form to a truncated 52 kDs fragment. 
This shorter PINK1 fragment is then degraded by a protease, keeping 
steady state levels of PINK1 low. However, on mitochondrial damage and 
depolarization, the import and processing of PINK1 are inhibited, leading to 
an accumulation of mature full-length PINK1 in the outer mitochondrial 
membrane. This then acts to recruit Parkin to the damaged mitochondrion. 
Parkin is an E3 ubiquitin ligase, producing ubiquitinylation of numerous 
mitochondrial proteins that lead to the initiation of mitophagy. The 
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accumulation of defective mitochondria in patients with mutations in parkin 
is thought to underlie the onset Parkinson’s diseases in these families.  
More recent work has linked mitochondrial damage to the activation 
of the inflammasome, and this is considered in more detail below. 
1.2.3 Role of autophagy in host defence 
              Autophаgy pаrticipаtes in neаrly аll аspects of immunity, аffecting 
both innаte аnd аdаptive immunity processes (Deretic, 2011) (Fig. 1-3).   	  	  
The autophagy pathway and autophagy proteins play a major part in 
controlling immunity in multicellular organisms. This has possibly evolved as 
a stress response to allow eukaryotic organisms to survive in unfavourable 
conditions,  probably by regulating energy homeostasis and quality control 
of proteins and organelles (Kroemer et al., 2010). There are direct 
interactions between autophagy proteins and immune signalling molecules 
(Saitoh and Akira, 2010).   
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Figure 1.3; Autophagy in immunity. 
 Schematic representation role of autophagy in immunity. Figure adapted from (Deretic, 2011) 
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The role of autophagy proteins in adaptive immunity, includes the 
development and homeostasis of the immune system and in antigen 
presentation. The knockout of different autophagy genes in specific 
lymphocyte populations in mice has shown a crucial role for autophagy 
proteins in the maintenance of a number of cell lineages of importance in 
the immune response, including B1a B cells, CD4+ T cells, CD8+ T cells 
and fetal haematopoietic stem cells  (Heath and Xavier, 2009b). In T cells, 
in which mitochondrial numbers are developmentally regulated during the 
transition from thymocyte to mature circulating T cell, the developmental 
defect in autophagy-deficient cells may be related to the defective 
clearance of mitochondria (Noda et al., 2009). Autophagy plays a role  in 
the elimination of autoreactive T cells in the thymus (Noda et al., 2009). 
Within thymic epithelial cells, in which autophagy participates in the delivery 
of self-antigens to MHC class II loading compartments. This is important as   
genetic disruption of Atg5 in thymic epithelial cells leads to the altered 
selection of certain MHC class II restricted T-cell specificities and 
autoimmunity (Meissner et al., 2010).  
Initially, autophagy was considered as a non-selective bulk 
degradation process, but now it has become quite clear that this process 
can degrade substrates in a selective manner as well (Kraft et al., 2010). 
For example, intracellular pathogens can be degraded by autophagy, a 
process called xenophagy. The precise mechanism of xenophagy and its 
membrane dynamics is still not clearly understood. The vacuoles of 
engulfed bacteria are similar to the autophagosomes and their formation 
requires the core autophagy machinery. The diameter of  the vacuoles 
containing bacteria are typically bigger than the autophagosomes which are 
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generated by the RAB7 dependent fusion of small isolation membranes 
(Yamaguchi et al., 2009). There are four pathways assumed to be used for 
ATG protein dependent targeting of bacteria to the lysosome(Levine et al., 
2011): 
1. Autophagy proteins may induce bacteria- containing phagosomes to fuse 
with lysosomes for degradation. 
2. Autophagosomal membranes may engulf bacterial 
phagosomes/endosomes.  
3. Fusion of bacteria containing phagosomes/ endosomes with 
autophagosomes, or 
4. Xenophobic capture of bacteria that are within the cytoplasm, but the 
precise route for several bacteria is still unclear. 
              A microbial sensor SLAM, the self-ligand and cell-surface receptor, 
recruits complex of beclin-1 class-III PI(3)K kinase to the bacteria 
containing phagosome. This facilitates phago-lysosomal fusion and 
activation of NADPH oxidase (NOX2) complex (Berger et al., 2010). In 
addition the engagement of TLR or Fcγ receptors during phagocytosis 
recruits LC3 to the phagosome through NOX2-dependent generation of 
reactive oxygen species (Huang et al., 2009a). In bacterial infections, this 
process may thus contribute to removal of intracellular bacteria. Impaired 
recruitment of autophagy proteins to the phagosome may contribute to the 
pathogenesis of chronic granulomatous disease, a genetic disorder caused 
by mutations in the NOX2 (CYBB) gene and characterized by recurrent 
bacterial and fungal infections and inflammatory complications. 
Autophagy proteins can also destroy pathogens independent of 
triggering autophagy, as seen in interferon-γ (IFN-γ) treated macrophages 
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infected with the parasite Toxoplasma gondii. A parasite derived 
membranous vacuole undergoes destruction through a mechanism that 
involves ATG5 dependent recruitment of the immunity-related GTPase 
proteins to the parasitophorous vacuole leading to parasite death inside the 
infected cell (Zhao et al., 2008, Zhao et al., 2009). The mechanisms that 
cells use to target intracellular bacteria to autophagosomal compartments 
are similar to the selective autophagy of endogenous cargo. Cellular cargo 
is commonly targeted to autophagosomes by interactions between a 
molecular tag and LC3 in the autophagosome membrane. Examples of 
such molecules are the polyubiquitin adaptor proteins i.e. p62 (SQSTM1 or 
sequestome-1) and NBR1 (which recognize these tags and contain an LC3-
interacting region (LIR) characterized by a WXXL or WXXI motif) (Kraft et 
al., 2010). After escape into the cytoplasm or in vacuolar membrane 
compartments damaged by type-III secretion system (T3SS) effectors, 
bacteria-containing compartments may become coated with ubiquitin and 
associate with p62 and nascent LC3-positive isolation membranes. 
Salmonella targeting also requires a cellular factor, NDP52 (nuclear dot 
protein-52), an autophagy adaptor protein that, like p62, contains an LIR 
and ubiquitin-binding domains restricting intracellular bacterial replication 
(Shahnazari et al., 2010) . 
These different molecular strategies may be used to target microbes 
inside the cytoplasm to the autophagosome, which will facilitate their 
destruction following fusion with lysosomes. In addation, autophagic 
targeting of pathogen-damaged membranes could help to control 
detrimental downstream inflammatory signalling during bacterial invasion in 
to host cell.  
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1.3 Inflammation  
Inflammation is а localized nonspecific response of the body to injury. 
It is characterized by five cardinal signs which are pain, redness, heаt, 
swelling, and loss of function. These signs reflect increased blood flow, 
elevated cellular metabolism, vasodilation, release of soluble mediators, 
extravasation of fluids and cellular influx. Inflammation usually is a self-
limiting process that protects the host аgаinst а variety of invading 
pathogens or injury. Inflammation can occur and dissipаte over а short time 
frame (аcute inflаmmаtion) or cаn persist for а much longer periods 
(chronic inflаmmаtion) (Ferrero-Miliani et al., 2007). Inflammation utilizes a 
great amount of metabolic energy and can result in damage and destruction 
of the tissue. Therefore, controls over the termination of inflammation are 
required, to limit any possible damage caused (Barton, 2008).  
1.3.1 Innate immune response 
Immunity is defined as the body’s resistance against infectious 
agents. There are two types of immunity: innate (natural) and acquired. 
Innate immunity is the type of immunity which is genetically pre-
programmed and is not specific to a particular pathogen. As a result, it is 
able to recognize diverse microorganisms such as bacteria, viruses, and 
fungi. Pattern recognition receptors (PRRs) allow the innate immune system 
to recognise specific molecular feature of microbes. Recognition of these 
lead to activation of various inflammatory pathway that contribute to host 
defence. Increasingly, it has been realized that PRRs not only recognize 
invading pathogens but also the damage they cause.  . 
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 PRRs are expressed by several cell types such as monocytes, 
macrophages, dendritic cells (DCs), neutrophils and epithelial cells 
(Martinon et al., 2009). PRRs include: soluble pentaxin receptors, 
membrane –bound receptors: Toll like receptors (TLRs) (Akira et al., 2006) 
C-type lectin receptors (CLRs) (Brown, 2006), as well as cytosolic Nod-like 
receptors (NLRs) (Martinon et al., 2009), RIG-like helicase, RLRs (Nakhaei 
et al., 2009) and DNA sensors (Hornung et al., 2009) (Fig. 1-4).   
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Figure 1.4; Structure of different PRRs 
 Schematic representation of PRRs. Abbreviation; TLR; Toll-like receptor, CLR; C-type lectin 
receptor, RLR; RIG-1-like receptor; NLR; NOD-like receptor, NLRP and NLRC; major 
subfamilies in NLR-protein family, Aim2; absence in melanoma 2 (DNA sensor), LRR; 
leucine-richrepeats, TIR;Toll-interleukin-1 receptor interacting domain, ITAM; immunoreceptor 
tyrosine-based activationmotif, NAD; NACHT associated domain, NACHT; nucleotide binding 
and oligomerization domain, PYD; pyrin domain, CARD; Caspase recruitment domain and 
HIN200, HIN200 domain.  Figure adapted from (Bryant and Fitzgerald, 2009).   
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1.3.2 Inflammasome  
 The inflammasome is a multi-protein complex that leads to activation 
of the 17KDa pro-inflammatory cytokine IL-1β, from its 31kDa precursor, 
pro-IL-1β, via caspase 1. This process also leads to activation of the IL-1 
family member IL-18. (Ghayur et al., 1997) IL-33 is another IL-1 family 
member, but it is not clear if caspase-1 is necessary for its activation in vivo 
(Carriere et al., 2007), although activation via caspase-1 has been 
demonstrated in vitro (Schmitz et al., 2005). Activation of the inflammasome 
is also associated with the onset of a form of cell death termed pyroptosis 
(Fernandes-Alnemri et al., 2007). The name inflammasome comes from the 
word inflammation, which reflects the function of the complex, and ˮsomeˮ, 
which is from the Greek word for body, soma. The name also reflects 
similarities with the apoptosome, which triggers apoptosis (Zou et al., 1999). 
The production of IL-1β and IL-18 by the inflammasome is one of the first 
lines of defence аgаinst tissue dаmаge аnd pаthogen invаsion.  
1.3.2.1 IL-1β and IL-18  
Interleukin-1β (IL-1β) аlso known аs cаtаbolin, is а member of the 
interleukin 1 cytokine fаmily of ligands, which include, IL-1α, IL-18 and IL-
33(Dinarello, 2009). IL-1β is related to IL-18 and IL-33 and all of these 
cytokines result in the intiation of a Myd88-depending signaling pathway, 
similar to the pathway intiated by TLR4 signalling. Inflammasome activation 
therefore leads to the activation of a TLR-like receptor such as IL-1R and 
IL-18R. IL-1β is а pleiotropic cytokine. It is involved in the inflаmmаtory 
response, cell growth, аnd tissue repair in the cortex. It is a proinflammatory 
cytokine, which plays an important role as a mediator of inflammation 
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(Dinarello, 2009). It is produced by blood monocytes but also by 
macrophage, dendritic cells and a variety of other cells in the body (Ferrero-
Miliani et al., 2007). IL-1β participates in the generation of systemic and 
local responses to infection and injury by generating fever, activating 
lymphocytes and by promoting leukocyte infiltration at sites of infection or 
injury.  IL-18 induces IFN-γ production and contributes to T-helper 1 (Th1) 
cell polarization.  IL-1β is believed to be the major mediator of inflammation 
in the periodic fever syndromes caused by mutations in the NLRP family 
genes. It has been shown that treatment of the patients with an inhibitor of 
IL-1(IL-1Ra) can improve their symptoms (Hawkins et al., 2003). IL-1Ra has 
also been shown to help patients with rheumatoid arthritis (Dinarello, 2009). 
 The inflаmmаsome is аble of recognizing a diverse range of threats, 
both from endogenous and exogenous sources. Endogenous signals that 
are known to аctivаte the inflаmmаsome include uric аcid, ATP, potassium 
efflux (Kahlenberg and Dubyak, 2004)  from the cell and a newly identified 
endogenous peptide, аcALY18. External stressors include pаthogen-
аssociаted moleculаr pаtterns derived from а diverse range of conserved 
moleculаr motifs that are unique to bacteria, viruses and pаrаsites, from 
exogenous chemicals or ultrаviolet light. The mechаnism by which these 
signals are detected has yet to be fully elucidаted for the mаjority of 
inflаmmаsomes.  
The core structure of all inflammasomes is of course caspase-1, 
variety of other proteins co-assemble with procaspase-1 to bring about its 
activation. Many, but not at all inflammasomes, have a member of the 
neucleotide-binding domin and leucine-rich repeat containing (NLR) gene 
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family (Ting et al., 2008). Protiens encoded by this gene family have a 
tripartite domain structure: a central nucleotide-binding oligomerization 
domain; a C terminal leucine-rich repeat containing domain; and an N 
terminal domain from four recognizable families. These N terminal domains 
are used to classify the NLR proteins into subfamilies, denoted by a letter 
appended to the NLR designation: an acidic transactivation domain (A); a 
pyrin domain (P); a caspase recruitment domain (CARD) (C); and a 
baculoviral inhibitory repeat-like (BIR) domain (B). Finally, for NLR proteins 
with an N terminal domain that has no recognizable homology to other NLR 
family members are denoted by appending X. Different members of the 
subfamilies are denoted by sequential numbers. More recently, 
inflammasome without a member of the NLR family have been recognized 
and these are considered further below.  
Another protein of central importance in controlling Inflammasome 
activation is apoptosis speck-like protein containing a caspase activation 
and recruitment domain (ASC),  which contains PYRIN domains but lacks a 
CARD domain. It also plays an important role in inflammasomes containing 
an NLR protein with CARD domains (Broz et al., 2010). Only one ASC 
speck is formed in a cell following infection (Huang et al., 2009b)  
Thus, the inflammasome contains a variety of proteins that following 
activation results in the recruitment of pro-caspase-1 in to the complex that 
is then proteolytically processed to active caspase-1 via an auto-catalytic 
pathway. Once caspase-1 is activated, it is then able to cleave and active a 
number of key pro-inflammatory cytokines, such as pro-IL-1β and pro-IL-18  
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(Fig. 1-5). In general, pro-IL-1β is present at very low level in resting 
cells, and requires activation of its gene to produce protein expression. This 
is typically achieved by inflammatory signalling through Toll-like receptor or 
other innate immune signalling pathways. Conversely, pro-IL-18 is present 
in resting cells and an induction stimulus is not required. 
  
Figure 1.5; Caspase-1 activation . 
Schematic representation of the activation of the inflammasome complex by a wide range of 
stimuli.  Figure adapted from (Evans, 2009).   
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A number of inflammasome complexes have been identified, of 
which we will consider four in more details; NLRP1, NLRP3, NLRC4 and 
Aim2. In addition, several NLRP proteins might be involved as scaffolding 
proteins of the inflammasome complex (Martinon et al., 2007) (Fig.1-6). 
  
Figure 1.6; The inflammasome structure. 
 The inflammasomes are assembled by self-oligomerizing proteins. The NLRP3 
inflammasome consists of NLRP3, ASC and caspase-1. NLRC4 directly binds with 
procaspase-1 but NLRC4 activation may require ASC. The AIM2 inflammasome is composed 
of AIM2, ASC and caspase-1. The PYD domain of AIM2 interacts with PYD of ASC through 
homotypic PYD-PYD interaction, so that the ASC CARD domain can recruit procaspase to 
the compex. Figure adapted from (Eitel et al., 2010) .   
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1.3.2.2 NLRP1 
The first inflammasome identified was the NLRP1 inflammasome by 
(Martinon et al., 2002). The NLRP1 inflammasome has been shown to be 
activated following exposure to anthrax lethal toxin. Anthrax is caused by 
Bacillus anthracis through the action of its secreted toxins. One of these 
toxins is anthrax lethal toxin. It has been shown that a polymorphism in the 
NLRP1 gene results in impaired caspase-1 activation (Boyden and Dietrich, 
2006). The proteolytic activity of LeTx appears to be responsible for NLRP1 
activation by causing cleavage of NLRP1B; this was sufficient for activation 
(Chavarria-Smith and Vance, 2013). NLRP1 is also activated following 
exposure to muramyl dipeptide (MDP) moiety of peptidoglycans (Faustin et 
al., 2007) . 
1.3.2.3 NLRP3 
The NLRP3 inflammasome consists of the NLR protein, NLRP3 the 
ASC adaptor, and caspase-1. The NLRP3 inflammasome is triggered upon 
exposure to pathogens, as well as numbers of structurally diverse and 
environmental irritants (Gross et al., 2011).  
NLRP3 is the best studied of all inflammasomes but it still remains 
unclear how such a wide array of stimuli elicit a response from a single 
sensor (Gross et al., 2011). One feature that many NLRP3 activators share 
is the ability to cause loss of intracellular potassium, first describe by Petrili 
(Petrilli et al., 2007). The activation of the NLRP3 inflammasome by 
reduction in intracellular potassium provided an explanation as to how so 
many different stimuli could all lead to NLRP3 activation. Thus, extracellular 
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ATP acts on the P2X7 receptor which acts as an ATP-gated potassium 
channel (Di Virgilio, 2007), while lytic toxins such as pneumolycin also 
cause potassium efflux from cells by forming non-selective pores in the cell 
membrane (Witzenrath et al., 2011). 
However, other intermediates also play a role in NLRP3 activation. 
Production of reactive oxygen species (ROS) is important (Cruz et al., 
2007). Although ROS production is often associated with a drop in 
intracellular potassium concentration, the exact relationship between ROS 
production and reduction in intracellular potassium remains unclear.  
Another report suggests that crystals formed within lysosomes cause 
disruptions and a release of active cathepsin-B which may act as an 
upstream activator of NLRP3 (Hornung et al., 2008). Once activated, 
NLRP3 interacts with ASC and procaspase-1 enzymes (Agostini et al., 2004) 
to cause the cleavage and activation of Caspase-1, which in turn cleaves 
and activates IL-1β and IL-18 cytokines.  
Recently, an important role for mitochondria in NLRP3 activation has 
been suggested (Zhou et al., 2011) . That ROS from damaged mitochondria 
activated NLRP3 also linked with earlier work showing that autophagy 
down-regulated NLRP3 activation (Saitoh et al., 2008a). Selective 
mitophagy of damaged mitochondria would thus act to down-regulate 
NLRP3 activation. Several papers suggest that mitochondria are the main 
source of ROS and oxidized DNA necessary to activate NLRP3 (Nakahira 
et al., 2011, Shimada et al., 2012) while others suggest that ROS 
production is sufficient to prime the NLRP3 response but not activate it 
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(Bauernfeind et al., 2011). Intriguingly, the studies of Nakahira et al and 
Shimada et al suggested it was the release of DNA from damaged 
mitochondria that was responsible for NLRP3 activation. Oxidation of this 
DNA was thought to potentiate its NLRP3 activating ability (Shimada et al., 
2012). However, this remains controversial since another study found no 
role for mitochondrial damage in NLRP3 activation, just loss of intracellular 
potassium (Munoz-Planillo et al., 2013). 
A number of accessory proteins are known to modify NLRP3 
activation (Latz et al., 2013). The role of these protiens is in many cases not 
entirely clear. For example, Guanylate binding protein 5 (GBP5) has been 
found to promote NLRP3 activation (Shenoy et al., 2012); however, GBP5 
seems to have no involvement in mitochondrial recruitment or other stimuli 
thought to active NLRP3. 
 Although the basic mechanisms of the NLRP3 inflammasome 
activation is remain unclear, its role within signalling in disease is better 
appreciated. Several autoimmune conditions are brought about by 
mutations which cause a gain of function which can be ameliorated by the 
neutralisation of IL-1β (Goldbach-Mansky and Kastner, 2009). Furthermore 
the NLRP3 inflammasome has been linked to the production of excess 
inflammation in response to host cell damage in the absence of infection 
(Duewell et al., 2010). Such cases are thought to increase the severity of 
tissue damage in sterile injury.  
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1.3.2.4 NLRC4   
In contrast to NLRP3, the inflammasome based on the NLR protein 
NLRC4 has been shown to respond to bacterial derived products delivered 
via secretion systems.  Activation of the NLRC4 inflammasome has been 
shown to be important in host defence for a number of pathogens. The first 
pathogen described to active the inflammasome in a NLRC4-dependent 
manner was Salmonella typhimurium (Mariathasan et al., 2004). Despite 
this NLRC4-dificient mice did not have enhanced susceptibility to infection 
with Salmonella typhimurium but caspase-1 deficient mice did (Lara-Tejero 
et al., 2006). This indicates that additional pathways are involved in the 
caspase-1 activation by Salmonella. L.pneumophila also activates the 
inflammasome in a NLRC4-dependent manner (Zamboni et al., 2006). 
Pseudomonas aeruginosa has been shown to active the inflammasome in a 
NLRC4-dependent manner. Additionally it has been shown that NLRC4-
deficient mice are more susceptible to infection by Pseudomonas 
aeruginosa in a pulmonary and peritoneal in vivo infection model (Franchi et 
al., 2007) (Sutterwala et al., 2007). However, another study found that 
activation of the NLRC4 inflammasome increases bacterial burden in a 
model of P. aeruginosa pneumonia (Cohen and Prince, 2013). NLRC4 
inflammasome activation is critical in host defence against Klebsiella 
pneumonia (Cai et al., 2012). 
In contrast to the NLRP3 inflammasome, the molecular mechanisms 
underlying NLRC4 activation are much better understood. Specific bacterial 
ligands are known to trigger the activation. The first of these to be described 
was bacterial flagellin (Miao et al., 2006, Franchi et al., 2006, Amer et al., 
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2006). The flagellin was introduced into the cell via a type III or type IV 
secretory system. 
However, certain aspects of this activation were not easily explained. 
Flagellin deficient mutants of P. aeruginosa were efficient activators of the 
NLRC4 inflammasome (Sutterwala et al., 2007, Arlehamn et al., 2010). 
Additionally, no direct interaction between NLRC4 and flagellin had been 
demonstrated. Further work has clarified the nature of the activation of 
NLRC4 by flagellin. Additonal proteins belonging to the NLR apoptosis-
inhibitory protein (NAIP) family, specifically NAIP5, has been shown to 
sense flagellin directly and to activate NLRC4 (Lightfield et al., 2008, 
Kofoed and Vance, 2011). Morever, further work identified a conserved 
protein called PrgJ in Salmonella spp. That is part of the T3SS rod 
apparatus as an additional activator of the NLRC4 inflammasome (Miao et 
al., 2010). This activation also required a NAIP family member, in this case 
NAIP2 (Zhao et al., 2011). More recently, it has been proposed that multiple 
needle proteins of the T3SS can also activate the NLRC4 inflammasome, 
requiring NAIP1 as an accessory protein (Yang et al., 2013). 
Additional signals also regulate NLRC4 activation. Phosphorylation 
of NLRC4 has been shown to be essential for its activation (Qu et al., 2012). 
How this relates to the interactions between bacterial proteins and NAIP 
family members is not clear.   
1.3.2.5 AIM2  
Aim2 is a member of the pyrin and HIN domain-containing protein 
(PYHIN) family. Double- stranded DNA triggers Aim2 oligomerization, which 
results in Aim2 inflammasome formation together with ASC and caspase-
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1(Fernandes-Alnemri et al., 2009).  Aim2 was recently identified as the key 
sensor for cytoplasmic dsDNA (Burckstummer et al., 2009) (Hornung et al., 
2009). Not surprisingly, Aim2 plays an important role in host defence 
against viruses such as CMV and vaccinia (Rathinam et al., 2010). 
However, it is also important in defence against a range of bacterial 
pathogens, including Francisella tularensis, Listeria monocytogenes, and 
Legionella pneumophila (Rathinam et al., 2010) (Kim et al., 2010) (Ge et al., 
2012). Release of bacterial DNA into the cytoplasm during infection would 
appear to be the trigger in these infections. Aim2 is also recently reported to 
be important in inflammasome activation during infection with Streptococcus 
pneumonia (Fang et al., 2014). 
1.3.2.6  Caspase-11  
Genetically engineerd mice lacking Caspase-1 have been widely 
used to determine the role that this protein plays in infection and immunity. 
However, the mouse strain in which the Caspase-1 gene was detected 
were generated using 129 ES cells which harbour a 5 bp detection 
encompassing the Cap11 exon 7 splice acceptor junction (Kayagaki et al., 
2011). Consequently, these mice have a non-functional Caspase-11 gene 
and do not produce functional Caspase-11. Caspase-1 and Caspase-11 are 
tightly linked, hence separation of the alleles by backcrossing is very rare 
and thus the Casp1 knockout mice are also Casp11 null as well. This led to 
a re-evaluation of the relative roles in of Caspase-1 and Caspase-11 in 
inflammasome function. Caspase-11 has been shown to be important in 
host defence against Salmonella typhimurium (Broz et al., 2012) and a 
33 
 
variety of Gram-negative and other bacteria that escape into the host 
cytosol (Rathinam et al., 2012) (Aachoui et al., 2013).       
1.3.3 Role of Autophagy in inflammatory and autoimmune diseases 
There are clear links between the genes controlling autophagy and 
control of immune response. For example, a study by (Barrett et al., 2008), 
identified a number of genes involved in the pathogenesis of  Crohn’s 
disease, that induced genes involved in the autophagy pathway such as 
ATG16L1  also described by (Saitoh et al., 2008a). Dendritic cells from 
patients with the Crohn’s disease associated ATG16L1 mutation (T300A) 
risk variant are defective in presenting bacterial antigen to CD4+ T cells 
(Cooney et al., 2010). However, it is not yet known how the T300A mutation 
affects the function of the mammalian ATG16L1 protein. This mutation 
resides in the carboxy-terminal WD-repeat domain that is absent in yeast 
Atg16 and is dispensable for autophagy. It remains controversial whether 
the increased risk versus protective alleles of ATG16L1 has differences in 
stability or antibacterial autophagic activity (Fujita et al., 2009).  
The study of (Saitoh et al., 2008a), shows that loss of Atg16L1 
function in mice results in enhanced TLR agonist induced pro-inflammatory 
cytokine production by macrophages. Other studies also suggest that 
changes in the autophagy pathway may also result in inflammatory 
autoimmune disease. Genome-wide association studies have linked several 
single nucleotide polymorphisms (SNPs) in ATG5 to SLE susceptibility (Han 
et al., 2009) . Atg5 has an important role in negative selection in the thymus 
during T cell development: this may underline the autoimmunity and multi-
organ inflammation in mice lacking Atg5 (Nedjic et al., 2008). 
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1.4 Reciprocal Interaction between inflammasome activation and 
autophagy   
Several studies have now shown strong cross-talk between 
autophagocytic pathways and inflammasome activation. Studies reveal that 
treatment with LPS, a potent TLR4 agonist, is not sufficient to induce 
inflammasome activation in wild type macrophages. However, Atg16L1-/- 
and Atg7-/- macrophages which lack specific autophagy receptors can 
undergo LPS-dependent inflammasome activation, implying that in wild type 
macrophages autophagy normally counters this activation with LPS (Saitoh 
et al., 2008b).  Although the specific mechanisms  were not identified in this 
study, LPS-dependent inflammasome activation in Atg16L1 knockout 
animals is dependent on K+ efflux and generation of reactive oxygen 
species, which suggests the involvement of NLRP3. It has been suggested 
that autophagosomes may target the inflammasome for degradation (Harris 
et al., 2011). However, given the dependency of NLRP3 activation on ROS 
generation and the suppressive effect ROS blockade has on NLRP3 
activation (Saitoh et al., 2008b, Bensaad et al., 2009, Dupont et al., 2009) 
an inhibition of the inflammasome through indirect suppression of ROS 
generation cannot be ruled out. Furthermore, autophagy appears to 
downregulate pyroptosis (Suzuki and Nunez, 2008)  and ROS derived from 
both NADPH oxidases and the mitochondrial electron transport chain up-
regulate autophagocytosis (Chen et al., 2009, Huang et al., 2009a). 
Therefore, the regulation of autophagy through ROS may represent a 
negative feedback system which acts to limit ROS modulated caspase-1 
activation while also removing organelles which have been damages by 
ROS. Another report by Suzuki et al. (2007) which implicates that the 
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inflammasome down-regulates autophagy further complicates the situation. 
This study found that Caspase-1 deficiency increases autophagy in cells 
infected with S. flexneri, an IPAF agonist. There is a considerable need for 
further research in order to fully understand the complexity of this 
relationship.    
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1.5 Hypothesis and aims  
Autophagy not only degrades unwanted organelles, but also helps in 
controlling immunity and inflammation. As outlined above, there is 
considerable evidence showing that autophagy can downregulate NLRP3 
inflammasome activation. This is little current information regarding any 
possible involvement of autophagy in controlling inflammasome activation 
by NLRC4.  Moreover, there are no studies that have addressed the 
possible influence of inflammasome activation on autophagy. The 
specialised bacterial virulence mechanism, the Type III secretion system 
(T3SS) is able to activate the inflammasome producing IL-1β production. 
The relationship between this process and induction of autophagy is not 
clear. 
The central hypothesis underlying this study is that induction of 
autophagy by infection will inhibit NLRC4 inflammasome activation in 
macrophages, limiting the inflammatory response and promoting cell 
survival. We also propose that other pro-inflammatory pathways will be 
similarly down-regulated. We studied the microbe Pseudomonas 
aeruginosa an extra-cellular bacterium which possesses a T3SS that can 
activate the inflammasome. Our aims are: 
1. To determine the role of the T3SS in the induction of autophagy within 
macrophages following infection. 
2. To investigate the effects of autophagy on activation of the NLRC4 
inflammasome by these bacteria. 
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3. To investigate the effects of autophagy on the activation of other pro-
inflammatory pathways following infection with these bacteria.  
4. To investigate the effects of inflammasome activation on the induction 
and progression of autophagy. 
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2    Materials and methods  
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2.1 Tissue culture  
2.1.1  Cell line 
2.1.1.1  THP-1 cells        
THP-1 cells are a human monocytic cell line (gift of Dr. Damo Xu, 
University of Glasgow). Cells are derived from an acute monocytic leukemic 
patient. Cells were grown in RPMI-1640 media (Sigma. Cat.No.R8758, USA) 
supplemented with 2mM L-glutamine (Invitrogen. Cat.No.25030, USA), 10% 
heat inactivated fetal calf serum (Invitrogen. Cat. No.15561020, USA), 100 
µg/ml Streptomycin, 100 IU/ml Penicillin (Sigma. Cat. No. P0781 UAS), and 
1 mM Hepes solution (Sigma. Cat. No. H0887, USA). To maintain cell 
culture, cells were split at approximately 85% confluence. 2hr before 
infection cells were washed twice with sterile PBS (Invitrogen. 
Cat.No.14190-094, USA) and complete media without Penicillin and 
Streptomycin was added. 
2.1.1.2  J774A.1 cells   
The murine macrophage cell line J774A.1 was grown in RPMI -1640 
medium as described for THP-1 cells. Cell culture was maintained at 37˚C 
in 5% CO2. Cell were cultured at a concentration 1×106cell/ml. 24 hr before 
infection, cells were seeded in complete RPMI-1640 media in 6, and 12 well 
tissue culture plates ( Costar. Cat.No.3513, USA). 2hr before infection cells 
were washed twice with sterile PBS and complete media without Penicillin 
and Streptomycin was added.  
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2.1.1.3 RAW264.7 cells    
The murine macrophage cell line RAW264.7 was grown as 
described for THP-1 cells.   
2.1.1.4 L929 cells    
The murine cell line L929 produce M-CSF in cell culture. They were 
cultured in RPMI-1640 media supplemented with 2mM L-glutamine, 10% 
heat inactivated fetal calf serum, 100 µg/ml Streptomycin, 100 IU/ml 
Penicillin. When cells were around 85% confluent they were treated with 
0.05% Trypsin with EDTA (Sigma. Cat.No.T3924, USA) to cover the cells. 
The culture flask was incubated for 5-10 min at 37˚C until cells had 
detached. Complete RPMI-1640 media was added to stop the Trypsin. 
Cells were resuspended in fresh media. When culturing to obtain M-CSF, 
cells were split in to large tissue culture flask (Corning. Cat.No.430824, 
USA) and cultured for 7 days following full confluency. Cells supernatant 
was taken off, sterile filtered and then stored at -20˚C until used for culturing 
of BMDMs.  
2.1.1.5 HEK 293 cells     
HEK 293 cells were grown in DMEM with 4.5gm/L D-Glucose and 
1mM Sodium pyruvate (Gibco. Cat. No. 21969-035, UK) supplemented with 
10% heat inactivated fetal calf serum, 100 µg/ml Streptomycin, 100 IU/ml 
Penicillin. When cells were around 85% confluent they were transfected 
with N-terminal FLAG-tagged WT and D281E D289E TRIF constructs. 
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2.1.2 Primary cell preparations   
2.1.2.1 Bone –marrow derived macrophages  
   Mice were maintained according to Institutional and National (UK 
Home Office) guidelines. C57/BL6 mice were obtained from Harlan UK. 
Primary bone-marrow macrophages BMDMs were isolated as described from 
C57/BL6 mice (Celada et al., 1984). Briefly, mice were sacrificed by cervical 
dislocation and femurs and tibias were dissected out. Femurs and tibias were 
flushed with media using a 25G needle (BD. Cat.No.300600, USA) to obtain 
bone marrow mononuclear phagocytic precursor cells. To remove tissues 
and debris cell suspension was passed through a Nitex mesh (Cadisch Sons, 
London, UK). Cells were cultured in RPMI-1640 supplemented with 10% heat 
inactivated FCS, Streptomycin (100 µg/ml), Penicillin (100 IU/ml), L-
glutamine (2mM) and 1 mM Hepes solution( Sigma.Cat.No. H0887, USA) pH 
7.3 on 9 cm plastic Petri dishes (Sterlin. Cat.No.24998, UK) at a 
concentration of 3×106 cells/plate.  Macrophages were selected by addition 
of M-CSF 10ng/ml (Peprotech. Cat.No.315-02, UK) or by using the 
supernatant of L929 cells at a final concentration of 30%. Cells were cultured 
at 37˚C, 5% CO2 and allowed to grow for between 6 – 9 days before use. 
Under these conditions, the resultant cell population was > 95% 
macrophages as judged by staining with the macrophage marker F4/80 (Fig 
2-1).    
2.1.2.2 Generation of bone-marrow derived dendritic cells  
Bone marrow derived dendritic cells was generated and grown as 
described for  BMDMs but, instead of M-CSF, cells were cultured in 
complete RPMI-1640 media supplemented with 20ng/ml GM-CSF 
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(Peprotech. Cat. No. 315-03, UK). Under these conditions, the resultant cell 
population was > 95% dendritic cell as judged by staining with the D.cells 
marker CD11c (Fig 2-2).    
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Figure 2.1; F4/80 staining of BMDMs. 
BMDMs cells were isolated from WT mice and analysed for F4/80. F4/80 staining 
compared to isotype. Cells were gated based on forward and side scatter (top panels, 
65.6% for isotype, and 64.1% for F4/80), these events were then gated based on 7-AAD 
(middle panel). Alive cells were gated based on F4/80 staining (bottom panel, 2.2% 
isotype, and 92.1% F4/80). 
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Figure 2.2; LPS CD11c staining of dendritic cells. 
a, Dendritic cells were isolated from WT mice and analysed for CD11c. CD11c staining 
compared to isotype. Cells were gated based on forward and side scatter (65.7% for 
isotype, and 68% for CD11c). b, events were then gated based on 7-AAD, 7-AAD 
negative are live cells. c,  Alive cells were gated based on CD11c staining. d, CD11c 
were treated with 1µg/ml LPS for 18 hrs for the expression of CD40. 
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2.2 Methods  
2.2.1 Cell viability assay     
Cell viability was determined by exclusion of trypan blue. 50µl of the 
cells were incubated at room temperature for 3 minutes with 50µl of 0.04% 
(w/v) trypan blue (Sigma. Cat. No. T8154, USA) in PBS and viable cells 
excluding trypan blue counted in a hemocytometer (Superior. Germany). 
Cell viability in all assays was >85%.  In addition, the viability of the cells 
remained comparable throughout all time points used in this study.  
2.2.2 Bacterial cultures 
   P. aeruginosa PA103ΔUΔT and PA103pcrV- were kindly provided by 
Dara Frank. Bacterial strains were cultured in LB broth (Invitrogen. Cat. 
No.12780-052, USA) to mid-log phase (OD 0.4-0.6) immediately prior to use. 
The bacteria were then centrifuged at 3500 ×g for 15 minutes at 4˚C, the 
pellet was washed twice in sterile PBS and then resuspended in the same 
PenStrep -free media as the cells being infected to a concentration of 
approximately 1× 106cfu/µl = (O.D.600/0.4) ×1.8 ml. (1×106 cell/ml) were then 
infected at indicated multiplicity of infection (MOI) and time.   
2.2.3  Immunofluorescence Microscopy 
  For immunofluorescence, cells were seeded onto Lab-tek 2 well 
chamber slides (Thermoscientific.Cat.No.177399, USA). Following 
experimental treatments, cells were washed 3 times with sterile PBS then 
fixed in 2% paraformaldehyde (VWR, UK) in PBS for 30 minutes at room 
temperature. Fixed cells were washed 3 times with PBS and then 
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permeabilized in 0.2% Triton X-100 (Sigma-Aldrich. Cat. No .9002-93-1, USA) 
in PBS for 20 minutes at room temperature. Permeabilized cells were 
washed 3 times in PBS and blocked with 10% normal goat serum (Sigma-
Aldrich. Cat No.G9023, USA) in PBS for 1 hour. Cells were then incubated 
overnight at 4˚C with1.25 µg/ml rabbit polyclonal LC3 (Abgent. Cat. No. 
AP1802a, USA), or with 1µg/ml mouse mab to ATPase inhibitory factor-1 
antibody (abcam. Cat.No.ab110277, UK) in 10% NGS in PBS. Cells were 
then washed three times with 1ml sterile PBS for 5 minutes and incubated 
with 1µg/ml Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen. Cat. 
No. A11034, USA), or with 1µg/ml Alexa Fluor 568-conjugated goat anti-
mouse IgG (Invitrogen. Cat.No.A11031, USA)   in 10% NGS in PBS for 1 
hour at room temperature. Following washing as before, cells were mounted 
in Vectashield with DAPI (Vector. Cat.No.H-1500, USA), and viewed using a 
Zeiss Axiovert S100 microscope using Open Lab software (PerkinElmer) or a 
LSM 510 Meta Confocal microscope (Carl Zeiss) using Meta 510 software.  
  For quantification of LC3 puncta, image analysis was performed 
using Image J (NIH, Maryland, USA). All results show values of mean 
number of puncta per cell; for each analysis at least 50 cells were analysed. 
2.2.4 Western blot   
Western blot was done according to manufacturer’s standard 
protocol (abcam). Cells were infected, or stimulated as indicated. The cell 
samples were washed in ice- cold PBS 3 times and lysed in cold lysis buffer 
(20 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1% SDS, and 1 mM EDTA) in the 
presence of protease inhibitors (Roche. Cat.No.04693159001, Germany) 
for 30 min on ice. Cells were harvested using a cell scraper (Greinor Bio-
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One. Cat.No.541070, Germany) and cell lysate was collected. The protein 
concentrations were determined with Micro BCA protein detection kit 
(Pierce. Cat.No.23235, USA) and adjusted to equal concentrations across 
different samples. Lysates were diluted using LDS sample buffer (Invitrogen. 
Cat.No.NP0007, USA) and sample reducing agent (Invitrogen. 
Cat.No.NP0004, USA). Samples were heated at 70˚C for 15 minutes and 
loaded on to NU-PAGE Bis-Tris gels (Invitrogen Cat.No.NP0322, NP0341, 
USA). 25µg of each sample was used. The gel was run at 100V, 125 mA 
until the dye reached the base of the gel. The samples were transferred on 
to Hybond-P polyvinylidene difluoride PVDF membrane (GE Healthcare 
Cat.No.RPN303F, UK) using a Hoefer TE 22 tank transfer unit (Amersham 
Bioscience. Cat. No. 80-6204-26, USA) and NuPAGE transfer buffer 
(Novex. Cat.No.NP0006-1, USA) supplemented with 20% methanol (Fisher 
chemicals. Cat.No.M/4000/PC17, UK) at 30v, 125mA for 2 hrs at room 
temperature. Transfer was checked by Ponceau’s solution (Sigma-Aldrich. 
Cat.No.P7170, USA). The membranes were blocked with 5% dried 
skimmed milk (Marvel. Cat.No.92962, Ireland) in PBS 1% for 1 hr and then 
incubated overnight at 4°C with primary antibodies as shown in table (2-2). 
The unbound primary antibodies were washed away three times in PBS -
Tween then the membranes were incubated with secondary antibodies 
table (2-2) for 1 hr in room temperature. The unbound secondary antibodies 
were washed off as above. Bound antibodies were detected using 
enhanced chemiluminescence ECL kit (GE Healthcare. Cat.No.RPN2209, 
UK) and visualized by exposure to X ray film. For reprobing blots they were 
rinsed in DD.W then Washed 3 times for 5 minutes in PBS/Tween. Stripping 
buffer (100m M 2-Mercaptoethanol, 2%SDS, 62.5 mM Tris-Hcl pH, 6.7) was 
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added to the blots, and incubated for 30 minutes at 50°C with occasional 
agitatation. Blots were then washed 3 times for 10 minutes in PBS/Tween 
before re-blocking in 5% dried skimmed milk for one hour at room 
temperature and then incubated overnight at 4°C with monoclonal Anti β-
tubulin antibody (Sigma-Aldrich. Cat.No.T8328, USA). The unbound 
primary antibody was washed away three times in PBS /Tween then the 
membranes were incubated with Anti-mouse IgG HRP linked antibody (Cell 
signalling technology. Cat.No.7076, UK) for 1 hr in room temperature .The 
unbound secondary antibody was washed off as above. Bound antibodies 
were visualised as above.  
2.2.5 ELISA   
The cytokine concentration (IL-1β) in cell culture supernatants was 
measured by ELISA kit according to manufacturer’s standard protocol (R 
and D systems Cat No. DY401, USA). ELISA flat bottom 96 well   plates 
(Corning Costar. Cat. No.9018, USA) were coated with 50 µl capture 
antibody at a concentration of 4 µg/ml diluted in PBS, sealed and incubated 
overnight at room temperature. The wells were washed five times with wash 
buffer (PBS, 0.05% Tween 20) and blocked with 1 % BSA (Sigma. Cat. No. 
A7030-50, USA) in PBS at room temperature for 1 hour. After five washes 
in wash buffer, the samples and standards (50µl) were added with a top 
standard of 1000 pg/ml serially diluted 1:2 10 times. After 2 hours 
incubation at room temperature and five washes, detection antibody was 
added at a concentration of 2.5 µg/ml diluted in reagent diluent (0.1% BSA, 
0.05% Tween 20 in Tris-buffered saline pH 7.4) and incubated 2hr at room 
temperature. After five washes, streptavidin-HRP was added at a dilution 
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1:200 in reagent diluent for 20 minutes at room temperature in the dark.  
After final five washes, TMB Micro well Peroxidase substrate solution          
(KPL, Cat.No. 52-00-00, USA) was added for 20 minutes at room 
temperature in the dark. Development was stopped by the addition 25µl of 
TMB stop solution (KPL, Cat.No.52-58-04, USA) and plates were read at 
570 nm on a Tecan sunrise plate reader using Magellan software. 
The cytokine concentration (TNF-α), in cell culture supernatants was 
measured by ELISA kit according to manufacturer’s standard protocol 
(eBioscience Cat No. 88-7324-22, USA).  
For human IL-1β, the protocol was as above for TNF-α assay except 
using coating buffer (Cat.No.00-0044-59), capture antibody ( Cat.No.14-
7018-68, USA), standard (Cat.No.39-8016-60, USA ), and detection 
antibody (Cat.No.33-7016-68, USA). 
2.2.6   Transmission electron microscopy  
   BMDM cells infected by Pseudomonas aeruginosa for 4 h were 
harvested by scraping the cells followed by centrifugation at 500 g for 10 min. 
The pellets were washed with Sorensen’s Phosphate buffer and pre-fixed 
with 2% glutaraldehyde, followed by post-fixation with 1% OsO4 in 6.6 mM 
Sorensen’s phosphate buffer. All pellets were dehydrated stepwise in a 
graded series of ethanol and embedded in araldite CY212. The blocks were 
sectioned on Reichert–JunG ultra-cut microtome. Ultra-thin sections were 
double stained with uranyl acetate and lead citrate (all stains from Agar 
scientific). Sections were examined using a Tecnai transmission electron 
microscope (Model No. 943205018411, FEI Company, Czech republic) 
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equipped with Olympus digital camera (VELETA) at the Department of 
Pathology, Western Infirmary, Glasgow. 
2.2.7      Flow cytometry   
Blocking of non-specific Fc-mediated binding of antibodies to Fc 
receptors was performed using 1ug/ml of a rat anti-mouse CD16/CD32 
antibody (BD Biosciences. Cat. No. 553141, USA) for 15 minute at 4°C. 
Intracellular LC3B II was detected as follows, following the method 
described by (Eng et al., 2010). Cells were fixed and permeabilized using 
fixation/permeabilization solution which contains 0.1% saponin (BD 
Bioscience, Cat. No. 51-2090KZ, USA) and resuspended in 
permeabilization wash buffer (BD Bioscience. Cat. No. 00-8333-56, USA). 
Cells were then incubated for 1hr at 4°C with 2 µg/ml rabbit polyclonal LC3 
(Novus biological. Cat.No.NB100-2220, UK) in 1X permeabilization /wash 
buffer. After washing, cells were then incubated with 1µg/ml Alexa Fluor 
488-conjugated goat anti-rabbit IgG (Invitrogen. Cat.No.A11034, USA) in 
1X permeabilization/wash buffer for 1 h at 4˚C. Cells were then washed and 
resuspended in phosphate buffered saline supplemented with 2.5% fetal 
calf serum for analysis. 
Bacterial uptake was measured in cells using 1mg/ml pHrodo E.coli 
Bio Particles for 2hrs at 37°C (Invitrogen. Cat. No. P35366, USA) prior to 
analysis by flow cytometry. Reactive oxygen intermediates were assayed 
using CellRox deep red reagent at 5µM for 30 min at 37°C (Invitrogen. Cat. 
No. C10422, USA) and flow cytometry.  
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Mitochondrial ROS were measured in cells after infection as 
indicated by using MitoSox staining (Invitrogen. Cat. No. M36008, USA) at 
2.5 µM for 30 min at 37˚C. For measurement of mitochondrial mass, cells 
were stained for 30 min at 37˚C with 50 nM MitoTracker Green FM 
(Invitrogen. Cat. No. M7514, USA), and 50 nM MitoTracker Red FM 
(Invitrogen. Cat. No. M22426, USA). Cells were then washed and 
resuspended in phosphate buffered saline supplemented with 2.5% fetal 
calf serum for analysis.  
Cells were analysed using a CyAn ADP (Beckman Coulter) or 
Facscalibur flow cytometer (BD). Flow cytometry data was analysed with 
Flowjo Software (Tree Star Inc.). 
2.2.8   RT-PCR   
Total cellular RNA was isolated with an RNeasy Mini kit (Qiagen. Cat. 
No. 74104, UK) according to the manufacturer’s instructions. cDNA was 
synthesised from DNase I treated RNA using Superscript II reverse 
transcriptase (Invitrogen. Cat. No. 18064-071, USA) according to the 
manufacturer’s instructions. Quantitative reverse transcription PCR (q RT-
PCR) was performed using fast SYBR Green PCR master mix (Applied 
Biosystems. Cat. No. 4385612, UK) using the 7900HT fast system (Applied 
Biosystems). The following primers were used for RT- PCR:  
Ifn-β: sense, 5'-CCGAGCAGAGATCTTCAGGAA-3';   
antisense, 5'-GCAACCACCACTCATTCT-3'.  
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Lc3b : sense, 5'-ACAAAGAGTGGAAGATGTCCG-3' ; antisense, 5'-  
CCCCTTGTATCGCTCTATATTCAC-3'.  
Gene expression levels were normalised to TATA binding protein (TBP): 
sense, 5'-TTCACCATGACTCCTATGACC-3';  
antisense, 5'-CAAGTTTACAGCCAAGATTCACG-3' .  
The mean relative gene expression was calculated using Livak’s 
method (Livak and Schmittgen, 2001). All determinations were performed in 
triplicate. 
2.2.9 Measuring Cytoplasmic mitochondrial DNA   
For measuring cytoplasmic mtDNA, 1 × 107 cells infected as 
indicated were homogenized with a Dounce homogenizer in 100 mM NaOH 
solution, pH 7.4, containing 0.25 M Sucrose, 1 mM EDTA, and protease 
inhibitors, then centrifuged at 800g for 12 min at 4 °C. The protein 
concentrations were determined with Micro BCA protein detection kit 
(Pierce. Cat.No.23235, USA) and adjusted to equal concentrations across 
different samples, followed by centrifugation at 12,000g for 30 min at 4 °C 
for the production of a supernatant corresponding to the cytosolic fraction. 
Total DNA was isolated from 200 µl of the cytosolic fraction with a DNeasy 
blood and tissue kit (Qiagen. Cat. No. 69504, UK).  
2.2.10 Quantitative real-time PCR   
Quantitative PCR was used for measurement of cytoplasmic 
mitochondrial DNA mtDNA using fast SYPR Green PCR master mix 
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(Applied Biosystems. Cat. No. 4385612, UK). The copy number of 
cytoplasmic mtDNA was normalized to that of nuclear DNA as the ratio of 
DNA encoding cytochrome c oxidase I to nuclear DNA encoding 18S 
ribosomal RNA  (Tal et al., 2009). The following primers were used for q-
PCR: 
  18S sense, 5′-TAGAGGGACAAGTGGCGTTC-3′,  
 anti-sense, 5′-CGCTGAGCCAGTCAGTGT-3′;  
 Mouse cytochrome c oxidase I sense, 5′-GCCCCAGATATAGCATTCCC-3′,  
anti-sense, 5′-GTTCATCCTGTTCCTGCTCC-3′. 
The copy number of DNA encoding cytochrome c oxidase I was measured by 
quantitative real-time PCR with same volume of the DNA solution. 
2.2.11 Isolation of mitochondrial DNA  
Mouse mitochondrial DNA (mtDNA) was isolated from 40 × 106 
J774A.1cell with a mitochondrial DNA isolation kit (Thermo scientific 
Cat.No.89874, USA) according to the manufacturer’s instructions. 
Mitochondrial DNA was isolated from the pellet with a DNeasy blood and 
tissue kit (Qiagen Cat. No. 69504, UK) according to the manufacturer’s 
instructions. To generate oxidized mtDNA, the material was incubated with 
100 µM hydrogen peroxide for 30 min at 37C. 
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2.2.12 Transfection of mtDNA 
   BMDMs were transfected for 6 hr with 2µg/ml isolated mtDNA, and 
oxidized mtDNA through the use of 3µl Attractene (Qiagen. Cat.No.301005, 
UK) according to the manufacturer’s instructions. 
2.2.13 Protein transfection  
Protein transfection was performed using Polyplus reagent according 
to the manufacturer’s standard protocol (Polyplus transfection. Cat. No. 
PPLU501-01, USA). Cells were incubated with the protein/transfection 
reagent complex for 5 hr at 37°C in a 5% CO2 incubator. After removing the 
media, cells were washed 2 times with sterile PBS, cells were incubated in 
complete growth media without antibiotic, and then infected with 
PA103ΔUΔT for 4 hr (MOI 1:25).  
2.2.14 siRNA and transfection  
Control siRNA and siRNAs to the indicated genes were all from 
Dharmacon RNAi Technologies UK (On Target plus SMART pool siRNA) 
Table (2-1). Silencing constructs were introduced into cells using HiPerfect 
transfection reagent (Qiagen. Cat.No.301704, UK), according to the 
Manufacturer’s instructions. Transfection of BMDMs was optimised using 
SiGLO Green transfection indicator (Dharmacon RNAi Technologies. Cat. 
No. D-001630-01-05, UK) and flow cytometry. Cells were plated at a 
density of 0.5 x 106 cells per well of a 12-well plate in 500 µl of RPMI1640 
culture medium. siRNA was added at a concentration of 40 nM together 
with 9 µl of transfection reagent. This routinely gave transfection efficiencies 
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greater than 90% Fig (2-3). For efficient knock down, cells were cultured for 
24 – 48 h.    
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Table 2.1 siRNA used in this study 
siRNA Target sequences  Cat. No. 
Lc3b   5´- ACUAUGGUGCGAUCAGUAA-3´ 
5´- CAUCCUAAGUUGCCAAUAA-3´ 
5´- GGAUAUAGCUCUAAGCCGG-3´ 
5´- CUAAUAAAGGCACAACGAA-3´ 
 
L-040989-01-0005 
Atg5 5´- GCAUAAAAGUCAAGUGAUC-3´ 
5´- CCAAUUGGUUUACUAUUUG-3´ 
5´- CGAAUUCCAACUUGCUUUA-3´ 
5´- UUAGUGAGAUAUGGUUUGA-3´ 
 
L-064838-0005 
Caspase-1 5´- GAAUACAACCACUCGUACA-3´ 
5´- GCCAAAUCUUUAUCACUUA-3´ 
5´- GGUAUACCGUGAAAGUGAA-3´ 
5´- GCAUUAAGAAGGCCCAUAU-3´  
L-048913-00-0005 
Caspase-11 5´-GAUGUGCUACAGUAUGAUA-3´  
5´-CGAAAGGCUCUUAUCAUAU-3´    
5´-AAGCUAAUCUGGAAAUGGA-3´  
5´-GUGCAACAAUCAUUUGAAA-3´ 
 
L-042432-00-0005 
TRIF  5´-GAUCGGUGCAGUUCAGAAUA-3´ 
5´-GAACAGCCUUACACAGUCU-3´    
5´-GGAAAGCAGUGGCCUAUUA-3´  
5´-GAGAUAAGCUGGCCUCCAU-3´ 
 
L-055987-00-0005 
Tlr4 5´- UGACGAACCUAGUACAUGU-3´  
5´- GGAAUUGUAUCGCCUUCUU-3´  
5´- GAGUUCAGGUUAACAUAUA-3´  
5´- GCAUAGAGGUAGUUCCUAA-3´  
  
L-047487-00-0005 
Nlrc4 5´- UCGAAACACUGUACGAUCA-3´ 
5´- GAACAUCCCUGACUAUUUA-3´ 
5´- CAAUAGGGCUCCUCUGUAA-3´ 
5´- GCGAUGACCUCUUUGCAUU-3´ 
 
L-055000-00-0005 
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Figure 2.3; siRNA transfection optimization  
 BMDMs were transfected using SiGLO Green transfection indicator at a concentration of 
(20, and 40 nM) with (3, 6, and 9 µl) of HiPerfect transfection reagent for 24 hr and then 
analysed using flow cytometry.     
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2.2.15 Transfection of electrocompetent E.coli (EC100)  
   TransforMax EC100 electrocompetent E.coli (Cambio 
bioscience .Cat.No.EC10005, UK) were transformed according to 
manufacturer’s protocol. Briefly, electroporation cuvettes GenePluser 
cuvettes 0.1 cm (Life Technologies.Cat.No.P410-50, USA) were chilled on 
ice and 50µl electrocompetent cells were defrosted on ice. TRIF FLAG WT 
and D281E D289E Plasmids were added and mixed gently with the bacteria. 
Immediately following this cells were transferred to an electroporation cuvette 
and pulsed on a Gene Pluser X cell system (BioRad.Cat.No.165-2660, UAS) 
using a program for E.coli (1800 V, 25µF, 200 Ω, 4 seconds time constant). 
950µl super optimal broth with catabolite repression (SOC) medium (Life 
technologies .Cat.No.15544-034, USA) at room temperature was then added 
and cells placed in a shaking incubator (Stuart scientific, UK) (250 RPM) at 
37˚C for 1.5 hour to allow expression of any antibiotic resistance marker. 200 
µl of bacteria were then plated on to appropriate LB-Agar plates with 75µg/ml 
Ampicillin (Sigma .Cat.No.A9518.USA) and allowed to grow at 37˚C 
overnight.   
2.2.16 TRIF- FLAG plasmids purification 
Plasmids were purified using plasmid maxi kit (Qiagen. Cat. No. 
12162, UK) according to manufacturer’s instructions. 
2.2.17 Plasmid transfection 
N-terminal FLAG-tagged WT and D281E D289E TRIF constructs 
(Lei et al., 2011) in pcDNA3.1 were kindly provided by Dr. Lei, (China). 
Plasmids were transfected into cells using Attractene (Qiagen. Cat. No. 
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301005, UK), or using Lipofectamine 2000 (Invitrogen, Cat. No.11668-027, 
USA), according to the manufacturer’s instructions. Cells were harvested at 
24 h after transfection.  
2.2.18 Construction of plasmids  
Restriction enzyme XbaI (New England BioLab. Cat. No. R0145S, 
UK), and BstXI (Promega. Cat. No. R6471, USA), all were used according 
to manufacturer’s instructions in suitable buffers provided with enzyme.  
C-terminal and N-terminal of WT FLAG plasmid were amplified using 
the following primers  
TRIF C- Terminal sense,  
5′-CACCATGCCCGCAGCTCCAGAAACCAGCA-3′,  
 anti-sense, 5′-TTCTGCCTCCTGCGTCTTGTC-3′;  
TRIF N-Terminal sense,  
5′-CACCATGGCCTGCACAGGCCCATCACTTC-3′,  
anti-sense, 5′-ATCTGGGGCCACTTCGGGAAGCCC-3′; 
The resulting product was cloned in to pcDNA3.1D/V5-His-Topo 
vector (Invitrogen. Cat. No. 45-0158, USA), according to manufacturer’s 
instructions.    
2.2.19 Agarose gel electrophoresis    
PCR products, plasmid preparations and restriction enzyme digests 
were resolved using agarose gel electrophoresis and a Horizon 58 life 
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technologies horizontal gel electrophoresis apparatus (Serial No. 00239825, 
USA). 2% agarose (BIO-RAD, Cat. No. 161-3101, USA) was dissolved in 
1x Tris/Borate/EDTA (TBE) buffer and 1x SYBR safe gel DNA stain 
(Invitrogen. Cat. No. S33102, USA). Gels were viewed and photographed 
using Gel Logic 200 imaging system (KODAK).      
2.2.20 Generation of mtDNA deficient ρ0 cells 
J774A.1 macrophages were grown in  RPMI 1640 media 
supplemented with 10% heat inactivated FCS, 100 µg/ml Streptomycin, 
100IU/ml Penicillin,  1mM Hepes solution, and Uridine 25µg/ml  . EtBr (500 
ng/ml) (Sigma- Aldrich. Cat. No. 1510, USA) was added to the medium for 
15 day (Hashiguchi and Zhang-Akiyama, 2009). Depletion of mitochondrial 
DNA was evaluated by quantitative PCR for the mitochondrial gene 
cytochrome c oxidase I and compared to nuclear DNA encoding 18S 
ribosomal RNA.  
2.2.21 Immunoprecipitation    
BMDMs were preloaded with BrdU (10 mM) (Sigma. Cat.No.B5002, 
USA) for 48 hr and then seeded into 6 well plates (Costar. Cat. No. 3516, 
USA) at 2.5 ×106 cell/ml RPMI 1640 media and then infected with 
PA103ΔUΔT (2, 4 hr) at (MOI 25). After infection cells were washed twice 
with ice-cold PBS and then lysed in 500µl RIPA lysis buffer (Thermo 
scientific. Cat.No.89900, USA) for 30 minutes. Cells were collected by cell 
scraper and the lysate centrifuged at 13,000 g at 4˚ C for 20 minutes. 
Lysates were pre-cleared by addition of 50 µl of anti-rabbit IgG beads 
(eBioscience. Cat.No.00-8800-25, USA) on ice for 50 minutes with gentle 
agitation and then spun at 11,000 x g for at 4˚ C for 3 minutes. 5µg of rabbit 
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anti-NLRC4 (Novus Biologicals. Cat. No. NBP1-78979SS, UK) antibody or 
5 µg of negative control rabbit IgG (Dakocytomation. Cat.No.X0936, 
Denmark) were added to 250 µl aliquots of the lysate and incubated on ice 
for 1.5 hr. 50µl of anti-rabbit IgG beads was added and the samples were 
further incubated at 4˚C for 1 hr. Immune complexes were then washed 3 
times with ice-cold RIPA lysis buffer and bound material eluted with distilled 
water at 100˚C for 10 minutes. A 20µl aliquot was analysed on a standard 
Western blot for NLRC4 protein. DNA in the remaining 80 µl aliquot was 
denatured by addition of 8 µl of 4M NaOH and 1.6µl of 0.5 M EDTA and 
incubated at 100˚C for 5 minutes. The sample was cooled on ice and 
neutralized by addition of 110µl of ice-cold 2M Ammonium acetate pH 7 
before transferring to nitrocellulose membranes using a Bio-Dot 
microfiltration apparatus (Bio-Rad Cat.No.170-6542, Germany). 
Membranes were rinsed in 2X SSC and cross-linked to the nitrocellulose 
using UV irradiation. Membranes were then blocked with 5% dried skimmed 
milk for 1 hr and incubated overnight at 4°C with primary antibodies to BrdU 
mAb (1.5µg/ml; Sigma. Cat.No.BU33, USA) or mouse anti-8OH-dG mAb 
(1µg/ml; Santa Cruz biotechnology. Cat.No.SC-66036, U.K.). Following 
washing and incubation with horseradish peroxidase conjugated secondary 
antibody, bound antibody was detected using enhanced a 
chemiluminescence ECL kit (Fisher scientific. Cat.No.RPN2209, UK).  
2.2.22 Gentamicin protection assay 
Viable intracellular bacterial counts were determined by a gentamicin 
protection assay as described (Lindestam Arlehamn et al., 2010).  
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2.2.23 LDH Release  
Cells were incubated in media lacking Phenol red. Lactate 
dehydrogenase release determinations were performed using the Cytotox 
96 cytotoxicity assay kit (Promega. Cat. No. G1781, USA).   
2.2.24  Animal models   
Model 1  
Female C57/BL6 mice aged 8 weeks were obtained from Harlan UK. 
Mice were randomly divided into to three groups, n=3 per group. Control 
groups were injected intraperitoneally (ip) with sterile PBS. Experimental 
groups were injected (ip) with PA103ΔUΔT (107 cfu) alone or with caspase 
inhibitor Z-YVAD-FMK 0.1mg/kg. 6 hours after infection, animals were 
sacrificed and blood and peritoneal fluid collected for analysis as indicated.   
Model 2     
  Peritoneal macrophages were depleted using clodronate liposomes 
(Foundation Clodronate Liposomes, Amsterdam). 200 μ l clodronate 
liposomes were injected 96 hours and 24 hours prior to infection. Depletion 
was confirmed by performing peritoneal lavage on animals injected with 
clodronate liposomes or PBS liposome controls and performing total cell 
counts and Romanowski staining after cytocentrifugation. Bone marrow 
derived macrophages were stained with eFluor 450 proliferation dye 
(eBioscience, Cat. No. 65-0842, UK) at a concentration of 10 µM according 
to the manufacturer’s instructions. Mice were injected intra-peritoneally with 5 
x 106 of eFluor 450 stained macrophages. 1 hour later mice were injected 
with 107 cfu of PA103ΔUΔT or PBS. After 6 hours mice were culled by 
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inhalation of CO2. Peritoneal fluid was collected by injection and subsequent 
aspiration of 5ml of cold PBS. 
Neutrophils were enumerated by performing total cell counts and 
Romanowski staining after cytocentrifugation or peritoneal lavage fluid. 
Cells were then stained with Alexa Fluor 700 anti-CD11b (M1/70, 
Biolegend), PE anti-F4/80 (BM8, Biolegend), Alexa Fluor 647 anti-Ly-6G 
(1A8, Biolegend) or appropriate isotype controls. Following fixation and 
permeabilisation cells were then stained for LC3 as already described. 
Macrophages were selected on the basis of being CD11b+F4/80+Ly-6G- 
and extrinsic macrophages were then identified on the basis of staining with 
eFluor 450. 
Model 3   
Female C57/BL6 mice aged 8 weeks were obtained from Harlan UK. 
Mice were randomly divided in to six groups (n=3 per group). Three control 
groups were injected intraperitonial (ip) with sterile PBS, rapamycin (1.5 
gm/kg) (Harris et al., 2011), or 3-MA (30mg/kg) (Kim et al., 2012). 
Experimental groups were injected (ip) with PA103ΔUΔT (107 cfu) alone, or 
with rapamycin or with 3-MA. Blood and peritoneal fluid was taken after 6 
hrs for analysis of IL-1β and TNF secretion by ELISA and for protein 
concentration.   
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Table 2.2 Antibodies used in this study  
Antibody 
description  
Manufacturer Cat. No. Applications Working 
concentration 
Purified rabbit 
polyclonal antibody 
Pab, Autophagy 
LC3 antibody (AP 
G8B) (N-term).  
Abgent (USA) AP 1802a IF  1.25µg/ml 
Alex flour 488 goat 
anti-rabbit IgG 
(H+L).  
Invitrogen 
(USA) 
A11034 IF  
FACS  
1µg/ml 
 
Alex flour 568 goat 
anti-mouse IgG 
(H+L).  
Invitrogen 
(USA) 
A11031  IF 
   
1µg/ml 
 Negative control , 
Rabbit 
immunoglobulin  
fraction (sold-
phase absorbed)  
DakoCytomation 
 (Denmark) 
X0936 IF  
FACS  
IP  
 
1.25µg/ml 
 
5µg/ml 
8-OHdG  
Mouse monoclonal 
IgG2b  
Santa cruz 
biotechnology 
(UK) 
Sc-66036 IP 1µg/ml 
Mouse monoclonal 
Anti-BrdU 
Sigma-Aldrich 
(USA) 
B8434 IP 2µg/ml 
Anti-rabbit IgG 
HRP- linked 
antibody.  
Cell signaling 
technology 
(UK) 
7074 WB 1:2000 
LC3  Antibody  
LC3 B  
Novus 
Biological (UK) 
NB100-
2220 
WB  
FACS  
1µg/ml 
 
Anti-Mouse IgG 
HRP- linked 
antibody. 
Cell signaling 
technology 
(UK) 
7076 WB 1:2000 
Monoclonal Anti-β-
Tubulin antibody 
produced in mouse  
Sigma-Aldrich 
(USA) 
T8328 WB 1µg/ml 
Capture Antibody.  R and D 80134 ELISA 4µg/ml 
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system (USA)  
Detection 
Antibody.  
R and D 
system (USA)  
80135 ELISA 600ηg/ml 
 
Caspase -1 p10 
(M-20) Antibody.  
Santa cruz 
biotechnology 
(UK)  
sc-514 WB 1µg/ml 
Caspase -1 (A-19) 
Antibody. 
Santa cruz 
biotechnology 
(UK) 
sc-622 WB 1µg/ml 
Capase-11 
Antibody 
Abcam (UK) ab22684 WB 1/5000 
Rabbit polyclonal 
to IL-1 β.  
Abcam (UK) ab9722 WB 1µg/ml 
Rabbit polyclonal 
to TRIF.  
abcam (UK) ab13810 WB 1 µg/ml 
NLRC4 Antibody. Novus 
Biologicals  
NBP1-
78979SS 
WB  
IP 
 
2µg/ml  
 
5µg/ml 
 
 
 
Monoclonal ANTI-
FLAG, M2, Clone 
M2. 
Sigma (USA) F1804 
 
WB 1µg/ml 
Mouse Anti-rabbit 
IgG .mAb (HRP 
conjugate). 
Cell signaling 
technology 
(UK) 
5127 WB  1:2000 
Anti-AIM2 Purified. eBioscience 
(UK) 
14-6008 WB 1. 5µg/ml 
Capture Ab 
purified anti-mouse 
TNF –α. 
eBioscience 
(UK) 
14-7423-
67A 
ELISA 1:250 
Detection Ab 
Biotin-conjugate 
anti-mouse TNF –
α polyclonal. 
eBioscience 
(UK) 
13-7341-
67A 
ELISA 1:250 
Capture Ab eBioscience 14-7018- ELISA 1:250 
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purified anti-
human IL-1β. 
(UK) 68 
Detection Ab 
Biotin-conjugate 
anti-human IL-1 β 
–α polyclonal 
eBioscience 
(UK) 
33-7016-
68 
ELISA 1:250 
Anti-Atg5 
Antibody. 
Novus 
Biologicals 
(UK) 
NB110-
53818SS 
WB 0.5µg/ml 
Ms mab to ATPase 
inhibitory factor 1. 
abcam  (UK) ab110277 WB 
IF  
1µg/ml 
 
Mouse TLR4 Ab Abcam(UK) Ab22048 WB 2µg/ml 
Anti- rabbit IgG IP 
beads  
eBioscience 
(UK) 
00-8800-
25 
IP  1:10 
Rabbit polyclonal  
anti-PINK1 
Antibody  
Novus 
Biological  
BC100-
494 
W.B.  1µg/ml 
Mouse anti- V5 tag Invitrogen 377500 W.B. 1µg/ml 
 
 
Table 3.3 Knockout mice used in this study  
 KO Mice Source 
Tlr4 Prof. Tim Mitchell  University of Glasgow ( UK) 
Nlrc4 Prof. Clare Bryant  University of Cambridge (UK) 
Trif Prof. Clare Bryant  University of Cambridge (UK) 
Aim2 Prof. Katherine Fitzgerald  University of Massachusetts (USA) 
Atg7 Prof. Anna Katharina Simon University of Oxford (UK) 
Myd88 Prof. David Gray University of Edinburgh (UK) 
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2.3 Solutions and buffers used in this study                                                             
• Phosphate buffer saline (8.0 gm Nacl+0.45gm NaH2Po4+2.3gm Na2HPo4+ 
0.2 gm KCl ) in 1liter of distilled water, PH=7.4.    
• Trypan blue stain.  (Sigma-Aldrich. Cat No.T8154, USA). 
• 10% Normal goat serum in PBS.  (Sigma-Aldrich. Cat No.G9023, USA).    
• Fetal calf serum. (Invitrogen .Cat No.15561020, USA). 
• Vectashield with DAPI. (Vector. Cat No.H-1500, USA).     
• Micro BCA Reagent  A (MA), 240 ml (in Product No. 23235), containing 
sodium carbonate, sodium bicarbonate, bicinchoninic acid and sodium 
tartrate in 0.2 M sodium hydroxide (Pierce. Cat.No.23231, USA).        
• MicroBCA Reagent B (MB), 240 ml, containing 4% bicinchoninic acid in 
water (Pierce. Cat.No.23232, USA).        
• MicroBCA Reagent C (MC), 12 ml, containing 4% cupric sulphate, 
pentahydrate in water (Pierce. Cat.No.23234, USA).         
• Albumin Standard Ampules, 2 mg/ml, 10 × 1 ml ampoules, containing 
bovine serum albumin (BSA) at 2.0 mg/ml in 0.9% saline and 0.05% sodium 
azide (Pierce. Cat.No.23209, USA).        
• Lysis buffer (1mM EDTA, 150 mM NaCl, 20 mM Tris-Cl, PH7.5, and 1% 
SDS in DW. 
• LDS (Loading) buffer 4X.  (Invitrogen.  Cat.No.NP0007, USA).  
• Sample reducing agent 10X. (Invitrogen. Cat.No.NP0004, USA). 
•  MES SDS Running buffer 20X. (Invitrogen. Cat.No.NP0002, USA). 
• Transfer buffer 20X. (Invitrogen. Cat.No.NP0006-1, USA). 
• Ponceau’s  solution 0.1% PonceauS. (w/v) in 5% (v/v) acetic acid. (Sigma-
Aldrich. Cat.No.P7170, USA).  
• HRP- Streptavidin Horseradish Peroxidase Conjugate. (Invitrogen. Cat 
No.43-4323, USA). 
• ECL kit (Lumigen P5-3 detection reagent solution A, Cat. No. RPN 2132 V1 
and Lumigen P5-3 detection reagent solution B, Cat. No. RPN 2132 V2, GE 
healthcare (UK).  
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• 5% dried skimmed milk (Marvel. Cat.No.92962, Ireland) in PBS. 
• Stripping buffer (100m M 2-Mercaptoethanol, 2%SDS, 62.5m M Tris-Hcl.  
pH 6.7). 
• (2S,3S)-Trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester, 
EST.  (Sigma-Aldrich. Cat. No. E8640, USA). 
• Pepstatin A. (Sigma-Aldrich Cat.No.P5318, USA). 
• Bafilomycin A (Sigma. Cat. No. B1793, USA).    
• 1% BSA (Sigma. Cat. No. A7030-50, USA) in PBS. 
•  ELISA Reagent diluent (0 .1% BSA, 0.05% Tween 20 in Trise-buffered 
saline (20 mM Trizma base, 150m M NaCl) PH 7.2-7.4, 0.2 µm filtered. 
•  ELISA Substrate Solution (1:1 mixture of colour reagent A H2O2  and colour 
reagent B Tetramethylbenzidine. (Rand D system.  Cat. No. DY 999, USA). 
•  ELISA Stop Solution 2N H2SO4. (R and D system. Cat. No. DY 994   USA). 
• Triton X-100. (Sigma-Aldrich. Cat. No .9002-93-1, USA).  
• Low- potassium buffer (140 mM NaCl, 5 mM KCl, 10 mM Hepes solution, 
1.3 mM  CaCl2, 0.5 mM MgCl2, 0.36 mM K2HPO4, 0.44 mM  KH2PO4, 5.5 mM 
D-glucose, and 4.2mM NaHCO3). Autoclaved and filtered then 
supplemented with 1X MEM vitamin solution (Cat.No.M6895), 2 mM L-
glutamine (Cat.No.G7513), 1X MEM amino acids solution (Cat.No.M1567), 
and 100 µM /ml Sodium Pyruvate (Cat. No. S 8636) all from (Sigma-Aldrich, 
USA).   
• High- Potassium buffer (5 mM NaCl, 140 mM KCl, 10 mM Hepes solution, 
1.3 mM  CaCl2, 0.5 mM MgCl2, 0.36 mM K2HPO4, 0.44 mM  KH2PO4, 5.5 mM 
D-glucose, and 4.2mM NaHCO3 ). Autoclaved and filtered then 
supplemented with 1X MEM vitamin solution (Cat.No.M6895), 2 mM L-
glutamine (Cat.No.G7513), 1X MEM amino acids solution (Cat.No.M1567), 
and 100 µM /ml Sodium Pyruvate (Cat. No. S 8636) all from (Sigma-Aldrich, 
USA).   
• 2% PFA (Alfa Aesas. Cat. No. 43368, USA). 
• Tween 20. (Sigma-Aldrich. Cat.No.P2287, USA). 
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•  LDH Assay buffer. (Promega. Cat. No. G 180, USA). Substrate mix 
(Promega. Cat. No. G 179, USA). 
• Stop solution. (Promega. Cat. No. G 183, USA).  
• 5X siRNA buffer (Dharmacon. Cat. No. B-002000-UB-100, UK) containing  
(300 mM  KCl, 30mM Hepes solution pH  7.5, and 1.0mM MgCl2 ). 
• 1X siRNA buffer four volumes of sterile RNase-free water- (Dharmacon. Cat. 
No. B-002000-WB-100, UK) with one volume of 5X siRNA buffer.   
• TE buffer 10 mM Tris pH 8.0 and 1 mM EDTA.  
• SOC medium (Invitrogen. Cat.No.15544-034, USA).  
• Mitochondrial isolation buffer (100 mM trise base, pH7.4 containing 0.25 M 
Sucrose, 1mM EDTA and protease inhibitor).   
• 20 X SSC (3M NaCl +0.3M Trisodium citrate). Dissolve 175.0 gm NaCl and 
88.2gm Trisodium citrate in D.W.  Adjust volume to 1 L with D.W.  
• RNase free water. (Qiagen.  Cat. No. 74104, UK).  
• Mitochondrial isolation reagent A. (Thermo scientific. Cat. No. 1859692, 
USA). 
• Mitochondrial isolation reagent B. (Thermo scientific, Cat. No. 1859693, 
USA).   
• Mitochondrial isolation reagent C. (Thermo scientific, Cat. No. 1859694, 
USA).   
• AW1. (Cat. No. 69504), AW2. (Cat. No. 69504), ATL.  (Cat. No. 69504), AE. 
(Cat. No. 69504), and AL. (Cat. No. 69504) (all from Qiagen, UK). 
• Buffer P1.  (Cat. No. 12162), Buffer P2. (Cat. No. 12162), Buffer P3. (Cat. 
No. 12162), Buffer QF. (Cat. No. 12162), Buffer QBT. (Cat. No. 12162), and 
Buffer QC. (Cat. No. 12162) (all from Qiagen, UK).  
• FACS buffer 2%FCS in PBS, and 0.05% Sodium azide.  
• Live imaging solution 1X pH 7.4 (Hepes buffered physiological saline) 
(Invitrogen. Cat.No.A1429IDJ, USA).  
• TBE buffer (54g Tris base, 27.5g of Boric acid, and 20ml of 0.5 M EDTA in 
1L DW). 
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2.4 Statistics                         
Comparison between groups at one time point was made using 
unpaired t test. A p value of < 0.05 was considered significant.  
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3    Role of T3SS in autophagy following Pseudomonas 
aeruginosa infection 
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3.1 Introduction 
Autophagy is a cellular process whereby cytosolic components are 
incorporated into a double membrane-bound compartment that is then 
targeted for lysosomal delivery and ultimate degradation. It was originally 
described as a process occurring in response to starvation that allowed 
degradation of cellular organelles and proteins to supply new materials for 
continued cell survival. It is a process found in virtually all eukaryotic cells 
and the basic machinery that regulates autophagy is evolutionarily highly 
conserved (Kundu and Thompson, 2008). Increasingly, autophagy is 
recognised as playing a part in many human diseases ranging from cancer 
to atherosclerosis. In infectious disease, autophagy is important in removing 
intracellular microbes, as well as producing and delivering ligands that 
trigger innate immune signalling (Deretic and Levine, 2009).  
Pseudomonas aeruginosa is an important gram negative organism 
and accounts for about 25% of all gram negative infections isolated from 
hospital environments. P. aeruginosa commonly infects immunodeficient 
people and those with Tuberculosis, cystic fibrosis and cancer could be 
potential victims of this pathogen (Yuan et al., 2012). P. aeruginosa has 
been classified as an extracellular pathogen with a spectrum of virulence 
factors, which help prevent it from clearance by the host innate immunity 
(Sadikot et al., 2005). P. aeruginosa can produce resistant strains and 
traditional antibiotic therapies fail to protect against these resistant strains 
(Chastre and Fagon, 2002). To study the relationship between 
macrophages and microorganisms is important to clear the picture of host 
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defence and might help finding some new therapies for the control of these 
pathogens (Wang et al., 2010)  (Yuan et al., 2012) 
Bacteria use many mechanisms to subvert cellular processes to their 
benefit. One such mechanism is the Gram-negative type III secretion 
system (T3SS), a nanomachine that directly introduces bacterial toxins into 
animal cells and is widely distributed amongst pathogenic Gram-negative 
organisms. In addition to delivering bacterial toxins, the T3SS has been 
implicated in delivering other pathogen-derived molecules that can activate 
the inflammasome, such as flagellin (Miao et al., 2006). 
The classical intracellular autophagic pathway consist of a signalling 
mechanism which relies mainly on two Ubiquitin-like conjugation systems 
involving autophagy-related genes (Atg), Atg7-Atg12-Atg5 or Atg4-Atg7-
Atg8 (called LC3 in mammals).These two systems rely on Atg6 (beclin-1 in 
mammals) which is crucial in early complex formation containing class III 
phosphoinositide3-kinase (PI3K, also known as VPS4), and eventually 
forming the autophagosome (Ohsumi and Mizushima, 2004). Another 
system involving Atg-8 (LC3) is cleaved by another autophagy related 
protein Atg-4 to expose its C terminal Glycine residue. This system is also 
similar to the first system  in which LC3 is activated by Atg7 and then 
transferred to Atg3 (a ubiquitin 2 like protein) The activated LC3 then forms 
complex with PE which is present abundantly in the membrane 
phospholipids of the cells (Ichimura et al., 2000) 
Recent research has demonstrated an essential role of autophagy in 
immune response against pathogens in many diseases including viral and 
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bacterial infections (Ogawa et al., 2005, Colombo, 2007). Virus and bacteria 
once engulfed by macrophages are capable of escaping from phagosome 
but they are taken up by autophagosome again for further survival and 
replication (Dorn et al., 2002, Campoy and Colombo, 2009). Autophagy 
potentially captures pathogens that have escaped from phagosome into the 
cytoplasm and thereby deliver it to autophagosomes and then to 
autolysosomes, where they are destroyed by the  lysosomal enzymes 
(Campoy and Colombo, 2009). 
According to some authors, the outcome of autophagy is specific for 
different types of bacteria and there are different mechanisms of autophagy 
for destruction of different bacteria (Colombo, 2007, Ogawa et al., 2005), i.e. 
Mycobacterium and group A Streptococci also induce autophagy  where 
they benefit from the host defence (Songane et al., 2012). Until now most of 
the studies demonstrated autophagy in the intracellular pathogens 
(Burdette et al., 2008, Ogawa et al., 2009, Songane et al., 2012) and very 
little is known about the autophagy induction in extracellular pathogens 
(Yuan et al., 2012).  
The inflammasome is a multi-subunit platform for the activation of 
caspase-1, resulting in processing of IL-1β and IL-18 from inactive 
precursors to their active secreted forms (Franchi et al., 2009, Martinon et 
al., 2009, Yu and Finlay, 2008). The inflammasome also triggers a form of 
cell death termed pyroptosis, itself also important in host defence (Miao et 
al., 2011). Although autophagy and inflammasome activation both play 
significant roles in host defence against microbial infection, they do have 
some clear opposing effects. Thus, autophagy can promote cell survival 
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(Baehrecke, 2005) while inflammasome activation will lead to cell death by 
pyroptosis (Bergsbaken et al., 2009). Additionally, autophagy can act to 
down-regulate inflammasome activation by the sequestration of defective 
mitochondria (Saitoh et al., 2008). This results in inhibiting the release of 
mitochondrial reactive oxygen intermediates and mitochondrial DNA that 
can activate the NLRP3 inflammasome (Martinon, 2012, Shimada et al., 
2012, Nakahira et al., 2011). The effects of inflammasome activation on 
autophagy are not known. 
 We hypothesized that inflammasome activation would lead to a 
reciprocal inhibition of autophagy. To test this hypothesis, we used a model 
system of infection of macrophages with the Gram-negative pathogen P. 
aeruginosa. This microbe is a common cause of pneumonia in 
immunocompromised and hospitalized patients, as well as cystic fibrosis 
(Pier and Ramphal, 2005). It activates the NLRC4 inflammasome through a 
type III secretion dependent pathway (Miao et al., 2008, Sutterwala et al., 
2007, Franchi et al., 2007). We demonstrate here that P. aeruginosa 
activates autophagy in macrophages following infection via the classical 
autophagy pathway. We show by multiple independent methods that 
inhibition of inflammasome and caspase-1 activation augments the 
autophagocytic response. 
To know whether autophagy is induced by P. aeruginosa, we studied 
this degradative mechanism in mammalian cells such as mice BMDMs, 
dendritic cells, RAW264.7 cells, J774A.1 cells, and human cell line THP-1 
cells. Our study revealed that autophagy is induced by P. aeruginosa in 
BMDMs through different pathways including Atg8 (LC3), Atg5 and Atg7. 
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Our observation could provide useful potential information for 
understanding this important mechanism in innate immune cells during 
infection with P. aeruginosa.  
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3.2 Results    
3.2.1 Pseudomonas aeruginosa induces autophagy that is enhanced in the 
absence of T3SS.  
P. aeruginosa PAO1 has been shown to induce autophagy (Yuan et 
al., 2012). We set out to determine the influence of the T3SS upon this 
process. We used a strain of P. aeruginosa, PA103ΔUΔT that has a 
functional T3SS but does not translocate any exotoxins, and an isogenic 
strain, PA103pcrV-, that lacks a functional T3SS (Frank et al., 2002, Vallis 
et al., 1999). Recent studies have demonstrated that inflammasome 
activation following infection is entirely dependent on a functional T3SS in 
both PAO1 and PA103ΔUΔT (Arlehamn and Evans, 2011, Sutterwala et al., 
2007). We used a number of different methods to quantify and confirm the 
presence of autophagy. Firstly, we followed the conversion of the protein 
LC3 to its lipidated form (LC3 II) by Western blot (Fig. 3-1), a modification 
that is produced following incorporation of LC3 into the autophagocytic 
vacuole (Mizushima et al., 2010). This clearly demonstrated a marked 
increase in the absolute amount of LC3 II relative to β-tubulin following 
infection, to levels in excess of those seen using the positive control of 
rapamycin, a classic inducer of autophagy. Moreover, the ratio of LC3 II to 
β-tubulin following infection with P. aeruginosa was consistently significantly 
greater with an otherwise isogenic strain that lacked PcrV, an essential 
component of the T3SS (Fig. 3-1, a, b and c).  
 We confirmed these observations using a number of different 
approaches. The localization of endogenous LC3 to autophagocytic 
vacuoles was visualized using immunofluorescence. Following infection 
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with P. aeruginosa, we observed a marked increase in the numbers of LC3 
containing vacuoles within BMDMs that was consistently significantly higher 
in the T3SS defective mutant (Fig. 3-2, a and b), and to a level comparable 
to that seen with rapamycin. Both in these experiments following LC3 by 
immunofluorescence and in those using Western blotting, we noticed that 
the apparent expression level of LC3 also increased. We quantified this 
using RT-PCR and found that P. aeruginosa infection increased the 
expression of Lc3b as has been described in the induction of autophagy in 
other systems, notably in yeast (Stromhaug and Klionsky, 2001). The 
increase in Lc3b expression was higher in the T3SS mutant (Fig. 3-2, c), 
consistent with the results obtained by Western blotting and 
immunofluorescence.  
Finally, we used a validated flow cytometric method to quantify 
intracellular LC3 II staining following cell permeabilization (Eng et al., 2010) . 
This was in agreement with our other results showing that the level of 
autophagy was increased in the absence of a functional T3SS (Fig. 3-2, d). 
Examination of infected cells by transmission electron microscopy 
confirmed the presence of autophagosomes containing cytoplasmic 
contents (Fig. 3-3) (Fig. 3-4). In these panels, the double membrane 
structure of the autophagosome is arrowed and surrounds another 
membrane bound organelle, probably degraded mitochondria as well as 
other cytoplasmic structures. During the time and dose course experiments 
we observed that P. aeruginosa induced autophagy which could be 
detected at 1hr with different MOI (5, 25) (Fig. 3-5).   
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  We confirmed that the increase in LC3 II reflected a real increase in 
flux through the autophagocytic pathway by repeating the experiment in the 
presence of inhibitors of lysosomal degradation (Fig. 3-6). This increased 
still further the amounts of LC3 II following infection, showing that the 
increased levels observed were due to greater flux of LC3 through the 
autophagocytic pathway and not inhibition of LC3 processing. Our data 
showed that conversion of LC3-I to LC3-II was increased when cells pre-
treated with lysosomes inhibitors such as Pepstatin A, E64d, and 
Bafilomycin A, which prevent loss of LC3-II during lysosomal degradation 
and recycling of the lipid conjugation form LC3-II to the cytosolic form LC3-I 
after fusion between autophagosome with lysosomes. Therefore these 
inhibitors increase the autophagy markers via blocking autophagy flux  
(Mizushima and Yoshimori, 2007). Importantly, under the conditions of 
these experiments, we did not observe a significant increase in cell death, 
as measured by the release of LDH (Fig. 3-7).  
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 Figure 3.1; Assessment of LC3 I and II levels in BMDMs cells infected with Pseudomonas aeruginosa.  
 
a, Western blot analysis of LC3-I and LC3-II protein levels in BMDM left untreated (B), infected 
with PA103ΔUΔT or PA103pcrV– strains of P. aeruginosa for 2,and 4 hrs (MOI 5), or treated 
with rapamycin (50µg/ml) for 4 h. Blot was stripped and reprobed for β-tubulin. b, BMDM left 
untreated (B), infected with PA103ΔUΔT or PA103pcrV– strains of P. aeruginosa for 3 hrs (MOI 
10), or treated with rapamycin (50µg/ml) for 4 hrs. Graph shows densitometric measurement of 
the ratio of LC3-II/ β-tubulin. * Statistically different from PA103ΔUΔT, p< 0.05. c,  BMDM left 
untreated (B), infected with PA103ΔUΔT or PA103pcrV– strains of P. aeruginosa for 4 h (MOI 
25), or treated with rapamycin (50µg/ml) for 4 hrs. Graph shows densitometric measurement of 
the ratio of LC3-II/ β-tubulin in 3 independent experiments. ** statistically different from 
PA103ΔUΔT, p < 0.01 (repeated in 3 independent experiments).      
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 Figure 3.2; P. aeruginosa induces autophagy in BMDMs that is enhanced in the absence of a functional T3SS. 
 
a , Representative immunofluorescence images of LC3 in BMDM left 
uninfected (Basal), treated with rapamycin, or infected with PA103ΔUΔT or 
PA103pcrV– strains for 4hrs at a MOI of 25. Cells were stained with DAPI to 
visualize nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm (5 
independent experiments). b, Number of LC3 puncta in BMDM cells following 
infection (at specified MOI) or rapamycin treatment as indicated cells were 
quantified using Image J software . Asterisks indicate statistically different from 
PA103ΔUΔT at the same MOI, * p < 0.05, *** p < 0.001. c, qRT-PCR of Lc3b 
mRNA following infection as indicated at a MOI of 25 for 4hr (3 independent 
experiments). ** Statistically different from PA103ΔUΔT, p < 0.01. d, FACS 
analysis for LC3 protein following infection with the strains indicated (MOI 25 
for 4h) or treatment with rapamycin (3 independent experiments). 
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 Figure 3.3; TEM observation of autophagosome in BMDMs infected with P. aeruginosa. 
 
Electron micrographs of autophagosomes in BMDM infected with PA103ΔUΔT 
or PA103pcrV– for 4hr, at (MOI 25). BMDM left uninfected (Basal), or treated 
with rapamycin 50µg/ml as a positive control. Arrows indicate autophagosomes 
in different stages. Scale bar 200 nm. 
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Figure 3.4; Ultrastructural analysis of Pseudomonas aeruginosa 
induced autophagy by TEM. 
 
Electron micrographs of autophagosomes in BMDM infected with 
PA103ΔUΔT or PA103pcrV– for 4hr, at (MOI 25). Arrows indicate 
autophagosomes in different stages.Graph represents quantitation of the 
number of autophagosomes per-cross sectioned cell.* Statistically different 
from PA103ΔUΔT, p < 0.05. 
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 Figure 3.5; P. aeruginosa  induced autophagy in a dose and time dependent manner. 
 
a ,Western blot analysis of LC3-I and LC3-II protein levels in BMDMs infected 
with    PA103ΔUΔT or PA103pcrV– for 1, 2, and 4hr,at (MOI 25). BMDM left 
uninfected (Basal), treated with rapamycin 50µg/ml for 4hrs as a positive control. 
b, Representative immunofluorescence images of LC3 in BMDMs were infected 
with PA103ΔUΔT or PA103pcrV– strains for indicated time  at (MOI 5, 25). Cells 
were stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as 
green. Scale bar 10 µm (5 independent experiments). c, Number of LC3 puncta 
in BMDM cells following infection (at specified MOI) . Asterisks indicate 
statistically different from PA103ΔUΔT at the same MOI. Columns are mean of 
five independent determinations; error bars are SEM. * p < 0.05, ** p < 0.01.  (5 
independent experiments). 
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 Figure 3.6; Lysosomes inhibitors increase autophagy flux . 
 
a ,b, Western blot analysis of LC3-I and LC3-II protein levels in BMDMs were   
infected with PA103ΔUΔT or PA103pcrV– for and 4hr in the presence (+) or 
absence(-) of 10µg/ml Pepstatin A , E64d (a) and 50nM/ml Bafilomycin A (b) ,at 
(MOI 25). BMDM left uninfected (Basal), treated with rapamycin 50µg/ml for 
4hrs as a positive control. c, Representative immunofluorescence images of 
LC3 in BMDMs were infected with PA103ΔUΔT or PA103pcrV– strains for 4hrs  
at (MOI  25). Cells were stained with DAPI to visualize nuclei (blue), and LC3 
staining is shown as green. Scale bar 10 µm .d, FACS analysis for LC3-II 
protein following infection with the strains indicated (MOI 25 for 4h) (3 
independent experiments).  
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 Figure 3.7; LDH release caused by P. aeruginosa in BMDMs. 
 
a, BMDMs were infected with PA103ΔUΔT or PA103pcrV– for 2hrs (MOI 5) . 
Supernatants were analysed for cytotoxicity caused by measurement of LDH 
release. b, Light microscope observation of BMDMs infected as indicated, or 
treated with 1% Triton-x as a positive control, or left without treatment (basal). 
Scale bar 10µm. (3 independent experiments).  
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3.2.2 Autophagy is induced by P. aeruginosa in several mammalian cells. 
 In order to investigate whether P. aeruginosa is able to induce 
autophagy in other mammalian cells, dendritic cells, J774A.1, RAW264.7 
cells, and THP-1 cells were infected with PA103ΔUΔT and PA103pcrV- as 
indicated. We used a number of different methods to quantify and confirm 
the presence of autophagy. Firstly, we followed the conversion of the 
protein LC3 to its lipidated form (LC3 II) by Western blot analysis and the 
localization of endogenous LC3 to autophagocytic vacuoles was visualized 
using immunofluorescence. Following infection with P. aeruginosa, we 
observed a marked increase in the number of LC3 containing vacuoles 
within cells that was consistently significantly higher in the T3SS defective 
mutant, to a level comparable to that seen with rapamycin. Both in these 
experiments following LC3 by immunofluorescence and in those using 
Western blotting, we noticed that the apparent expression level of LC3 also 
increased. We quantified this using RT-PCR and found that P. aeruginosa 
infection increased the expression of Lc3b as has been described in the 
induction of autophagy in other systems, notably in yeast following 
incorporation of LC3 into the autophagocytic, Finally, we used a validated 
flow cytometric method to quantify intracellular LC3 II staining following cell 
permeabilization. Our results showed PA induces autophagy. Since both 
strains induce autophagy, a functional T3SS does not seem to be required 
for this process (Figures (3-8), (3-9), (3-10), and (3-11) respectively).  
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 Figure 3.8; Induction of autophagy in THP-1 cells by P. aeruginosa. 
 
a ,Western blot analysis of LC3-I and LC3-II protein levels in THP-1 cells infected 
with    PA103ΔUΔT or PA103pcrV– for  2, and 4hr,at (MOI 25) or left uninfected 
(Basal). b, FACS analysis for LC3-II protein following infection with the strains 
indicated (MOI 25 for 4h) . c, Representative immunofluorescence images of 
LC3 in THP-1 left uninfected (Basal), treated with rapamycin as a positive 
control, or infected with PA103ΔUΔT or PA103pcrV– strains for 4hrs at a MOI of 
25. Cells were stained with DAPI to visualize nuclei (blue), and LC3 staining is 
shown as green. Scale bar 10 µm. d, Number of LC3 puncta in THP-1 cells 
following infection (at 25 MOI) or rapamycin treatment as indicated. Staining was 
quantified using Image J software. Asterisks indicate statistically different from 
PA103ΔUΔT at the same MOI. error bars are SEM. * p < 0.05. (3 independent 
experiments). 
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 Figure 3.9; Induction of autophagy in D.cells by P. aeruginosa. 
 
a ,Western blot analysis of LC3-I and LC3-II protein levels in D.Cs infected with    
PA103ΔUΔT or PA103pcrV– for 4hrs,at (MOI 25). D.Cs left uninfected (Basal) or 
treated with rapamycin as a positive control. b, Representative 
immunofluorescence images of LC3 in D.Cs left uninfected (Basal), treated with 
rapamycin as a positive control, or infected with PA103ΔUΔT or PA103pcrV– 
strains for 4hrs at a (MOI of 25). Cells were stained with DAPI to visualize nuclei 
(blue), and LC3 staining is shown as green. Scale bar 10 µm. c, Number of LC3 
puncta in D.Cs cells following infection (at 25 MOI) or rapamycin treatment as 
indicated. Staining was quantified using Image J software. Asterisks indicate 
statistically different from PA103ΔUΔT at the same MOI, * p < 0.05. d, qRT-PCR 
of Lc3b mRNA following infection as indicated at a MOI of 25 for 4hr (3 
independent experiments). * Statistically different from PA103ΔUΔT, p < 0.05. e, 
FACS analysis for LC3-II protein following infection with the strains indicated 
(MOI 25 for 4h) or treatment with rapamycin (3 independent experiments).  
 
90 
 
 
 
    
 Figure 3.10; Induction of autophagy in J774A.1 cells by P. aeruginosa. 
 
a, Western blot analysis of LC3-I and LC3-II protein levels in J774A.1 cells 
infected with  PA103ΔUΔT or PA103pcrV– for 4hrs,at (MOI 25) or left uninfected 
(Basal) or treated with rapamycin as a positive control. b, Representative 
immunofluorescence images of LC3 in J774A.1 left uninfected (Basal), treated 
with rapamycin as a positive control, or infected with PA103ΔUΔT or 
PA103pcrV– strains for 4hrs at a MOI of 25. Cells were stained with DAPI to 
visualize nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm. c, 
Number of LC3 puncta in J774A.1 cells following infection (at 25 MOI) or 
rapamycin treatment as indicated. Staining was quantified using Image J 
software. Asterisks indicate statistically different from PA103ΔUΔT at the same 
MOI, * p < 0.05.d, qRT-PCR of Lc3b mRNA following infection as indicated at a 
MOI of 25 for 4hr.* Statistically different from PA103ΔUΔT, p < 0.05. e, FACS 
analysis for LC3-II protein following infection with the strains indicated (MOI 25 
for 4h) or cells left untreated(Basal) (3 independent experiments).  
 
91 
 
 
 
    
 Figure 3.11; Induction of autophagy in RAW264.7 cells by P. aeruginosa. 
 
a, Western blot analysis of LC3-I and LC3-II protein levels in RAW264.7 cells infected with 
PA103ΔUΔT or PA103pcrV– for 4hrs,at (MOI 25) or left uninfected (Basal) or treated with 
rapamycin as a positive control. b, Representative immunofluorescence images of LC3 in 
RAW264.7 left uninfected (Basal), treated with rapamycin as a positive control, or infected 
with PA103ΔUΔT or PA103pcrV– strains for 4hrs at a MOI of 25. Cells were stained with 
DAPI to visualize nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm. c, 
Number of LC3 puncta in RAW264.7 cells following infection (at 25 MOI) or rapamycin 
treatment as indicated. Staining was quantified using Image J software. Asterisks indicate 
statistically different from PA103ΔUΔT at the same MOI, * p < 0.05.d, qRT-PCR of Lc3b 
mRNA following infection as indicated at a MOI of 25 for 4hr (3 independent experiments). 
* Statistically different from PA103ΔUΔT, p < 0.05. e, FACS analysis for LC3-II protein 
following infection with the strains indicated (MOI 25 for 4h) or treatment with rapamycin 
(3 independent experiments).  
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3.2.3 Pseudomonas aeruginosa induced autophagy in BMDMs cells via 
classical autophagy pathway 
We tested the role of the genes involved in the classical 
autophagocytic pathway. Knockdown of Lc3b confirmed that the signals 
used to quantify autophagy by analysis of LC3 by Western blot, 
enumeration of puncta, RT-PCR and flow cytometry were indeed specific 
for this gene and protein (Fig. 3-12). In a similar fashion, we tested the 
dependence of autophagy following P. aeruginosa infection on the genes 
Atg7 and Atg5. Infection of BMDMs from mice with a conditional KO of Atg7 
in bone marrow precursors (Mortensen et al., 2010) compared to control 
BMDMs showed a large significant reduction in the processing of LC3 to its 
lipidated form  as well as the accumulation of LC3 in autophagocytic 
vacuoles,and RT-PCR  (Fig. 3-13). Finally, using siRNA to knockdown Atg5, 
we showed that, as with Atg7, this resulted in a reduction in LC3 lipidation, 
accumulation of autophagocytic puncta and increased detection of 
intracellular LC3 as assayed by flow cytometry (Fig. 3-14). Using the same 
assays, we also showed the autophagy following infection was inhibited by 
3-methyladenine (Fig. 3-15), and (Fig. 3-16) respectively.   
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 Figure 3.12;  P. aeruginosa induced autophagy is dependent on Lc3b. 
 
a, Western blot analysis of LC3-I and LC3-II protein levels in BMDMs. Cells transfected with 
siRNA against Lc3b then infected with PA103ΔUΔT or PA103pcrV– for 4hrs,at (MOI 25) or 
left uninfected (Basal). b, Levels of intracellular LC3-II assayed by flow cytometry following 
treatments as indicated. c, Representative immunofluorescence images of LC3 in BMDMs 
left uninfected (Basal), treated with rapamycin as a positive control, or infected with 
PA103ΔUΔT or PA103pcrV– strains for 4hrs at a MOI of 25. Cells were stained with DAPI to 
visualize nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm. d, 
Quantification of LC3 puncta present per cell following treatments and infections as 
indicated. *** denotes significant difference between control and Lc3b siRNA, p < 0.001. e, 
qRT-PCR of Lc3b mRNA levels following treatments as shown; *** significant difference 
between control and Lc3b, p < 0.001 . (3 independent experiments).  
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Figure 3.13;  P. aeruginosa induced autophagy is dependent on Atg7. 
a, Western blot analysis of LC3-I and LC3-II protein levels in BMDMs lacking Atg7 (Vav-
Atg-/-) vs WT BMDMs Vav-Atg7+/+ . Cells were infected with PA103ΔUΔT or PA103pcrV– 
for 4hrs,at (MOI 25) or left uninfected (Basal). b, Representative immunofluorescence 
images of  BMDMs lacking Atg7 (Vav-Atg-/-) vs WT. Cells left uninfected (Basal), or 
infected with PA103ΔUΔT or PA103pcrV– strains for 4hrs at a MOI of 25. Cells were 
stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as green. Scale bar 
10 µm. c, Quantification of LC3 puncta present per cell following treatments and infections 
as indicated. *** denotes significant difference between BMDMs WT and Vav-Atg7-/-, p < 
0.001. d,  qRT-PCR of Lc3b mRNA levels following treatments as shown; ** significant 
difference between BMDMs WT and Vav-Atg7-/-, p < 0. 01. (3 independent experiments).  
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Figure 3.14; P. aeruginosa induced autophagy is dependent on Atg5. 
 a, Western blot of Atg5 was performed to show the successful reduction in Atg5. β-
tubulin was probed as a loading control. b, Representative immunofluorescence images 
of LC3 in BMDMs left uninfected (Basal) or infected with PA103ΔUΔT or PA103pcrV– 
strains for 4hrs at a MOI of 25. Cells were stained with DAPI to visualize nuclei (blue), 
and LC3 staining is shown as green. Scale bar 10 µm. c, Quantification of LC3 puncta 
present per cell following treatments and infections as indicated. *** denotes significant 
difference between control and Atg5 siRNA, p < 0.001. d, Levels of intracellular LC3-II 
assayed by flow cytometry following treatments as indicated. e, qRT-PCR of Lc3b 
mRNA levels following treatments as shown; ** significant difference between control 
and Atg5, p < 0.01 . (3 independent experiments). 
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Figure 3.15; 3-MA inhibits autophagy following P.aeruginosa infection in BMDMs. 
 BMDMs were infected with P.aeruginosa at (MOI 25) for the indicated time in hours in 
the presence (+) or absence (–) of 3-MA (10 mM). a, Western blot analysis of LC3-I and 
LC3-II protein levels in BMDMs cells infected with PA103ΔUΔT or PA103pcrV– for 
4hrs,at (MOI 25) or left uninfected (Basal) or treated with rapamycin as a positive 
control. b, Representative immunofluorescence images of LC3 in BMDMs left uninfected 
(Basal) or infected with PA103ΔUΔT or PA103pcrV– strains for 4hrs at a MOI of 25. 
Cells were stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as 
green. Scale bar 10 µm. c, Quantification of LC3 puncta present per cell following 
treatments and infections as indicated. *** significant difference between infected 
BMDMs±3-MA, p < 0.001.d, qRT-PCR of Lc3b mRNA levels following treatments as 
shown; *** significant difference between infected BMDMs ±3-MA, p < 0.001 . (3 
independent experiments). 
 . 
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Figure 3.16; 3-MA inhibits autophagy following P.aeruginosa infection in THP-1 
cells. 
THP-1 were infected with PA103ΔUΔT (MOI 25) for the indicated time in hours in the 
presence (+) or absence (–) of 3-MA (10 mM). Levels of intracellular LC3-II assayed by 
flow cytometry following treatments as indicated. Cells left uninfected (Basal), or 
infected with PA103ΔUΔT, and PA103pcrV- strain for 4hrs at a MOI of 25. 
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3.2.4  Caspase-1 activation by the inflammasome down regulates autophagy.   
The reduction in autophagy following infection with P. aeruginosa in 
a strain with a functional as compared to a non-functional T3SS suggested 
that this might be due to the effects of caspase-1 activation by the 
inflammasome that is induced by the T3SS. We thus tested the effect of Z-
YVAD-FMK, a selective caspase-1 inhibitor, on autophagy following 
PA103ΔUΔT infection. This drug produced the expected reduction in 
caspase-1 processing and secretion of IL-1β as shown in (Fig. 3-17). 
Inhibition of caspase-1 with this drug increased autophagy following 
infection as evidenced by enhanced levels of LC3- II as detected by 
Western blotting and a marked increase in the number of LC3 containing 
vacuoles. Additionally, level of lc3b mRNA increased as shown by RT-PCR, 
and increased intracellular staining of LC3-II as assayed by flow cytometry 
(Fig. 3-18). We repeated this experiment using different mammalian cells. 
Again, in the presence of caspase-1 inhibitor, we observed a marked 
increase in the level of LC3II as detected by western blotting, and increased 
intracellular staining of LC3-II assayed by flow cytometry (Fig. 3-19). 
 To confirm the role of caspase-1 in inhibiting autophagy, we 
measured levels of LC3 II following infection of BMDMs derived from mice 
lacking capase-1. This showed an increase in the conversion of LC3 I to 
LC3 II following infection in the absence of caspase-1 (Fig. 3-20).  However, 
caspase-1 knockout animals also lack a functional caspase-11, which has 
been shown to be important in inflammasome activation with various 
bacteria, but not P. aeruginosa possessing a functional T3SS that we are 
using in our experiments (Rathinam et al., 2012, Kayagaki et al., 2011).  We 
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tested specifically for a role of caspase-1 by knocking down the gene using 
siRNA (Fig. 3-21a). Knockdown of caspase-1 increased LC3 lipidation and 
formation of autophagocytic puncta, increased expression of lc3b mRNA, 
and increased intracellular staining of LC3-II as assayed by flow cytometry  
(Fig. 3-21c, d, e, and f) respectively. We tested for involvement of caspase-
11 by knocking down the protein using siRNA (Fig. 3-22a). This had no 
effect on induction of autophagy or production of IL-1β following infection 
(Fig. 3-22b-e).Taken together, these results demonstrate that activated 
casapse-1 inhibits the process of autophagy following infection with P. 
aeruginosa and that caspase-11 is not involved. 
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Figure 3.17; Inflammasome activation by P.aeruginosa is inhibited by caspase-1 inhibitor 
Z-YVAD-FMK. 
a, BMDMs were infected with PA103ΔUΔT (MOI 25) for the indicated time in hours in the 
presence (+) or absence (–) of the capsase-1 inhibitor Z-YVAD-FMK (10µM/ml). The panels 
show Western blot of pro-caspase-1, the caspase-1 p10 subunit, and β-tubulin as a loading 
control. b, Western blot analysis of Pro-IL-1β and mature IL-1β in cell supernatants form 
BMDMs infected as indicated in the presence(+) or absence(-) of the caspase-1 inhibitor Z-
YVAD-FMK(10µM/ml). c, IL-1β levels following infection as indicated in the absence (open bars) 
or presence (filled bars) of Z-YVAD-FMK. Column shows the mean;  error bars are SEM. ** and 
*** indicate significant differences between the levels in the presence and absence of the 
inhibitor, p < 0.01 and < 0.001 respectively. d, percent cytotoxicity in supernatant were 
measured using LDH release.  (3 independent experiments). 
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Figure 3.18; Caspase-1 inhibitor Z-YVAD-FMK Up-regulates autophagy following    
P.aeruginosa infection. 
a, BMDMs were infected with PA103ΔUΔT (MOI 25) for the indicated time in hours in the 
presence (+) or absence (–) of the capsase-1 inhibitor Z-YVAD-FMK (10µM/ml). The panels show 
Western blot analysis of LC3-I and LC3-II protein levels, and β-tubulin as a loading control. b, 
densitometric ratio of LC3-II to β-tubulin for 5 independent experiments; each column shows the 
mean; error bar is SEM. ***, significantly different between untreated and treated cells, p < 
0.001.c, Representative immunofluorescence images of LC3 in BMDMs left uninfected (Basal) , 
or infected with PA103ΔUΔT  for 4hrs at a MOI of 25 in the presence (+) or absence (–) of the 
capsase-1 inhibitor Z-YVAD-FMK (10µM/ml) . Cells were stained with DAPI to visualize nuclei 
(blue), and LC3 staining is shown as green. Scale bar 10 µm. d, Quantification of LC3 puncta 
present per cell following treatments and infections as indicated. *** significant difference between 
infected BMDMs± Z-YVAD-FMK, p < 0.001. e, Levels of intracellular LC3-II assayed by flow 
cytometry following treatments as indicated. f, qRT-PCR of Lc3b mRNA levels following 
treatments as shown; ** significant difference between BMDMs ± Z-YVAD-FMK, p < 0.01 . (3 
independent experiments).    
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Figure 3.19; Caspase-1 inhibitor Z-YVAD-FMK Up-regulates autophagy following   
P.aeruginosa infection in mammalian cells. 
a, Cells  were infected with PA103ΔUΔT (MOI 25) for 4hrs in the presence (+) or absence (–
) of the capsase-1 inhibitor Z-YVAD-FMK (10µM/ml). The panels show Western blot 
analysis of LC3-I and LC3-II protein levels, and β-tubulin as a loading control. b, Secreated 
IL-1β  released during  infection as indicated in the absence  or presence  of Z-YVAD-FMK 
a measured by ELISA. ** and *** indicate significant differences between the levels in the 
presence and absence of the inhibitor, p < 0.01 and < 0.001 respectively. c, Levels of 
intracellular LC3-II assayed by flow cytometry following treatments as indicated .  (2 
independent experiments). 
 . 
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Figure 3.20; Caspase-1 Knockout BMDMs  Up-regulate autophagy following    
P.aeruginosa infection. 
a, IL-1β levels in supernatants of BMDMs treated as shown (MOI of 25) in WT (open bars) 
and Casp1-/- animals (filled bars). Bars are mean of triplicate determinations; error bars are 
SEM. *** significant difference between animal groups, p < 0.001. b, Western blot of LC3 I 
and II isoforms in cells left uninfected (Basal), treated with rapamycin (R), or infected with 
PA103ΔUΔT (MOI 25) for the indicated time in hours in WT (Casp1+/+) mice or in animals 
lacking Caspase-1 (Casp1-/-). Experiment repeated with the same results. 
  
 . 
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Figure 3.21; Caspase-1 Knock -down Up-regulated autophagy following    
P.aeruginosa infection. 
a, Western blot of caspase-1 was performed to show the successful reduction in levels 
after siRNA knockdown. β-tubulin was probed as a loading control. b,  IL-1β levels in 
supernatants of BMDMs treated as shown (MOI of 25) in control siRNA against Casp1 
siRNA BMDMs. Bars are mean of triplicate determinations; error bars are SEM. ** 
significant difference between animal groups, p < 0.01. c, Western blot analysis of LC3 I 
and II levels following infection for 4h at MOI of 25 with PA103ΔUΔT as show in BMDMs 
transfected with control siRNA  or siRNA specific for caspase-1 . d, shows the ratio of LC3 
II/β-tubulin with indicated treatments for 3 independent experiments. Bars are means; error 
bars are SEM. **, significantly different from control siRNA. e, Levels of intracellular LC3 
assayed by flow cytometry following treatments as indicated. f, Representative 
immunofluorescence images of LC3 in BMDMs left uninfected (Basal) or infected with 
PA103ΔUΔT  for 4hrs at a MOI of 25. Cells were stained with DAPI to visualize nuclei 
(blue), and LC3 staining is shown as green. Scale bar 10 µm. g, Quantification of LC3 
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puncta present per cell following treatments and infections as indicated. *** denotes 
significant difference between control siRNA and Casp.1 siRNA, p < 0.001. h, qRT-PCR of 
Lc3b mRNA levels following treatments as shown; * significant difference between control 
and caspase-1, p < 0.05. (3 independent experiments). 
 
  
 . 
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Figure 3.22; Caspase-11 does not influence autophagy following  P.aeruginosa 
infection. 
a, Western blot of caspase-11 was performed to show the successful reduction following 
siRNA knockdown. β-tubulin was probed as a loading control. b,  IL-1β levels in 
supernatants of BMDMs treated as shown (MOI of 25) in  control siRNA against caspase-
11 siRNA BMDMs. Bars are mean of triplicate determinations; error bars are SEM. ns is 
non- significant difference between  groups, p > 0.05. c, Western blot analysis of LC3 I and 
II levels following infection for 4h at MOI of 25 with PA103ΔUΔT as show in BMDMs 
transfected with control siRNA  or siRNA specific for caspase-11.  d, Levels of intracellular 
LC3-11 assayed by flow cytometry following treatments as indicated. e, qRT-PCR of Lc3b 
mRNA levels following treatments as shown; ns is non- significant difference between 
control and capase-11, p > 0.05 .  
 
  
 . 
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 This inhibitory effect of caspase-1 on autophagy was most likely 
mediated by the activation of the NLRC4 inflammasome following P. 
aeruginosa infection. To confirm this supposition, we assayed the amount 
of autophagy observed following P. aeruginosa infection after inhibition of 
this inflammasome by various means. Previously, it has been shown that 
elevation of extracellular K+ inhibits NLRC4 inflammasome activation by P. 
aeruginosa (Lindestam Arlehamn et al., 2010). We confirmed that BMDMs, 
THP-1 cells, dendritic cells, and J774A.1cells incubated in a high 
extracellular concentration of K+ had a markedly attenuated production of 
caspase-1 p10 and IL-1β following infection (Fig. 3-23), while maintaining 
very similar levels of production of TNF-α (Fig. 3-23b). This inhibitory effect 
on inflammasome activation resulted in elevation of the levels of LC3 II, 
increased numbers of autophagocytic puncta, increased expression of lc3b 
mRNA, and increased intracellular staining of LC3-II as assayed by flow 
cytometry (Fig. 3-24) (Fig. 3-25). Similarly, in BMDMs derived from animals 
with a targeted gene deletion of Nlrc4, infection with P. aeruginosa resulted 
in increased conversion of LC3 to its lipidated form, and increased numbers 
of autophagocytic puncta (Fig. 3-26). Knockdown of Nlrc4 mRNA with 
siRNA also increased autophagy following infection, as evidenced by an 
increase in the numbers of autophagocytic LC3 containing puncta per cell, 
and increased formation of LC3 II as well as intracellular LC3 and levels of 
Lc3b mRNA (Fig. 3-27). Taken together, these data demonstrate that 
activation of the NLRC4 inflammasome following P. aeruginosa infection 
leads to an inhibition of autophagy and that this is directly mediated by 
caspase-1. 
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Figure 3.23; Inflammasome activation following P.aeruginosa infection is dependent on 
Potassium efflux.           
BMDMs, THP-1cells, D.Cs, and J774A.1 cells were incubated in media with normal K+ (5 mM; Low K+) 
or high K+ (140 mM) as indicated and infected with PA103ΔUΔT (4h, MOI of 25) and levels of processed 
caspase-1, and procaspase-1 (a), secreted IL-1β, and secreted TNF (b) determined as shown. 
Columns are means of triplicate determinations; error bars are SEM. Open bars are in low K+, closed 
bars high K+. ***, significantly different from levels seen with low K+ (p < 0.001). c, Western blot analysis 
of Pro-IL-1β and mature IL-1β in cell supernatants form BMDMs infected as indicated in  media with 
normal K+ (5 mM; Low K+) or high K+ (140 mM) as indicated. d – f, shows Western blot analysis of pro-
caspase- 1 , caspase-1, and mature IL-1β in cells lysates, and β-tubulin was probed as a loading 
control in DCs(d), THP-1 cells(e), or J774A.1 cells(f) . Graphs show IL-1β secretion was measured by 
ELISA. Columns are means of triplicate determinations; error bars are SEM. Open bars are in low K+, 
closed bars high K+. **, ***, significantly different from levels seen with low K+ (p<0.01),(p < 0.001) 
respectively. (Experiments repeated three times).  
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Figure 3.24; Blocking K+ efflux up-regulates level of autophagy  following P.aeruginosa 
infection. 
BMDMs  were incubated in media with normal K+ (5 mM; Low K+) or high K+ (140 mM) as indicated 
and infected with PA103ΔUΔT (4h, MOI of 25). a, Western blot analysis of LC3 I and II levels 
following infection for 4h at MOI of 25 with PA103ΔUΔT. b, shows the ratio of LC3 II/β-tubulin with 
indicated treatments for 5 independent experiments. Bars are means; error bars are SEM. ***, 
significantly different between groups, (p < 0.001). c, Representative immunofluorescence images of 
LC3 in BMDMs left uninfected (Basal) or infected with PA103ΔUΔT  for 4hrs at a MOI of 25. Cells 
were stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as green. Scale bar 10 
µm. d, Quantification of LC3 puncta present per cell following treatments and infections as indicated. 
*** significant difference between group, p < 0.001. e, Levels of intracellular LC3-II assayed by flow 
cytometry following treatments as indicated. f, qRT-PCR of Lc3b mRNA levels following treatments 
as shown; * significant difference between groups, p < 0.05 . (3 independent experiments).   
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Figure 3.25; Blocking Potassium efflux up-regulates level of autophagy following 
P.aeruginosa infection in different mammalin cells. 
 THP-1cells, D.Cs, and J774A.1 cells were incubated in media with normal K+ (5 mM; Low K+) or 
high K+ (140 mM) as indicated and infected with PA103ΔUΔT (4h, MOI of 25). a, Western blot 
analysis of LC3 I and II levels following infection for 4h at MOI of 25 with PA103ΔUΔT. b, 
Representative immunofluorescence images of LC3 in BMDMs left uninfected (Basal) , or 
infected with PA103ΔUΔT  for 4hrs at a MOI of 25. Cells were stained with DAPI to visualize 
nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm. c, Levels of intracellular 
LC3-II assayed by flow cytometry following treatments as indicated. (Experiments repeated 
three times).   
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Figure 3.26; Nlrc4 influences level of autophagy following P. aeruginosa infection. 
  a, IL-1β levels in supernatants of BMDMs treated as shown (MOI of 25) in WT  and Nlrc4-/- 
animals. Bars are mean of triplicate determinations; error bars are SEM. *** significant 
difference between animal groups, p < 0.001. b, Western blot of LC3 I and II isoforms in cells 
left uninfected (Basal), or infected with PA103ΔUΔT (MOI 25) for 4hrs in WT (Nlrc4+/+) mice 
or in animals lacking Nlrc4 (Nlrc4-/-). c, Representative immunofluorescence images of LC3 in 
BMDMs left uninfected (Basal) or infected with PA103ΔUΔT  for 4hrs at a MOI of 25. Cells 
were stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as green. Scale 
bar 10 µm. Experiment repeated with the same results. 
 
  
 . 
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Figure 3.27; Nlrc4 Knock-down up-regulates  autophagy following P. aeruginosa 
infection. 
a, Western blot of Nlrc4 was performed to show the successful reduction in Nlrc4. β-tubulin 
was probed as a loading control. b,  IL-1β levels in supernatants of BMDMs treated as shown 
(MOI of 25) in control siRNA against Nlrc4 siRNA treated BMDMs. Bars are mean of triplicate 
determinations; error bars are SEM. *** significant difference between groups, p < 0.001. c, 
Western blot analysis of LC3 I and II levels following infection for 4h at MOI of 25 with 
PA103ΔUΔT as show in BMDMs transfected with control siRNA  or siRNA specific for Nlrc4 .   
d, Representative immunofluorescence images of LC3 in BMDMs left uninfected (Basal) or 
infected with PA103ΔUΔT  for 4hrs at a MOI of 25. Cells were stained with DAPI to visualize 
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nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm. e, Quantification of LC3 
puncta present per cell following treatments and infections as indicated. *** Significant 
difference between control siRNA and Nlrc4 siRNA, p < 0.001. f, Levels of intracellular LC3 
assayed by flow cytometry following treatments as indicated. g, qRT-PCR of Lc3b mRNA 
levels following treatments as shown; ** significant difference between control and Nlrc4, p < 
0.01 . (3 independent experiments). 
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3.3 Discussion          
In our study, we found that P. aeruginosa infection induces 
autophagy in macrophages, D.Cs, J774A.1 and RAW264.7 cells, and the 
human cell line THP-1 cells. We observed that autophagy could be induced 
in macrophages through a classical pathway including Atg7 and Atg5. We 
also observed the involvement of LC3 (Atg-8) in the induction of autophagy 
through P. aeruginosa. Previous literature has shown the induction of 
autophagy with intracellular bacteria but the involved pathway, the impact 
and outcome of infection with these bacteria remained is different as 
compared to P. aeruginosa. 
P. aeruginosa is considered as an extracellular bacterium and its 
virulence factors e.g. biofilms and type III secretion systems are crucial in 
its pathogenicity (Hoiby et al., 2011). These virulence factors could possibly 
be involved in the autophagic pathway.  
As we know from the previous literature that new microtubule 
associated protein light chain-3 MAP-LC3 is produced in the cells and is 
processed at its C terminus through an autophagy related protein, Atg4. 
After processing LC3 is converted to LC3-I and is distributed in the 
cytoplasm. When there are some stressful conditions like starvation or 
infection, LC3-1 is converted to LC3-II by the conjugation of phosphatidyl 
ethanolamine (PE) (Ichimura et al., 2004). The conjugated form of LC3 is 
distributed to both outer and inner membranes of autophagosome, a double 
membrane vesicle inside the cells. The presence of LC3-II is used as a 
typical marker for the autophagy detection. 
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Rapamycin a widely used autophagy inducer was used as positive 
control and we found a similar strong signal in samples infected with 
Pseudomonas aeruginosa mutant strain pcrV- and found that there is 
increase in the signal produced by the bacterial infection. When we 
compared our results using genetic methods such as Atg7 knock out 
animals , Atg5 siRNA, and Lc3b siRNA, or with 3 Methyl adenine (3MA), we 
found that autophagy was inhibited and the production of LC3 positive 
markers decreased with 1 hour pre-treatment with 3-MA. 
In our experimental work, we used some genetic methods to inhibit 
autophagy. Deletion of Atg7 blocked autophagy induction by the bacterium 
P. aeruginosa. Similarly Atg5-siRNA transfection was also performed and 
found also resulted in autophagy inhibition. These experiments together 
indicated that P. aeruginosa induces autophagy and is dependent upon the 
classical pathway for autophagy.  
Macrophages play an important role in innate and adaptive immunity 
during bacterial infection and the induction in these macrophages could 
impact infection with P. aeruginosa. To find whether autophagy only occurs 
in BMDMs, we also investigated P. aeruginosa infection in murine D.Cs, 
J774A.1 cells, RAW264.7 cells and the human cell line THP-1 cells. A 
similar pattern of autophagy induction was seen in these cells.  
  
In conclusion, the results presented in this chapter demonstrate that 
the extracellular bacterium P. aeruginosa infection induced autophagy in 
BMDMs, DCs, J774A.1 cells, RAW264.7 cells, and THP-1 cells. We have 
studied this using the human pathogen P. aeruginosa and different cell type. 
To determine the role of the T3SS in this process, we utilised two bacterial 
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strains, both derivatives of the type strains, PA103ΔUΔT has a fully 
functional T3SS but does not translocate any bacterial exotoxins and 
PA103pcrV- lacks a functional T3SS.Our results showed PA induces 
autophagy. Since both strains induce autophagy, a functional T3SS does 
not seem to be required for this process. PA also infection also strongly 
induced activation of the inflammasome which was absolutely dependent 
on a functional T3SS. We found that inhibition of inflammasome activation 
increased autophagy, suggesting that the inflammasome normally inhibits 
this process. Loss of type III secretion increased autophagy, which was due 
to NLRC4 activation and caspase-1 activity. We also addressed another 
important question: what specific role does autophagy play in the immune 
response? 
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4     TRIF –Dependent TLR4 signalling is required for 
Pseudomonas aeruginosa induced autophagy 
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4.1 Introduction  
Microbial interactions with host immune cells can trigger a number of 
innate immune responses (Akira et al., 2006, Kumar et al., 2009, Diacovich 
and Gorvel, 2010). Two fundamental processes that can be initiated are 
those of macroautophagy (Orvedahl and Levine, 2009, Deretic and Levine, 
2009) (hereafter termed autophagy) and activation of the inflammasome 
(Martinon et al., 2009, Franchi et al., 2012b). Autophagy is a process that 
results in sequestration of cytoplasmic contents within a membranous 
vacuole that then fuses with lysosomes, ultimately resulting in degradation 
and recycling of the vacuole contents (Kundu and Thompson, 2008). 
Autophagy has now been to occur found in almost all eukaryotic cells, with 
genes controlling the pathway being highly conserved from yeast to 
mammals (Stromhaug and Klionsky, 2001). Autophagy also occurs in 
response to microbial infection and has been shown to be important in host 
defence against a number of microbes, such as Mycobacterium 
tuberculosis, group A streptococcus, Shigella flexneri, Salmonella enterica, 
and Listeria monocytogenes, viruses such as herpes simplex virus type 
1(HSV-1), and parasites such as Toxoplasma gondii  (Songane et al., 2012, 
Birmingham et al., 2006, Py et al., 2007, Iwasaki, 2007, Andrade et al., 
2006) as well as enhancing antigen presentation in adaptive immune 
response to a variety of pathogens (Patterson and Mintern, 2012).  
TLR4 is the signаlling receptor thаt mediаtes а robust inflаmmаtory 
response to LPS, but it requires severаl co-receptors аs well аs аdаptor 
molecules for signаl trаnsduction (Lu et al., 2008).Toll-like receptors (TLRs) 
are membrane-expressed signaling pattern recognition receptors (PRRs). 
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For example, TLR2, and TLR4, distributed on the cell surface, and 
TLR3/7/8/9, located within endosomаl compartments, can recognize viral 
molecular determinants. With the exception of TLR3, all these TLRs recruit 
the аdаptor MyD88 upon engagement. TLR4 recruits in addition the аdаptor 
TRIF, which is also used by TLR3. MyD88 аssociаtes with а serine 
proteаse to trаnsduce signаls to аctivаte nucleаr fаctor-kаppа B (NF-κB), а 
trаnscription fаctor thаt regulаtes the synthesis of inflаmmаtory cytokines 
(Lebeis et al., 2009). TRIF relаys signаls leаding to the аctivаtion of type I 
IFN regulаtory trаnscription fаctors (IRF), for type I IFN synthesis. A 
MyD88-dependent signal may also trigger type I IFN production upon virus 
infection. Newly synthesized type I IFN аre the mаjor effector cytokines of 
the host immune response аgаinst virаl infections. They bind to the type I 
IFN receptor (IFNAR) which transduces signals leading to the expression of 
hundreds of IFN stimulating genes (ISGs) that have а direct аntivirаl effect 
(Guo and Cheng, 2007).  
We demonstrate in chapter three that P. aeruginosa activates 
autophagy in macrophages following infection via the classical autophagy 
pathway. We show by multiple independent methods that inhibition of 
inflammasome and caspase-1 activation augments the autophagocytic 
response. This inhibitory effect of caspase-1 on induction of autophagy is 
shown to result from caspase-1 mediated cleavage of the signalling 
intermediate TRIF, an essential part of the TLR4 mediated signalling 
pathway leading to promotion of autophagy (Xu et al., 2007). Moreover, we 
also found that caspase-1 cleavage of TRIF reduced the signalling required 
to induce type I IFNs. We show that these inhibitory effects of activated 
caspase-1 have important functional effects, reducing macrophage 
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phagocytosis and reactive oxygen generation. Additionally, the caspase-1 
mediated down-regulation of autophagy results in a reduction of NLRP3 
inflammasome activation by LPS+ATP.  
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4.2 Results  
4.2.1 Autophagy following P. aeruginosa infection is mediated via 
TLR4 and TRIF.     
LPS has been shown to induce autophagy through TLR4 signalling 
to the intermediate TRIF (Xu et al., 2007). We hypothesised that a similar 
pathway might operate to induce autophagy following P. aeruginosa 
infection. We tested this by measuring the amount of autophagy in BMDMs 
from mice with a targeted deletion of Tlr4 compared to wild-type animals. 
Firstly, we confirmed that LPS induced autophagy in BMDMs by assaying 
for conversion of LC3 I to the lipidated LC3 II form. This conversion was 
significantly abrogated in BMDMs from Tlr4 KO mice, reduced numbers of 
autophagocytic puncta, and reduced intracellular LC3 II as assayed by flow 
cytometry (Fig 4-1). We then followed the conversion of LC3 to its lipidated 
form over time following P. aeruginosa infection (Fig 4-2a). This showed 
clearly that the increase in autophagy following infection was largely 
abolished in the absence of TLR4, both for the PA103ΔUΔT and 
PA103pcrV– strains. Autophagy induced by rapamycin was, as expected, 
not diminished in the absence of TLR4 (Fig 4-2a). To confirm these 
observations, we followed the accumulation of LC3 puncta following 
infection as a marker of autophagy. This also showed a virtual abolition of 
autophagy following infection in the absence of TLR4 (Fig 4-2a and b). 
Finally, using siRNA to knockdown Tlr4, our results showed reduced 
intracellular LC3 II as assayed by flow cytometry (Fig 4-2d). 
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Figure 4.1; LPS induces autophagy via Tlr4 dependent signaling. 
 a, Western blot analysis of LC3 I and II levels. Cells were treated with LPS 500ng/ml for 
4h. b, Representative immunofluorescence images of LC3 in BMDMs left untreated 
(Basal), or treated with LPS 500ng/ml  for 4hrs. Cells were stained with DAPI to visualize 
nuclei (blue), and LC3 staining is shown as green. Scale bar 10 µm. c, Western blot of 
Tlr4 was performed to show the successful reduction in Tlr4. β-tubulin was probed as a 
loading control. d, levels of intracellular LC3 assayed by flow cytometry following 
treatments as indicated. e, electron micrographs of autophagosome in Tlr4 WT BMDMs 
after treated with 500ng/ml LPS for 4 hrs. Arrow indicated autophagosome. ( Experiments 
repeated 2 times) 
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Figure 4.2; Autophagic signaling is induced by Pseudomonas aeruginosa  via Tlr4 
dependent signaling. 
 a, LC3 I and II assayed by Western blotting in BMDMs from WT or Tlr4-/- mice (KO), 
uninfected (Basal), rapamycin (Rap) or infected with P. aeruginosa strains as indicated 
(MOI 25) for 1, 2 or 4 h. b, Representative immunofluorescence images of LC3 in 
BMDMs left uninfected (Basal) , or infected with P.aeruginosa strains as indicated(MOI 
25) for 4hrs. Cells were stained with DAPI to visualize nuclei (blue), and LC3 staining is 
shown as green. Scale bar 10 µm. c, Number of puncta per cell in BMDMs infected as 
shown under the conditions in panel b. Bars are means of 3 independent counts for at 
least 50 cells; error bars are SEM. ***, significantly different from WT cells, p < 0.001.d, 
Levels of intracellular LC3 assayed by flow cytometry following treatments as indicated. 
(Experiments repeated 2 times) 
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We then determined the role of Myd88 and TRIF in the induction of 
autophagy following P. aeruginosa infection. In macrophages from mice 
with a deletion of Myd88, there was no reduction in autophagy following 
infection with the PA103 strains or the wild type PAO1 (Fig 4-3a). In 
macrophages from mice with deletion of Trif, we found that autophagy as 
measured by conversion of LC3 I to the LC3 II form was greatly reduced 
(Fig 4-3b) following infection with both PA103 strains and the wild type 
PAO1. Similarly, the accumulation of LC3 puncta was abrogated in the 
absence of TRIF (Fig 4-3c and d). Taken together, these data show that P. 
aeruginosa induces autophagy via signalling through TLR4 and the 
intermediate TRIF.   
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Figure 4.3; TRIF is required for Pseudomonas aeruginosa induced autophagy. 
 a, b, Western blot analysis of LC3 I and II levels. Cells were infected with P. aeruginosa 
strains as indicated (MOI 25) for 4hr in wild type or Myd88 and Trif deficient macrophages 
(KO). c, Representative immunofluorescence images of LC3 in BMDMs left uninfected 
(Basal) , or infected with P.aeruginosa strains as indicated (MOI 25) for 4hrs. Cells were 
stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as green. Scale 
bar 10 µm. d, Number of puncta per cell in BMDMs infected as shown under the 
conditions in c. Bars are means of 3 independent counts for at least 50 cells; error bars 
are SEM. ***, significantly different between (WT) and (KO) Trif cells, p < 0.001. 
(Experiments repeated 3 times). 
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4.2.2 Caspase-1 Cleaves TRIF  
Caspases have been proposed to cleave the signalling intermediates 
Cardif and TRIF (Rebsamen et al., 2008). We hypothesised that one 
mechanism that could explain why caspase-1 activation down-regulated 
autophagy was through proteolytic cleavage of TRIF. To test this 
hypothesis we examined cell lysates for endogenous TRIF fragments 
following infection of BMDMs with P. aeruginosa. After infection with the 
inflammasome activating strain PA103ΔUΔT, we observed immunoreactive 
TRIF fragments between 28 – 30 kDa at 4 hours after infection. These were 
not seen following infection with the T3SS inactive strain PA103pcrV– which 
does not activate the inflammasome, and were also considerably reduced 
in the presence of ZYVAD-FMK, a caspase-1 inhibitor (Fig 4-4a). This was 
a highly reproducible finding, shown for four independent cell lysates in (Fig 
4-4b), although the separation of the cleaved product into two bands of 
similar molecular weight varied depending on the exact conditions under 
which the proteins were separated by SDS PAGE. The antibody used in 
these immunoblots recognises a C terminal epitope, thus suggesting that 
the cleavage site lies in the middle portion of TRIF (molecular weight 
74kDa), to generate the ~ 30kDa fragments seen in (Fig 4-4).  
To confirm that the observed cleavage products were produced by 
caspase-1, we examined lysates from BMDMs from mice with targeted 
deletion of the Caspase-1 gene as well as WT animals (Fig 4-5a). This 
showed that the cleavage products were absent following infection of 
BMDMs from the Capsase-1 knock out animals. We obtained the same 
results with knockdown of Caspase-1 (Fig 4-5b). Knockdown of caspase-11 
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had no effect on TRIF cleavage following infection (Fig 4-6a), which was 
also seen with the wild type PAO1 strain. In macrophages from NLRC4 
knockout mice, no TRIF cleavage was seen, either with PA103ΔUΔT or the 
wild type PAO1 (Fig 4-6b). Similarly, infection of BMDMs in high 
extracellular potassium (which inhibits inflammasome activation), also 
inhibited the appearance of these cleaved products (Fig 4-7).   
 
 
 
.  
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Figure 4.4; TRIF is cleaved following infection with P. aeruginosa PA103ΔUΔT strain. 
 a, Western blot using 12% acrylamide gel for TRIF in BMDMs lysates that were 
uninfected (Basal), or infected with the P. aeruginosa strains shown for 1, 2, and 4 hrs. 
Where shown, cells were treated with the caspase-1 inhibitor Z-YVAD-FMK. Full length 
and cleaved TRIF products are labelled. Molecular weight markers in kDa are shown to 
the left of the gel. The blot was re-probed for β-tubulin as a loading control (lower panel). 
Experiment repeated with the same results. b As a, but using 4-12% acrylamide gel; cells 
infected for 4h at MOI of 25. Each lane of infected samples represents an independent 
experiment. 
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Figure 4.5; TRIF is cleaved by Caspase-1 following P. aeruginosa activation of the 
inflammasome. 
 a, Western blot using 4-12% acrylamide gel for TRIF in BMDMs lysates from WT 
(Casp1+/+) or Casp1 KO mice (Casp1-/-) that were uninfected (Basal), or infected with the 
P. aeruginosa strains shown (MOI 25) for 4 hrs. Full length and cleaved TRIF products 
are labelled. Molecular weight markers in kDa are shown to the left of the gel. The middle 
panels shown Pro-caspase-1, Caspase-1, and mature IL-1β. The blot was re-probed for 
β-tubulin as a loading control (lower panel). Experiment repeated with the same results. b 
As a, but using BMDMs from control siRNA against Caspase-1 siRNA.  (Experiment 
repeated with the same results) 
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Figure 4.6;  Role of Nlrc4 and Caspase-11 in TRIF cleavage following P. aeruginosa 
infection. 
Western blot using 4-12% acrylamide gel for TRIF in BMDM lysates that were uninfected 
(Basal), or infected with the P. aeruginosa strains shown (MOI 25) for 4 hrs. Cells were 
transfected with Control siRNA or siRNA specific for Caspase-11 (a) and in BMDMs from 
(WT) or Nlrc4 (KO) mice (b). Full length and cleaved TRIF products are labelled. 
Molecular weight markers in kDa are shown to the left of the gel. Experiment repeated 
with the same results. 
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Figure 4.7; Role of extracellular Potassium in TRIF cleavage following P. aeruginosa 
infection. 
BMDMs cells were incubated in media with normal K+ (5 mM; Low K+) or high K+ (140 
mM).  Western blot using 4-12% acrylamide gel for TRIF in BMDM lysates that were 
uninfected (Basal), or infected with the P. aeruginosa strains shown for 4 hrs. Full length 
and cleaved TRIF products are labelled.  Molecular weight markers in kDa are shown to 
the left of the gel. Graph shows cytotoxicity under the same conditions, measured by LDH 
release.  
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Although these data show that caspase-1 is required for the 
generation of TRIF cleavage products, it might be an indirect effect via 
activation of other caspases or proteases by caspase-1. To prove that 
caspase-1 directly cleaved TRIF, we purified recombinant TRIF expressed 
in HEK cells with the FLAG epitope tag. The previous report that suggested 
TRIF was a substrate for caspase cleavage identified the aspartic acid 
residues at positions 281 (VAPDA) and 289 (GLPDT) of the human 
sequence as essential for caspase-mediated cleavage (Rebsamen et al., 
2008). Mutation of both of these residues to glutamic acid residues (D281E 
D289E) effectively abolished caspase cleavage. Murine TRIF has similar 
well conserved caspase-1 cleavage sites at positions 286 (ILPDA) and 292 
(AAPDT). We thus additionally purified recombinant FLAG-tagged D281E 
D289E TRIF from HEK cells. The purified proteins were then incubated with 
recombinant activated human caspase-1. This cleaved the WT TRIF but not 
the D281E D289E mutant. Thus, caspase-1 directly cleaves TRIF (Fig 4-8). 
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Figure 4.8; Caspase-1 is required for the generation TRIF cleavage products. 
HEK cells were transfected with WT TRIF-FLAG, and D281E D289E TRIF-FLAG 
plasmids.  Purified recombinant TRIF proteins as shown incubated with active caspase-1 
as shown and analysed by Western blot for the FLAG epitope.   
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4.2.3 Prevention of TRIF Cleavage by Caspase-1 Augments Autophagy 
 To confirm that the cleavage products we observed in pervious 
figures were truly derived from TRIF, we expressed FLAG-tagged human 
TRIF within BMDMs. Following infection with PA103ΔUΔT, we again saw 
the appearance of a cleaved product of molecular weight ~ 30kDa (Fig 4-9). 
This was not seen following infection with the T3SS defective mutant strain 
PA103pcrV– that does not activate the inflammasome. Moreover, mutation 
of the sites previously identified as essential to TRIF cleavage by caspases 
also inhibited the production of the cleaved products following infection 
(cells transfected with plasmid expressing D281E D289E TRIF-FLAG) (Fig 
4-9) .   
We noted in these experiments that although TRIF was cleaved, the 
levels of full-length TRIF were not significantly diminished. We hypothesised 
that cleavage of TRIF would generate products that could exert a dominant 
negative effect and thus inhibit TRIF function as previously described 
(Yamamoto et al., 2002). To test this hypothesis, we cloned the segments 
of TRIF encoding the N terminal (amino-acids 1 - 281) and C terminal 
(amino-acids 290 – 712) that are generated by caspase-1 cleavage and 
expressed these in BMDMs. Expression of both the N and C terminal 
fragments individually and together potently inhibited the induction of 
autophagy following infection (Fig 4-10), even at low levels of expression. 
The two fragments also inhibited the induction of Ifnb mRNA induction in 
BMDMs following treatment with the TLR3 agonist polyI:C (Fig 4-11). Thus, 
caspase-1 cleavage of TRIF generates products that inhibit TRIF induction 
of autophagy and Ifnb gene expression. 
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 Proteolytic cleavage of TRIF prevents it functioning normally. Thus, 
cells expressing the D281E D289E TRIF-FLAG that is not cleaved by 
caspase-1 should have enhanced TRIF functions under conditions where 
caspase-1 is active compared to cells expressing the WT TRIF. To test this 
hypothesis, we transfected BMDMs with WT TRIF-FLAG or D281E D289E 
TRIF-FLAG and then followed the progress of autophagy within these cells 
after infection with the PA103ΔUΔT strain of P. aeruginosa. This strain will 
activate the inflammasome, leading to capsase-1 cleavage and inactivation 
of TRIF. Since TRIF is an essential intermediate in initiating autophagy 
following P. aeruginosa infection, prevention of its cleavage by caspase-1 
should lead to increased autophagy. We tested this directly by infecting 
BMDMs transfected with either WT TRIF or the non-cleavable D281E 
D289E TRIF construct. When cells were transfected with the D281E D289E 
TRIF construct we observed an increase in the degree of autophagy, as 
assayed by increased amounts of LC3 II (Fig 4-12), increased number of 
LC3 containing puncta (Fig 4-13), increase in intracellular LC3 II staining on 
flow cytometry, and increase in the degree of induction of the Lc3b mRNA 
(Fig 4-14). This was under conditions where the expression level of the 
different TRIF proteins was identical (Fig 4-9).  
Previous study of the TRIF fragments generated by caspase 
cleavage clearly demonstrated that the D281E D289E mutant TRIF had 
completely normal signal-transducing functions (Rebsamen et al., 2008). 
We tested the effects of expression of the D281E D289E mutant TRIF on 
Ifnb expression induced by PolyI:C (Fig 4-15). Expression of the mutant did 
not affect TLR3 signal transduction; additionally, no cleavage of TRIF was 
seen in response to PolyI:C which does not activate the inflammasome 
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when added extracellularly (Rajan et al., 2010). Thus, the effects of the 
mutant non-cleavable TRIF are not due to effects on over all TRIF function. 
Similarly, infecting human THP-1 cells transfected with either WT 
TRIF or the non-cleavable D281E D289E TRIF construct. When cells were 
transfected with the D281E D289E TRIF construct we observed an increase 
in the degree of autophagy, as assayed by increased amounts of LC3 II (Fig 
4-16). Thus, capsase-1 activation leads to TRIF cleavage, which partially 
inhibits the pathway leading to autophagy following infection. 
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Figure 4.9;  Effect of mutant Caspase-1 cleavage site on TRIF cleavage following P. 
aeruginosa infection. 
Cells were transfected with plasmids encoding FLAG-tagged WT TRIF or with the 
indicated mutations, and then left uninfected (Basal), or infected for the indicated times 
with the P. aeruginosa strains as shown (MOI 25). Western blot was probed with anti-
FLAG antibody. β -tubulin western blot is shown as loading control. (Experiment repeated 
three times).  
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Figure 4.10;  Dominant negative effect of TRIF cleavage inhibits autophagy following 
P. aeruginosa infection. 
 BMDMs transfected with indicated amounts of TRIF expression plasmids (µg) and left 
uninfected (B) or infected as shown. Panel shows cell lysates blotted for V5 (epitope tag 
for TRIF) and LC3; β-tubulin shown as loading control.  
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Figure 4.11; TRIF N and C fragments inhibit induction of Ifnb mRNA following 
treatment with TLR3 agonist PolyI:C.   
Levels of Ifnb mRNA assayed by RT-PCR following PolyI:C treatment and transfection 
with TRIF constructs as shown. Columns are means of triplicates; error bars sem. ** 
significantly different from untreated (p<0.01). 
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Figure 4.12;  Effect of inhibiting TRIF cleavage  on the level of LC3-II following P. 
aeruginosa infection. 
 a, Western blot analysis of LC3 I and II levels. BMDMs cells transfected with the 
indicated amounts of plasmids (in µg), using Attractene (in µl). Cells were left uninfected 
or infected with P. aeruginosa strain as indicated (MOI 25). b,  BMDMs transfected with 
plasmids encoding FLAG-tagged WT TRIF or with the indicated mutations  (0.8µg), 
using Attractene(3µl). Cells were infected as shown (4h, MOI 25) and assayed for LC3 I 
and II levels by Western blot (upper panel). Lower panel shows LC3/β-tubulin ratio for 3 
independent experiments under the indicated conditions. Columns show means; error 
bar is SEM. ***, significantly different from infected cells transfected with WT TRIF, p < 
0.001. 
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Figure 4.13;  Inhibiting TRIF cleavage  increases formation of autophagosomes   
following P. aeruginosa infection. 
BMDMs transfected with plasmids encoding FLAG-tagged WT TRIF or with the indicated 
mutations. Cells were infected as indicated for 4 hrs. (MOI 25). a, Representative 
immunofluorescence images of LC3 in BMDMs left uninfected (Basal), or infected with 
P .aeruginosa strain PA103ΔUΔT . Cells were stained with DAPI to visualize nuclei 
(blue), and LC3 staining is shown as green. Scale bar 10 µm. b, LC3 puncta quantified in 
BMDMs transfected with indicated constructs and infected as shown (4hrs, MOI 25). ***, 
significantly different from infected cells transfected with WT TRIF, p < 0.001. 
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Figure 4.14;  Inhibiting TRIF cleavage  increases autophagy markers following P. 
aeruginosa infection. 
a, Intracellular LC3 II levels assayed by flow cytometry in cells transfected with indicated 
plasmids and left uninfected (Basal) or infected as indicted (4h, MOI 25)b, Levels of Lc3b 
mRNA  with conditions as in a . ***, significantly different from infected cells transfected 
with WT TRIF, p < 0.001. 
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Figure 4.15;  Non-cleavable TRIF mediated normal signal transduction after 
PolyI:C treatment. 
BMDMs were treated with PolyI:C (1µg/ml for 5 hours) after transfection with TRIF 
constructs as shown. Levels of Ifnb mRNA were measured by RT-PCR; columns are 
means of triplicates; error bars are sem. *** and **, significant different from 
unstimulated cells, p<0.001 and 0.01 respectively. Differences between the results in 
the presence of PolyI:C were not significantly different from one another. Western blot 
shows TRIF following the same treatment as indicated. 
 
 
 
 
144 
 
    
                                                                                        
 
Figure 4.16;  Inhibiting TRIF cleavge  increases autophagy markers  in human THP-1 
cells. 
a, Human THP-1 cells transfected with the indicated amounts of plasmids (in µg) were 
left uninfected or infected as shown (4h, MOI 25) and probed with antibody to FLAG. 
Experiment performed on two occasions with same results. b, THP-1 cells were 
transfected with plasmids encoding FLAG-tagged WT TRIF or with the indicated 
mutations (0.8µg), using Attractene(3µl). Cells were infected as shown (4h, MOI 25) and 
assayed for LC3 I and II levels by Western blot.  
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4.2.4 TRIF Cleavage by Capsase-1 Down-regulates Induction of Type I 
IFNs Following P. aeruginosa infection.  
 Next, we tested whether preventing TRIF cleavage by caspase-1 
would lead to upregulation of other pathways mediated by TRIF following P. 
aeruginosa infection. Activation of TLR4 leads to induction of the type I IFNs 
via TRIF; type I IFN production plays a number of important roles in 
bacterial infection (Kelly-Scumpia et al., 2010). Firstly we showed that P. 
aeruginosa infection led to induction of IFN-β mRNA in BMDMs. Consistent 
with down-regulation of this pathway by caspase-1 activation, we found that 
the T3SS mutant PA103pcrV– produced greater levels of Ifnb1 mRNA 
compared to the T3SS competent PA103 ΔUΔT strain (Fig 4-17). In both 
cases, knockout of TRIF led to marked inhibition of Ifnb1 mRNA induction, 
confirming that TRIF plays an essential role in the induction of type I IFNs 
following P. aeruginosa infection (Fig 4-17).  
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Figure 4.17; Role of  TRIF in induction of type I IFNs following P.aeruginosa infection. 
Quantitative RT-PCR levels of Ifnb1 in BMDMs Cells from (WT) or Trif (KO) and left 
uninfected (Basal) or infected as shown (4h MOI 25). ***, shows significant difference 
between the pairs of values, p < 0.001. 
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 We then investigated whether inhibition of caspase-1 activation 
following P. aeruginosa infection would lead to increased induction of Ifnb1 
mRNA. Inhibiting caspase-1 by chemical inhibition (Fig 4-18a) and by knock 
down of the caspase-1 gene by siRNA (Fig 4-18b) both led to a significant 
rise in the levels of Ifnb1 mRNA following infection. Additionally, blocking 
inflammasome activation by raising extracellular K+ concentration also led 
to increased Ifnb1 mRNA induction (Fig 4-18c). These results support the 
conclusion that caspase-1 activation via the inflammasome leads to down-
regulation of type I IFN induction by the proteolytic degradation of TRIF. 
  We confirmed this conclusion by comparing the degree of Ifnb1 
mRNA induction after infection in BMDMs transfected either with WT TRIF 
or the non-cleavable D281E D289E mutant TRIF. As shown in (Fig 4-19), in 
cells expressing the non-cleavable TRIF mutant, the levels of Ifnb1 mRNA 
induced following infection were significantly increased. Thus, caspase-1 
activation by the inflammasome leads to a reduction in TRIF activity and 
hence inhibition of the induction of type I IFNs. 
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Figure 4.18;  Inhibition of Caspase-1 increases induction of type I IFNs following 
P.aeruginosa infection. 
Quantitative RT-PCR levels of Ifnb1 in BMDMs a, cells infected as shown (4h MOI 25) 
in the absence (–) or presence (+CI) of the caspase-1 inhibitor Z-YVAD-FMK. **, 
significantly different from untreated, p < 0.01. b,  cells transfected with control siRNA 
(C) or with siRNA specific for Caspase-1 and infected as in a. ***, significantly different 
from control siRNA, p < 0.001. c,  cells infected as in a under conditions of low and high 
K+ . **, significantly different from low K+, p < 0.01.  
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Figure 4.19;  Inhibiting TRIF cleavge  increases induction of type I IFNs following 
P.aeruginosa infection. 
Quantitative RT-PCR levels of ifnb1 mRNA in BMDMs cells transfected with the 
constructs as shown and left uninfected (basal) or infected with PA103ΔUΔT (4h, MOI 
25). ***, significantly different from WT TRIF, p < 0.001. 
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4.2.5 Functional Effects of TRIF Inactivation by Caspase-1 in BMDMs 
 Type I IFNs increase the phagocytic activity of macrophages as well 
as their production of reactive oxygen intermediates, both important in host 
defence against bacteria. We thus set out to determine whether the 
reduction in type I IFN induction resulting from caspase-1 cleavage of TRIF 
had such functional effects. We measured phagocytic activity of BMDMs by 
uptake of a tagged E. coli that only gave a fluorescent signal on trafficking 
to an acidic lysosomal compartment, and reactive oxygen production by 
another fluorescent probe, CellROX Deep Red. Firstly, we compared 
phagocytosis and production of reactive oxygen intermediates following 
infection of BMDMs with the T3SS competent strain of P. aeruginosa 
PA103ΔUΔT compared to the T3SS defective strain PA103pcrV–. This 
showed that PA103ΔUΔT led to less phagocytosis and lower production of 
reactive oxygen intermediates following infection compared to the 
PA103pcrV– strain (Fig 4-20). This is consistent with the reduced levels of 
type I IFNs resulting from inflammasome activation by the T3SS competent 
strain and hence capsase-1 cleavage of TRIF. Importantly, adding β-IFN 
back to the BMDMs infected with the T3SS competent PA103ΔUΔT strain 
restored the level of phagocytosis and reactive oxygen production to the 
levels seen with the T3SS defective PA103pcrV– strain (Fig 4-20). Thus, the 
defect in phagocytosis and production of reactive oxygen observed in the 
strain of P. aeruginosa that activates capsase-1 could be corrected by 
addition of a product normally produced via TRIF mediated signalling.   
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Figure 4.20; Type I IFNs is required for phagocytosis and intracellular killing of  
P.aeruginosa . 
a, amount of phagocytosed E. coli particles (pHrodo E. coli; and b reactive oxygen 
(CellROX) Deep Red as assayed by Flow cytometry. BMDMs pre-treated with IFN 
(10ng/ml) and then infected as indicated (3h, MOI 25) or left uninfected (Basal). 
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To establish that the reduction in these macrophage functions was 
due to caspase-1 degradation of TRIF, we tested the effect of knocking 
down both TRIF and caspase-1 on phagocytosis and production of reactive 
oxygen. When TRIF levels were reduced by siRNA, the ability of BMDMs to 
perform these functions was markedly reduced (Fig 4-21a, and b). This 
inhibitory effect was reversed by the addition of β-IFN, demonstrating the 
importance of TRIF-mediated production of this cytokine in enhancing 
phagocytosis and production of reactive oxygen. Knock down of caspase-1 
enhanced the ability of BMDMs to phagocytose and produce reactive 
oxygen following P. aeruginosa infection (Fig 4-21c, and d). This 
enhancement in these functions was similar to that seen following the 
addition of β-IFN to BMDMs infected with the inflammasome activating P. 
aeruginosa strain PA103ΔUΔT (Fig 4-21c, and d). Taken together, these 
results support the conclusion that caspase-1 mediated proteolysis of TRIF 
following P. aeruginosa infection of BMDMs leads to down regulation of 
IFN-β production and reduction in phagocytosis and reactive oxygen 
production.  
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Figure 4.21; TRIF cleavage reduces type I IFN mediated increases in phagocytosis 
and generation of reactive oxygen intermediates.  
a and c phagocytosed E. coli particles (pHrodo E. coli and b and d reactive oxygen 
(CellROX) Deep Red as assayed by Flow cytometry. Cells were treated with control (C) 
siRNA or specific siRNA as shown (KD). Where indicated, cells were pre-treated with 
IFN-β (IFN) (10ng/ml) and then infected as indicated (3h, MOI 25) or left uninfected 
(Basal). 
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 To confirm that the cleavage of TRIF was responsible for the down-
regulation of phagocytosis and reactive oxygen production following 
caspase-1 activation, we examined these functions in BMDMs transfected 
with wild-type and non-cleavable TRIF (D281E D289E TRIF). Compared to 
cells transfected with wild-type TRIF, BMDMs transfected with the D281E 
D289E TRIF had higher levels of phagocytosis and reactive oxygen 
production (Fig 4-22a, and b). Again, we could increase the lower levels 
seen in cells expressing wild-type TRIF by addition of β-IFN. Thus, by 
preventing TRIF cleavage by caspase-1, we could augment the ability of 
BMDMs to phagocytose E. coli particles and produce reactive oxygen 
intermediates through TRIF-mediated β-IFN production.    
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Figure 4.22;  Inhibiting TRIF cleavge  increases phagocytosis and intracellular killing 
of  P.aeruginosa . 
a, phagocytosed E. coli particles (pHrodo E. coli and b reactive oxygen (CellROX) Deep 
Red as assayed by Flow cytometry. Cells were transfected with plasmids encoding the 
TRIF constructs as shown. Cells were pre-treated with IFN-β (IFN) (10ng/ml) and then 
infected as indicated (3h, MOI 25) or left uninfected (Basal). 
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We determined the numbers of viable internalised P. aeruginosa in 
BMDMs following infection to gauge the net result of both phagocytosis and 
intracellular killing. Knock down of TRIF led to an increase in the numbers 
of viable intracellular PA103ΔUΔT; this could be reversed by the addition of 
β-IFN (Fig 4-23a). This suggests that under these conditions the reduction 
in reactive oxygen resulting from TRIF knock down is more significant than 
the reduction in phagocytosis, hence leading to an increase in the numbers 
of internalised viable bacteria. Inhibiting TRIF breakdown by adding 
inhibitors of caspase-1 or knock down by siRNA led to a reduction in the 
numbers of viable internalised bacteria (Fig 4-23b, and c). This was again 
consistent with the predominant effect of inhibiting TRIF function being to 
reduce the ability of BMDMs to kill intracellular bacteria. The reduction in 
viable intracellular bacteria consequent to inhibition or knock down of 
caspase-1 was reproduced by treating the BMDMs with β-IFN (Fig 4-23b, 
and c). Finally, we examined the numbers of viable intracellular bacteria 
recovered after infection in BMDMs transfected with expression vectors for 
either the WT or the non-cleavable D281E D289E TRIF. In the presence of 
the non-cleavable TRIF, fewer viable intracellular bacteria were recovered 
compared to cells expressing the WT TRIF protein (Fig 4-23d). This 
reduction in viable internalised bacteria could be reproduced in cells 
expressing WT TRIF by treatment with β-IFN. Thus, taken together, these 
data suggest that the caspase-1 mediated cleavage of TRIF leads to a 
reduction in β-IFN production that result in an increase in the numbers of 
viable P. aeruginosa following infection of BMDMs.  
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Figure 4.23;  Bactericidal assay of infected BMDMs  with P.aeruginosa. 
Panels show numbers of viable internalized bacteria 3h after infection with PA103ΔUΔT 
(MOI 25) with the indicated treatments. Columns are means of triplicate determinations; 
error bars are SEM. Differences with IFN addition were significantly different, ** p < 0.01, 
*** p < 0.001. 
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4.2.6 Effect of caspase-1 TRIF cleavage on infection with P.aeruginosa 
in vivo   
These data from macrophages in culture show important functional 
effects of TRIF cleavage but do not evaluate the total effect of this process 
on the cytokine responses and bacterial killing in an infectious process. 
Thus, we evaluated the effects of Caspase-1 TRIF cleavage on the cytokine 
responses and bacterial killing in an in vivo model of infection. We utilized 
an acute intraperitoneal model of P. aeruginosa infection in mice. Firstly, we 
evaluated the effects of inhibiting Caspase-1 activity in infection by 
intraperitoneal administration of ZYVAD-FMK. In this model, inhibition of 
caspase-1 led to reduced serum levels of IL-1β as expected with no 
reduction in TNF (Fig 4-24a). In cells harvested from the peritoneum 6 
hours following infection (predominantly neutrophils), there was an increase 
in the level of lipidated LC3 in animals treated with the caspase-1 inhibitor 
(Fig 4-24a). The treated animals had a significant reduction in the numbers 
of viable bacteria recovered from the peritoneum (Fig 4-24a). These data 
suggest that the decreased IL-1β production and increased autophagy 
produced by caspase-1 inhibition results in increased bacterial clearance.  
 As a more direct test of the effect of preventing Caspase-1 mediated 
TRIF cleavage during infection, we set up the following animal model. We 
depleted intraperitoneal macrophages by instillation of liposomal clodronate 
(Fig 4-24b). We then re-introduced macrophages transfected with 
expression plasmids for either wild type TRIF or the D281E D289E mutant; 
these were loaded with a fluorescent dye to allow subsequent identification 
using flow cytometry. Animals were then infected with P. aeruginosa by the 
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intraperitoneal route. 6 hours following infection, we harvested serum and 
peritoneal contents. Autophagy within the introduced transfected 
macrophages was measured by flow cytometric measurement of 
intracellular LC3 II (Fig 4-24c and d). This showed that macrophage 
autophagy was increased following infection in vivo, and that macrophages 
expressing the non-cleavable TRIF mutant showed increased levels of 
autophagy compared to the wild type protein. Interestingly, animals 
populated with macrophages expressing the non-cleavable D281E D289E 
mutant TRIF had lower serum IL-1β levels compared to those populated 
with macrophages expressing wild type TRIF; TNF levels were the same 
(Fig 4-24d). Expression of the non-cleavable TRIF was also associated with 
significantly lower intraperitoneal protein concentrations and viable bacterial 
counts (Fig 4-24d). Thus, in this model, preventing TRIF cleavage results in 
increased autophagy following infection that is associated with reduced IL-
1β production but decreased numbers of viable intraperitoneal bacteria. 
This suggests autophagy may well control NLRC4 inflammasome activation 
following P. aeruginosa infection as has been found for NLRP3 
inflammasome activation (Saitoh et al., 2008).    
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Figure 4.24;  Role of TRIF cleavage by caspase-1 in an vivo infection model. 
a, Mice were infected with P. aeruginosa ip or treated with PBS. Panels show LC3 
immunoblot with loading control of total cell extract from one representative animal, mean 
levels of serum  IL-1β and TNF (n = 3, error bars are SEM) and recovered viable bacteria 
161 
 
from the peritoneal cavity at 6h (n=3, error bars SEM). Animals were pre-treated with Z-
YVAD-FMK (CI) as shown). * and *** are significant differences from untreated animals, p 
<0.05 and p < 0.001 respectively. b, Peritoneal macrophage population in animals 
treated with liposomal clodronate as shown. Columns are means of three determinations; 
error bars are SEM. **, significantly different from control (p < 0.01). c and d show results 
from animals infected ip following depletion of intraperitoneal macrophages and 
reconstitution with macrophages transfected as shown.  c, Levels of intracellular LC3 II 
assayed by flow cytometry, gated on introduced macrophage populations, transfected 
with constructs as shown.  Representative plot from one animal. d, Panels show mean 
values of indicated measures from n=3 animals, error bars are SEM. Values are of LC3 II 
mean fluorescence intensity (LC3 MFI), serum IL-1β and TNF, peritoneal protein 
concentration, and recovered viable bacterial colonies (CFU/ml x 103). Peritoneal 
macrophages were transfected with constructs as shown before repopulation of the 
peritoneal cavity.  
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4.2.7 Effect of Caspase-1 TRIF Cleavage on Activation of the NLRP3 
Inflammasome 
 We wished to extend our observations to other situations where 
TRIF cleavage by caspase-1 could have important effects. Recently, 
activation of the NLRP3 inflammasome has been shown to be triggered by 
mitochondrial damage (Nakahira et al., 2011). This activation is limited by 
autophagy of mitochondria – mitophagy – which by limiting release of 
mitochondrial DNA into the cytoplasm acts to inhibit NLRP3 inflammasome 
activation. We reasoned, therefore, that caspase-1 mediated inactivation of 
TRIF would limit mitophagy and thus could act to enhance NLRP3 
activation, leading to greater capsase-1 activation and production of IL-1β. 
To test this hypothesis, we examined the effects of limiting TRIF cleavage 
by casapse-1 in BMDMs stimulated with LPS and ATP, which is a potent 
stimulus to NLRP3 inflammasome activation. We transfected BMDMs with 
expression vectors encoding either WT TRIF or the D281E D289E TRIF 
mutant that is resistant to caspase-1 cleavage. Following LPS/ATP 
stimulation, we observed increased levels of caspase-1 p10 and secreted 
IL-1β as expected in the BMDMs transfected with WT TRIF (Fig 4-25). This 
was associated with cleavage of TRIF as we have observed with 
inflammasome activation by P. aeruginosa. We also found that the LPS 
stimulus increased autophagy, as we have previously observed in these 
cells (Fig 4-1). In the cells transfected with the D281E D289E TRIF mutant 
that is resistant to caspase-1 cleavage, we observed an increase in levels 
of the LC3 II isoform following LPS/ATP stimulation, indicative of increased 
autophagy (Fig 4-25), a marked increase in the numbers of LC3 containing 
vacuoles, and increased intracellular staining of LC3 as assayed by flow 
163 
 
cytometry (Fig 4-26). We also observed a marked reduction in 
inflammasome activation and secretion of IL-1β (Fig 4-25), but not TNF. 
Thus, a highly significant effect of the caspase-1 induced cleavage of TRIF 
is to inhibit on going autophagy that otherwise would severely limit the 
degree of inflammasome activation and resultant IL-1β produced.  
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Figure 4.25; Effect of Inhibition of  TRIF cleavge on NLRP3 activation following 
treatment with LPS+ATP. 
BMDMs were transfected with plasmids expressing WT TRIF or the D281E D289E 
mutant as shown. Cells were left untreated (Basal) or LPS (500 ng/ml) was added for 4 
hours followed by 5 mM ATP for 20 minutes where indicated (LPS + ATP). Western blot 
of the indicated proteins are shown. The bottom panel shows the levels of secreted Il-
1β and TNF from the same cells as used in the Western blot with the treatments as 
indicated. Each column is mean of 3 determinations; error bars are SEM. Filled columns 
are results from cells transfected with the non-cleavable TRIF, open columns from WT 
TRIF. ***, significant from WT, p < 0.001.    
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Figure 4.26;  Inhibition of TRIF cleavage  increases  autophagy markers  in 
BMDMs  following treated with LPS+ATP. 
BMDMs were transfected with plasmids expressing WT TRIF or the D281E D289E 
mutant as shown. Cells were left untreated (Basal) or LPS (500 ng/ml) was added for 4 
hours followed by 5 mM ATP for 20 minutes where indicated (LPS + ATP). a, 
Representative immunofluorescence images of LC3 in BMDMs left untreated (Basal) , 
or treated with LPA+ATP. Cells were stained with DAPI to visualize nuclei (blue), and 
LC3 staining is shown as green. Scale bar 10 µm. b, Intracellular LC3 II levels assayed 
by flow cytometry in cells transfected with indicated plasmids and left uninfected (Basal).   
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 We repeated this experiment but additionally down-regulated 
autophagy by knock down of Lc3b or Atg5 expression using siRNA (Fig 4-
27). In cells in which autophagy was inhibited, the amount of secreted IL-
1β and caspase-1 activation in the presence of WT TRIF was significantly 
increased compared to cells transfected with control siRNA (Fig 4-27). This 
is consistent with autophagy down-regulating the signals required to trigger 
NLRP3 inflammasome activation and secretion of IL-1β in response to LPS 
+ ATP. In cells expressing the D281E D289E mutant TRIF with inhibition of 
autophagy by Lc3b or Atg5 knockdown, although there was a reduction in 
secreted IL1-β, this did not reach statistical significance compared to cells 
expressing WT TRIF (Fig 4-27). This is consistent with the conclusion that 
the reduction in secreted IL-β in the presence of TRIF that cannot be 
cleaved by caspase-1 is as a result of an increase in auto- and mitophagy 
that acts to attenuate the triggering of the NLRP3 inflammasome by LPS + 
ATP. Prevention of TRIF cleavage results in increased type I interferon 
production in infection; this has been shown to suppress NLRP3 
inflammasome activation principally through an IL-10 mediated down-
regulation of pro-IL-1β levels (Guarda et al., 2011) as well as an 
uncharacterised direct effect on the NLRP3 inflammasome that required at 
least 6 hours treatment. The suppressive effect of the non-cleavable TRIF 
is evident after 4 hours of LPS/ATP, and we did not observe any changes in 
pro-IL-1β or pro-caspase-1 levels in treated cells that had been transfected 
with the mutant D281E D289E non-cleavable TRIF (Fig 4-27). Thus, the 
observed effects of preventing TRIF cleavage on inhibiting NLRP3 
activation by LPS/ATP would seem most likely mediated by the increased 
levels of autophagy rather than increased type I interferon production, 
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although some contribution of type I interferon directly inhibiting NLRP3 
inflammasome activation cannot be ruled out entirely.  
                                                             
      
                      
Figure 4.27; Prevention of TRIF cleavage attenuates NLRP3 mediated caspase 1 
activation and production of mature IL-1β . 
BMDMs were transfected with control siRNA or lc3b (left panel), or control or Atg5 siRNA 
(right panel). Cells were left untreated (Basal) or LPS (500 ng/ml) was added for 4 hours 
followed by 5 mM ATP for 20 minutes where indicated (LPS + ATP). BMDMs were 
transfected with plasmids expressing WT TRIF or the D281E D289E mutant as shown.     
Western blot of the indicated proteins is shown. The bottom panel shows the levels of 
secreted IL-1β from the same cells as used in the immunoblotting with the treatments as 
indicated. Each column is mean of 3 determinations; error bars are SEM. Filled columns 
are results from cells transfected with the non-cleavable TRIF, open columns from WT 
TRIF. Statistical differences between bracketed columns are shown: *p<0.05, **, p < 
0.01, *** p < 0.001. All experiments repeated 2 times.    
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 Finally, we extended these observations using the human 
macrophage cell line THP-1 (Fig 4-28). In the presence of the mutant TRIF 
that cannot be cleaved by caspase-1, LPS + ATP produces less caspase-1 
activation, less secreted IL-1β and a greater amount of autophagy as 
measured by conversion of LC3 to its lipidated type II isoform (Fig 4-28a). 
We also confirmed the increase in autophagy by measuring the numbers of 
LC3 puncta within the cells under the different conditions (Fig 4-28b).  
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Figure 4.28; Prevention of TRIF cleavage attenuates NLRP3 mediated caspase-1 
activation and production of mature IL-1β  in THP-1 cells.   
a, THP-1 cells were transfected with plasmids expressing WT TRIF or the D281E 
D289E mutant as shown. Cells were left untreated (Basal) or LPS (500 ng/ml) was 
added for 4 hours followed by 5 mM ATP for 20 minutes where indicated (LPS + ATP). 
Western blot of the indicated proteins are shown. The bottom panel shows the levels of 
secreted Il-1β from the same cells as used in the Western blot with the treatments as 
indicated. Each column is mean of 3 determinations; error bars are SEM. Filled columns 
are results from cells transfected with the non-cleavable TRIF, open columns from WT 
TRIF. **, significant from WT, p < 0.01. b, Representative immunofluorescence images 
of LC3 in THP-1 cells treated as in (a). Cells were stained with DAPI to visualize nuclei 
(blue), and LC3 staining is shown as green. Scale bar 10 µm.               
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4.3 Discussion     
In this chapter, we have shown that activation of caspase-1 by either 
the NLRP3 or NLRC4 inflammasome leads to proteolytic cleavage of the 
signalling intermediate TRIF in both murine and human cells. TRIF plays a 
key role in mediating some of the effects of TLR4 signalling, including the 
induction of autophagy as well as the production of type I IFNs. By multiple 
independent methods, we demonstrate that TRIF cleavage leads to a 
down-regulation of autophagy following infection of BMDMs by P. 
aeruginosa or stimulation via LPS. Additionally, this cleavage of TRIF 
results in an inhibition of the production of type I IFN. We show that this 
results in a diminution in phagocytosis and production of reactive oxygen 
intermediates within BMDMs, and reduced the ability of macrophages to kill 
intracellular bacteria. In an in vivo model of Pseudomonas aeruginosa 
infection, preventing TRIF cleavage augmented bacterial clearance but 
reduced the production of IL-1β. One additional consequence of the 
inhibition of autophagy by caspase-1 is to prevent the limiting effect of 
autophagy on caspase-1 activation, hence leading to greater activation of 
this protein and increased IL-1β production. Thus, caspase-1 cleavage of 
TRIF results in multiple effects with significant impact on processes that are 
central to host defence and inflammation.  
 The results of TRIF cleavage by caspase-1 have a number of   
effects on immediate host defence to a pathogen such as P. aeruginosa. 
On the one hand, the reduction in production of type I IFNs results in a 
diminution in macrophage phagocytosis and production of reactive oxygen. 
However, we also found that following in vivo infection, there was a 
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reduction in production of IL-1β. This was associated with increased 
bacterial clearance, as has been found by others (Cohen and Prince, 2013). 
The reduction in IL-1β production following infection with Pseudomonas 
aeruginosa under condition where TRIF cleavage is blocked, suggest that 
autophagy restrains NLRC4 inflammasome activation in this infection, in 
much the same way as has been shown for NLRP3 activation. We have 
gone to explore this in depth and have found that autophagy does inhibit 
NLRC4 inflammasome activation by Pseudomonas aeruginosa (chapter 5). 
The reduction in auto- and mitophagy consequent to TRIF cleavage 
prevents these processes inhibiting NLRP3 caspase-1 activation. If TRIF 
were not cleaved in this way, the degree of activation of this inflammasome 
would be much less and production of IL-1β significantly reduced. The 
magnitude of this effect is large (Figs 4-26, 4-27, and 4-28) and thus we 
speculate that this is the principal evolutionary selection pressure that has 
maintained the cleavage site for caspase-1 within the TRIF protein. IL-1β is 
a key cytokine in promoting host defence and without cleavage of TRIF by 
caspase-1, the levels of active IL-1β following NLRP3 activation would be 
much less. The overall effect of increased inflammasome activation 
consequent to TRIF cleavage varies depending on the specific infection 
involved. NLRC4 inflammasome activation is critical in host defence against 
Klebseilla pneumoniae (Cai et al., 2012) and oral Salmonella infection in 
Balb/c mice (Franchi et al., 2012a), but increases bacterial burden in model 
of Pseudomonas aeruginosa pneumonia (Cohen and Prince, 2013). 
Moreover, TRIF has been shown to be an important intermediate in 
triggering autophagy not just from TLR4 but also from TLR3 stimulation 
(Delgado et al., 2008). Thus, cleavage of TRIF may also play a role in 
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limiting autophagy and enhancing inflammasome activation in infections 
that signal via TLR3, such as influenza. Additionally, a previous study with 
Shigella flexneri infected macrophages suggested that caspase-1 activation 
limited autophagy (Suzuki et al., 2007). The data presented in the work 
described here suggest cleavage of TRIF would account for this effect. 
 TRIF has recently been shown to be an important intermediate in the 
induction of NLRP3 inflammasome activation by Gram-negative bacteria 
(Rathinam et al., 2012). Type I IFNs triggered by TLR4 via TRIF mediate 
the induction of capsase-11, a protease that can amplify caspase-1 
activation by NLRP3. This has been shown to be of importance in infections 
caused by enterohemorrhagic E.coli and Citrobacter rodentium (Kayagaki 
et al., 2011), as well as other Gram-negative organisms (Broz et al., 2012, 
Aachoui et al., 2013). It does not seem to play a role in the activation of the 
NLRC4 inflammasome, the mechanism by which P. aeruginosa activates 
the inflammasome via its type III secretion apparatus. However, in 
organisms lacking a functional type III apparatus, the TLR4/TRIF/caspase-
11 pathway can act to produce NLRP3 activation, albeit with much slower 
kinetics than the NLRC4 mediated effects (Rathinam et al., 2012). We show 
here by specific knockdown of Caspase-11 using siRNA that this protein 
does not play a role in the activation of the inflammasome by PA103ΔUΔT 
or in the cleavage of TRIF. From our results, we would predict that TRIF 
cleavage by caspase-1 would serve to down-regulate activation of caspase-
11 by attenuating the continued production of type I IFNs. The overall 
influence of TRIF cleavage in an infection will thus be dependent on 
potentially complex interactions between caspase-11 dependent and 
independent pathways. 
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 Although TRIF cleavage restricts autophagy and thus can augment 
NLRP3 activation and IL-1β secretion, it will also lead to down-regulation of 
type I IFN production. We show here that in isolated BMDMs these results 
in decreases in phagocytic ability and production of reactive oxygen 
intermediates. A number of studies have shown the importance of TRIF-
mediated type I IFN production in a variety of enteric and pulmonary Gram-
negative infections (Kelly-Scumpia et al., 2010). Again, the overall outcome 
will depend on the relative balance between effective IL-1β production and 
attenuation of type I IFN. This may be of greater significance in viral 
infections that trigger caspase-1 activation. In this setting, type I IFN 
production can be crucial in determining outcome. 
 The cleavage of TRIF by caspase-1 does reduce to some degree the 
levels of full-length TRIF, but not to an extent that could account for the 
inhibitory effects observed. We speculate, therefore, that one or more of the 
cleavage products of TRIF that are produced by caspase-1 is acting as a 
dominant-negative inhibitor. The central TIR domain of TRIF has been 
shown to be such an inhibitor (Yamamoto et al., 2002). Cleavage of TRIF at 
amino-acids 281 and 289 results in N- and C-terminal truncated products 
that have been shown to lack most TRIF activity (Rebsamen et al., 2008). 
Caspase-1 activation results in activation of caspase-7, which may cleave 
additional sites within the molecule (Lamkanfi et al., 2008). Moreover, initial 
cleavage may expose additional sites that can be cleaved by other cellular 
proteases. The detailed molecular mechanisms whereby TRIF cleavage 
results in inhibiting TRIF function requires further study. However, it is clear 
that in both human and murine cells, expression of mutated TRIF lacking 
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caspase-1 cleavage sites results in a molecule that augments autophagy 
and hence down-regulates the activation of the NLRP3 inflammasome.  
 Autophagy can down-regulate the activation of the NLRP3 
inflammasome by removal of damaged mitochondria (Nakahira et al., 2011). 
We describe here a reciprocal process by which inflammasome activation 
of caspase-1 acts to down-regulate autophagy. This is achieved through the 
specific proteolysis of TRIF, the key signalling intermediate that triggers 
autophagy following TLR4 activation. We also show that this removal of 
TRIF activity acts to further enhance NLRP3 inflammasome activation, 
although it does limit TRIF-dependent induction of type I IFN responses. 
Modulation of autophagy is thus a possible therapeutic target – either to 
limit its negative effects on inflammasome activation to augment host 
defence or to augment its action to limit excessive inflammation by 
caspase-1 and to enhance TRIF-mediated responses. 
In conclusion, we found that Pseudomonas aeruginosa induced 
autophagy through signalling via TLR4 and TRIF. Loss of type III secretion 
increased autophagy, which was due to NLRC4 activation and caspase-1 
activity. We show that caspase-1 cleaved TRIF, resulting in a diminution of 
TRIF-mediated signalling, not only resulting in inhibition of autophagy but 
also in production of type I IFNs. Prevention of TRIF cleavage through 
mutation of the caspase-1 cleavage sites resulted in augmented autophagy, 
increased type I IFN production and enhanced phagocytosis and reactive 
oxygen production within macrophages. Expression of a mutated TRIF 
lacking caspase-1 cleavage sites enhanced autophagy and diminished 
NLRP3 inflammasome activation in both mouse and human cells, leading to 
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a marked reduction in IL-1β production. We have thus defined caspase-1 
mediated TRIF cleavage as a key event in controlling both NLRP3 
inflammasome activation and autophagy, with important functional 
consequences.  
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5    Pseudomonas aeruginosa activation of the NLRC4 
inflammasome is dependent on release of Mitochondrial 
DNA and is inhibited by autophagy   
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5.1 Introduction   
The innate immune response to infection is a key component in host 
defence that not only provides immediate protection but also shapes the 
nature of the subsequent adaptive immune response (Schenten and 
Medzhitov, 2011, Kumar et al., 2009). One of the main mediators of the 
innate response is the cytokine IL-1β, which has diverse roles, including 
induction of fever, production of pro-inflammatory chemokines and 
prostanoids, augmenting neutrophil, B cell and dendritic cell function, and 
acting as a co-factor in the differentiation of Th17 cells (Dinarello, 2009). IL-
1β production is tightly regulated by a multi-subunit protein complex termed 
the inflammasome (Franchi et al., 2012, Brodsky and Monack, 2009, 
Martinon et al., 2009). At its core is caspase-1, which on activation will not 
only produce mature IL-1β from pro-IL1β but also release of active IL-18, a 
cytokine important in Th1 cell development (Smith, 2011). Understanding 
the mechanisms regulating inflammasome activation is thus of crucial 
importance in comprehending its role in innate immune response to 
infection as well as numerous inflammatory conditions. 
Apart from caspase-1, a variety of other proteins can be present in 
the inflammasome and these determine the nature of the stimuli that will 
lead to inflammasome activation. One of the best understood 
inflammasomes is that based on the NOD-like receptor family protein 
NLRP3 (Franchi et al., 2012). The NLRP3 inflammasome can be activated 
by a wide variety of stimuli, including bacterial toxins (Chu et al., 2009), inert 
particles such as urate crystals (Martinon et al., 2006) and silica (Hornung 
et al., 2008), and ATP (Hogquist et al., 1991). The exact molecular 
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mechanisms by which these diverse stimuli activate the NLRP3 
inflammasome are not clear. Another caspase, caspase-11 synergises with 
the assembled NLRP3 inflammasome and augments its activity (Aachoui et 
al., 2013, Rathinam et al., 2012, Kayagaki et al., 2011). Several groups 
have shown the importance of mitochondrial damage and sensing of 
released mitochondrial DNA in NLRP3 inflammasome activation (Nakahira 
et al., 2011, Shimada et al., 2012). Mitochondrial generation of reactive 
oxygen species has been implicated in the activation of the NLRP3 
inflammasome, and removal of damaged mitochondria by selective 
autophagy (mitophagy) inhibits this activation. Nakahira et al showed that 
release of mitochondrial DNA following damage to this organelle was 
responsible for the NLRP3 activation (Nakahira et al., 2011). Shimada et al 
found that release and binding of oxidised mitochondrial DNA to the NLRP3 
inflammasome was important in its activation (Shimada et al., 2012). 
However, a recent report found that lowering of intracellular K+ levels was 
the only common factor in the diverse signals that can activate the NLRP3 
inflammasome (Munoz-Planillo et al., 2013).  
 The inflammasome based on the NLR protein NLRC4 is activated by 
a number of bacterial pathogens (Franchi et al., 2012). The activation is 
dependent on bacterial products, notably flagellin (Miao et al., 2006, Franchi 
et al., 2006) and PrgJ (Miao et al., 2010, Zhao et al., 2011), one of the rod 
proteins found in the type III secretion system (T3SS) that are conserved in 
a number of Gram-negative organisms. These proteins in murine cells 
interact with the adaptors NAIP5 and NAIP2 respectively leading to NLRC4 
inflammasome activation (Lightfield et al., 2008, Zhao et al., 2011). 
However, NAIP5 is dispensable for inflammasome activation by Salmonella 
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enterica, despite the flagellin of this organism binding to NAIP5 (Kofoed and 
Vance, 2011). T3SS needle proteins homologous to Salmonella enterica 
PrgI are also reported to activate NLRC4 via the adaptor NAIP1 (Yang et al., 
2013).  
 Previous work demonstrated  that activation of the NLRC4 
inflammasome can be prevented by raising extracellular potassium ion 
concentration (Lindestam Arlehamn et al., 2010); similar findings have been 
reported for the NLRP1 (Fink et al., 2008) and AIM2 (Muruve et al., 2008) 
based inflammasomes. A previous study of inflammasome activation by the 
pathogen Vibrio parahaemolyticus suggested that a bacterial effector, Vop, 
inhibited NLRC4 inflammasome activation by inducing autophagy 
degradation, but the mechanism was not determined (Higa et al., 2013). 
This strongly suggests that additional mechanisms for activating these 
inflammasomes are operative. We set out therefore to examine in more 
details the nature of activation of the NLRC4 inflammasome using infection 
with the common human pathogen Pseudomonas aeruginosa, which 
produces a rapid activation of the inflammasome by a mechanism that is 
entirely dependent on its T3SS (Sutterwala et al., 2007, Miao et al., 2008, 
Franchi et al., 2007, Arlehamn and Evans, 2011). Infection with this 
bacterium also initiates autophagy (Yuan et al., 2012). 
The NLRC4 inflammasome can be activated by pathogenic bacteria 
via products translocated through the microbial type III secretion apparatus 
(T3SS). Recent work has shown that activation of the NLRP3 
inflammasome is down-regulated by autophagy, but the influence of 
autophagy on NLRC4 activation is unclear. We set out to determine how 
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autophagy might influence this process, using the bacterium P. aeruginosa, 
which actives the NLRC4 inflammasome via its T3SS. Infection resulted in 
T3SS-dependent mitochondrial damage with increased production of 
reactive oxygen intermediates and release of mitochondrial DNA. Inhibiting 
mitochondrial reactive oxygen release or degrading intracellular 
mitochondrial DNA abrogated NLRC4 inflammasome activation. Moreover, 
macrophages lacking mitochondria failed to activate NLRC4 following 
infection. Removal of damaged mitochondria by autophagy significantly 
attenuated NLRC4 inflammasome activation. Mitochondrial DNA bound 
specifically to NLRC4 immunoprecipitates and transfection of mitochondrial 
DNA directly activated the NLRC4 inflammasome; oxidation of the DNA 
enhanced this effect. We found that inhibition of autophagy upregulated 
inflammasome activation following P. aeruginosa infection. This was due to 
autophagy removing damaged mitochondria that released mitochondrial 
DNA following infection in a process dependent on production of reactive 
oxygen intermediates. Released mitochondrial DNA was found to bind and 
activate the NLRC4 inflammasome. Manipulation of autophagy altered the 
degree of inflammasome activation and inflammation in an in vivo model of 
P. aeruginosa infection.  Our results reveal a novel mechanism for NLRC4 
activation by P. aeruginosa via release of mitochondrial DNA triggered by 
the bacterial T3SS that is down-regulated by autophagy. 
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5.2 Results   
5.2.1 Autophagy inhibits inflammasome activation following P. 
aeruginosa.   
We have previously demonstrated that P. aeruginosa induces 
autophagy in BMDMs in a TLR4 dependent fashion (Jabir et al., 2014). We 
infected cells with P. aeruginosa PA103ΔUΔT which has a functional T3SS 
that activates the inflammasome via NLRC4. We set out to examine the 
effect of an absence of autophagy on the activation of the NLRC4 
inflammasome by P. aeruginosa using BMDMs from mice with a targeted 
deletion of the essential autophagy gene Atg7 in marrow precursors (Vav-
Atg7-/- mice) (Mortensen et al., 2011, Mortensen et al., 2010). We assayed 
for the induction of autophagy by measuring production of the lipidated form 
of LC3 (LC3 II) (Mizushima et al., 2010), and intracellular LC3 staining  (Fig. 
5-1a and b). In infected cells from the Vav-Atg7-/- mice there was a virtually 
complete inhibition of autophagy compared to infected cells from wild type 
mice. We then compared inflammasome activation following infection in 
macrophages from wild type and Vav-Atg7-/- mice. In the absence of 
autophagy, we found that inflammasome activation was markedly increased, 
as shown by enhanced conversion of caspase-1 to the active p10 form (Fig. 
5-1c), and greater production of secreted IL-1β (Fig. 5-1d), but no 
significant change in secreted TNF (Fig. 5-1d). We used a different method 
to inhibit autophagy by knockdown of the essential autophagy gene Atg5 
(Fig. 5-2a). This also led to increased production of IL-1β, but not TNF and 
enhanced conversion of pro-caspase-1 and pro-IL-1β to the active p10 and 
secreted p17 IL-1 β forms respectively (Fig. 5-2b and c).  
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In a similar fashion, knock down of Lc3b with siRNA in BMDMs also 
increased production of activated caspase-1 (Fig. 5-3a) and IL-1β following 
infection (Fig. 5-3b) but not TNF (Fig. 5-3c).  
To confirm these observations, we used 3-MA to inhibit autophagy 
following infection of BMDMs, murine J774A.1, and dendritic cells as well 
as the human macrophage cell line THP-1 (Fig. 5-4). 3-MA inhibited 
autophagy in all these cells, as assayed by conversion of LC3 to its 
lipidated form (Fig.5-4a), enumeration of LC3 containing puncta, and LC3 
intracellular staining (Fig 5-4b and c). Inflammasome activation in these 
cells was determined by measurement of secreted IL-1β and conversion of 
caspase-1 to its active p10 subunit (Fig. 5-5 a and b). 3-MA enhanced 
production of the caspase-1 p10 subunit in BMDMs and increased the 
levels of IL-1β and did not affect TNF-α secretion (Fig. 5-5 c), and increased 
production of IL-1β in THP-1, J774 and dendritic cells (Fig. 5-5d). The P. 
aeruginosa PAO1 strain also induced autophagy in BMDMs. We verified 
this observation by assaying LC3 I conversion to LC3 II in these cells, which 
was prevented by 3-MA (Fig. 5-6). Taken together, these data show that in 
the absence of autophagy, there is an increase in the activation of the 
NLRC4 inflammasome following P. aeruginosa infection. 
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Figure 5.1; Absence of  autophagic protein Atg7 increases  Inflammasome 
activation following P.aeruginosa PA103ΔUΔT infection.       
 a – d, BMDMs from wild type mice (Vav-Atg7+/+) or mice with a conditional deletion of 
Atg7 in bone-marrow derived cells (Vav-Atg7-/-) were infected with PA103ΔUΔT and 
autophagy quantified. a, Western blot of cell lysates infected as shown and 
immunostained for LC3. The unmodified (LC3 I) and lipidated isoform (LC3 II) are 
shown in three separate experiments. β-tubulin is shown as a loading control. b, Levels 
of intracellular LC3 assayed by flow cytometry following treatments as indicated. c, 
immunoblot for pro-caspase-1 and pro-IL-1β , and caspase-1 p10 fragment and mature 
IL-1β p17 (supernatants) of cells infected as shown. d, secretion of active IL-1β and 
TNF from basal and infected BMDMs as shown. Columns are means of 3 independent 
determinations; error bars are SEM. *** indicates a significant difference between the 
levels in BMDMs from WT or Vav-Atg7-/- mice, p < 0.001.   
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Figure 5.2; Absence of  autophagic protein Atg5 increases  Inflammasome 
activation following P.aeruginosa PA103ΔUΔT infection. 
a, LC3 I and II assayed by Western blotting in BMDMs transfected with control siRNA or 
siRNA to Atg5, uninfected (Basal), or infected with P. aeruginosa strain as indicated 
(MOI 25) for 4 hr. Blot shows 4 independent experiments. b, immunoblot for pro-
caspase-1 and pro-IL-1β , and caspase-1 p10 fragment and mature IL-1β p17 of cells 
infected as shown.  c, ELISA of IL-1β and TNF secretion from cells treated as shown. 
Columns are means of triplicate independent experiments; error bars SEM. ** indicates 
significant difference between the levels in infected BMDMs transfected with siRNA to 
Atg5, compared to control siRNA, p < 0.01. n.s., not significant.  
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Figure 5.3; Gene silencing of  Lc3b by siRNA increases Inflammasome 
activatation following P. aeruginosa  PA103ΔUΔT infection.   
a, immunoblot of cell lysates (LC3 and pro-caspase-1) and (capsase-1 p10) from cells 
infected and treated as shown. β-tubulin is shown as a loading control. b, Immunoblot 
of pro-IL-1 β and mature IL-1 β in cell supernatant after infections and treatments as 
indicated. c, ELISA of IL-1β and TNF secretion from cells treated as shown. Columns 
are means of triplicate independent determinations; error bars are SEM. ** indicates 
significant difference from control siRNA treated cells, p < 0.01. Data are representative 
of 3 independent experiments. 
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Figure 5.4; 3-MA inhibits autophagy following P.aeruginosa PA103ΔUΔT infection. 
BMDMs, THP-1, dendritic cells, and J774A.1 cells were infected with PA103ΔUΔT (MOI 
25) for the indicated time in hours in the presence (+) or absence (–) of 3-MA (10 mM). 
a, The panels show representative Western blot of LC3 isoforms and β-tubulin as a 
loading control. b, representative immunofluorescence images of cells as indicated; 
LC3 staining is green and nuclei are stained blue (DAPI). Scale bar is 10µm. c, Levels 
of intracellular LC3 assayed by flow cytometry following treatments as indicated. 
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Figure 5.5; 3-MA increases  Inflammasome activation following P.aeruginosa 
PA103ΔUΔT infection.  
a, immunoblot of cell lysates of pro-caspase-1 and capsase-1 p10 subunit of cells 
infected and treated as shown. b, Immunoblot of mature IL-1 β in cell supernatant after 
infections and treatments as indicated. (3 independent experiment). c, d,  ELISA of 
secreted IL-1β and TNF from cells as shown. Columns are means of triplicate 
independent determinations; error bars are SEM. * indicate significant differences 
between the levels in the presence and absence of 3-MA, p<0.05, and ** p < 0.01.  
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Figure 5.6; 3-MA increases  Inflammasome activation following infection with 
P.aeruginosa PAO1.  
BMDMs cells were infected with PAO1 (MOI 25) for 4 hours in the presence (+) or 
absence (–) of 3-MA (5,10 mM). The panels show representative Western blot of LC3 
isoforms and β-tubulin as a loading control.  ELISA of secreted IL-1β and TNF from cells 
supernatents as shown. Columns are means of triplicate independent determinations; 
error bars are SEM. * indicate significant differences between the levels in the presence 
and absence of 3-MA, p<0.05, and ** p < 0.01 respectively.  
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5.2.2 Mitochondrial Reactive Oxygen activates the inflammasome 
following P. aeruginosa infection.    
Autophagy can removed damaged mitochondria by mitophagy. Thus, 
we hypothesized that the increase in inflammasome activation in P. 
aeruginosa infected cells after inhibition of autophagy was due to an 
increase in release of reactive oxygen intermediates from defective 
mitochondria that failed to be removed by mitophagy. To confirm that 
autophagy was indeed directly targeting mitochondria and removing them 
through mitophagy, we performed localization studies using 
immunofluorescent microscopy (Fig. 5-7). Mitochondria were visualised by 
staining with an antibody to the mitochondrial protein ATPase inhibitory 
factor. Following infection of BMDMs with PA103ΔUΔT, we found extensive 
co-localization of mitochondria with the LC3 protein that localizes on 
autophagocytic vacuoles. Transmission electron microscopy revealed the 
presence of mitochondria within double-membraned autophagocytic 
vacuoles (Fig. 5-8). The delivery of damaged mitochondria to 
autophagocytic vacuoles is controlled by the mitochondrial protein PINK-
1(Narendra et al., 2012, Jin and Youle, 2012, Narendra et al., 2010). This 
normally undergoes proteolytic processing by healthy mitochondria, but 
following damage and depolarization, this processing is abrogated and full 
length PINK-1 accumulates on the surface of mitochondria. Full length 
PINK-1 then recruits Parkin to the mitochondrial surface and initiates 
mitophagy. Western blotting of BMDM lysates following infection with 
PA103ΔUΔT showed an accumulation of full length compared to cleaved 
PINK-1 (Fig. 5-9). This was partially reversed by Mito-TEMPO, a specific 
inhibitor of mitochondrial reactive oxygen production (Smith et al., 2011) 
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(Fig. 5-8). PA103 lacking a functional T3SS that does not activate the 
inflammasome, PA103pcrV-, did not prevent cleavage of PINK-1 (Fig. 5-9). 
These data show that mitochondria are damaged by the T3SS system in P. 
aeruginosa infection leading to inhibition of PINK-1 cleavage that then 
initiates mitophagy.  
 
Figure 5.7; Mitochondria targeted by autophagosomes following P.aeruginosa infection.  
Representative confocal images of BMDMs infected with PA103ΔUΔT (MOI 25 for 4h), fixed, 
permeabilized and stained for LC3 (green), and mitochondrial ATPIF1 (Mito, red); nuclei are 
stained blue with DAPI. Colo shows areas of colocalization of the mitochondrial and LC3 staining 
in grey. Overlay shows the merged LC3 and mitochondrial signals; co-localising areas shown as 
yellow. Scale bar is 0.5µm. Repeated three times.    
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Figure 5.8; EM analysis of Mitochondria targeted by autophagosomes following P.aeruginosa 
infection. 
Electron micrographs of a untreated BMDM (control) or b-d infected with PA103ΔUΔT (MOI 25) 
for 4 hrs. Arrow indicates autophagosome, M indicate mitochondria. Scale bar is 500 nm. 
Representative image from > 10 infected cells. 
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Figure 5.9; PINK-1 cleavage following P.aeruginosa infection.  
Immunoblot of BMDMs infected at a MOI of 25 with PA103pcrV- or PA103ΔUΔT± Mito-
TEMPO (500µM) for 4 hours and probed for PINK-1. Full length and cleaved PINK-1 are 
labelled. The blot was re-probed for β-tubulin as a loading control. Representative of two 
independent experiments. 
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Next, we examined the production of reactive oxygen by 
mitochondria following infection with P. aeruginosa and the effect of this on 
inflammasome activation. We measured production of reactive oxygen 
intermediates from mitochondria using the selective fluorescent indicator 
MitoSox (Li et al., 2003). Following infection with the PA103ΔUΔT strain of 
P. aeruginosa, there was a marked increase in mitochondrial reactive 
oxygen production. However, following infection with the PA103pcrV- 
mutant that does not have a functional T3SS and does not produce 
inflammasome activation, mitochondrial reactive oxygen was not increased 
(Fig. 5-10 a and b). To test the dependence of inflammasome activation 
following P. aeruginosa infection on production of mitochondrial reactive 
oxygen production, we used the general reactive oxygen inhibitor N-acetyl 
cysteine (NAC) as well as Mito-TEMPO, a specific inhibitor of mitochondrial 
reactive oxygen production. Following infection, both these inhibitors 
produced a dose-dependent reduction in capsase-1 activation and 
production of active IL-1β (Fig 5-11a), but with no effect on secreted TNF. 
Both inhibitors produced the expected reduction in mitochondrial production 
of reactive oxygen (Fig. 5-11b).  PA103 lacks functional flagella, thus it 
activates NLRC4 via NAIP2 rather than NAIP5/6 (Zhao et al.2011; Kofoed 
and Vance, 2011). To determine if reactive oxygen production was 
important in infection with flagellated P. aeruginosa that can active NLRC4 
via NAIP5/6, we utilised the strain PAO1. Infection of BMDMs with this 
strain activated the inflammasome with production of the p10 caspase-1 
fragment and secreted IL-1β. Both NAC and Mito-TEMPO inhibited this 
activation (Fig 5-12a). Additionally, PAO1 infection produced an increase 
output of mitochondrial reactive oxygen that was inhibited by Mito-TEMPO 
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and NAC (Fig. 5-12b). Thus, P. aeruginosa signalling via either NAIP2 or 
NAIP5/6 produce mitochondrial reactive oxygen intermediates that are 
important in NLRC4 inflammasome activation.   
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Figure 5.10;   Mitochondrial ROS generation is dependent on inflammasome activation 
following Peudomonas aeruginosa infection. 
a, Western blot  analysis of Pro-caspase, caspase-1 p10 subunit, and mature IL-1β p17 ( in 
cells supernatant) of  BMDMs. Cells were left uninfected (basal) or infected with  PA103pcrV - , 
and PA103ΔUΔT at ( MOI of 25) for 4 hr. ELISA of secreted IL-1β and TNF from cells as 
shown. Columns are means of triplicate independent determinations; error bars are SEM. *** 
indicate significant differences. p<0. 001. b, Flow cytometry of untreated BMDMs (basal) or 
infected  as indicate. Cells stained with MitoSox (2.5 µM for 30 min at 37˚C).    
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Figure 5.11; Mitochondrial inhibitors reduce inflammasome activation following  
P.aeruginosa PA103ΔUΔT infection. 
a, Western blot  analysis of Pro-caspase, caspase-1 p10 subunit, pro-IL1 β and mature IL-1β 
p17 of BMDMs. Cells were left uninfected(basal) or infected with  PA103DUDT at a MOI of 25 
for 4 hr ± Mito-TEMPO (µM), or ± NAC (mM). ELISA of IL-1β and TNF-α in BMDMs. Columns 
are means of triplicate independent determinations; error bars are SEM. **, and *** indicate 
significant differences between levels in the presence and absence of mitochondrial inhibitors. 
p<0.01, p<0. 001 respectively. b, Flow cytometry of untreated BMDMs (basal) or infected  as 
indicated. Cells stained with MitoSox (2.5 µM for 30 min at 37˚C).       
197 
 
  
 
Figure 5.12; Inhibition of mitochondrial reactive oxygen production attenuates 
inflammasome activation by PAO1. 
a, Western blot  analysis of Pro-caspase, caspase-1 p10 subunit, pro-IL1 β and mature IL-1β 
p17 of BMDMs. Cells were left uninfected(basal) or infected with  PAO1 at a MOI of 25 for 4 hr 
± Mito-TEMPO (500µM), or ± NAC (25mM). ELISA of IL-1β and TNF-α in BMDMs. Columns 
are means of triplicate independent determinations; error bars are SEM. **, indicates 
significant differences between levels in the presence and absence of mitochondrial inhibitors. 
p<0.01. b, Flow cytometry of untreated BMDMs (basal) or infected  as indicated. Cells stained 
with MitoSox (2.5 µM for 30 min at 37˚C).       
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Next, we tested the effect of inhibiting autophagy on the production 
of mitochondrial reactive oxygen intermediates and assessed the functional 
mitochondrial pool in cells following infection of BMDMs with P. aeruginosa 
PA103ΔUΔT. Production of mitochondrial reactive oxygen intermediates 
following infection was further increased when autophagy was inhibited with 
3-MA (Fig. 5-13). Next, we attenuated autophagy by knockdown of the 
essential autophagy genes Lc3b and Atg5 using siRNA. Using both these 
approaches, we observed a marked increase in the production of 
mitochondrial reactive oxygen intermediates following infection. Finally, in 
BMDMs from mice lacking the essential autophagy gene Atg7 in bone-
marrow cells (Vav-Atg7-/-) there was an increase in the amount of 
mitochondrial reactive oxygen produced following infection compared to 
control wild type animals (Fig. 5-14), and (Fig. 5-15) . Taken together, these 
data show that autophagy reduced the levels of mitochondrial reactive 
oxygen produced following infection of BMDMs with P. aeruginosa.  
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Figure 5.13;  Inhibition of autophagy/mitophagy using 3-MA increases ROS 
generation and mitochondrial damage following P.aeruginosa PA103ΔUΔT 
infection.  
a, Flow cytometry of untreated BMDMs (basal) or infected  for  4h at MOI of 25 with 
PA103ΔUΔT. Cells stained with MitoSox( 2.5 µM for 30 min at 37˚C) . b, Flow cytometry 
of BMDMs following treatments as in (a). Cells were stained with MitoTracker deep Red 
and MitoTracker Green (50 nM for 30 min at 37˚C).  Numbers above indicate % cells 
with loss of mitochondrial membrane potential (damaged mitochondria). Representative 
of two independent experiments.  
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Figure 5.14; Gene silencing of  Lc3b by siRNA increases  ROS generation and 
mitochondrial damage following P.aeruginosa PA103ΔUΔT infection. 
a, Flow cytometry of BMDMs transfected as shown and then left uninfected (basal) or 
infected  for  4h at MOI of 25 with PA103ΔUΔT. Cells stained with MitoSox(2.5 µM for 30 
min at 37˚C) . b, Flow cytometry of BMDMs following treatments as in (a). Cells were 
stained with MitoTracker deep Red and MitoTracker Green (50 nM for 30 min at 37˚C).  
Numbers above indicate % cells with loss of mitochondrial membrane potential (damaged 
mitochondria). Representative of three independent experiments.  
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Figure 5.15;  Depletion of  autophagic proteins  increases  ROS generation and 
mitochondrial damage following P.aeruginosa PA103ΔUΔT infection. 
 a, Flow cytometry in BMDMs from WT  or Vav-Atg7 -/-  mice , and transfected with  
control siRNA or siRNA to Atg5 as shown. Cells were left BMDMs (basal) or infected  for  
4h at MOI of 25 with PA103ΔUΔT. Cells stained with MitoSox ( 2.5 µM for 30 min at 
37˚C) . b, Flow cytometry of BMDMs transfected with control siRNA or siRNA to Atg5. 
Cells were left untreated (basal) or infected for 4h at MOI of 25 with PA103ΔUΔT. Cells 
were stained with MitoTracker deep Red and MitoTracker Green (50 nM for 30 min at 
37˚C).  Numbers above indicate % cells with loss of mitochondrial membrane potential 
(damaged mitochondria).  Representative of two independent experiments. 
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We then determined whether increased inflammasome activation 
following inhibition of autophagy in infected cells was due to increased 
mitochondrial reactive oxygen production. In BMDMs in which autophagy 
was inhibited by knock down of Lc3b, both NAC and mito-TEMPO 
prevented caspase-1 activation and production of mature IL-1β, without 
affecting TNF production (Fig. 5-16). In BMDMs in which autophagy was 
inhibited by 3MA, both NAC and mito-TEMPO prevented caspase-1 
activation and production of mature IL-1β, without affecting TNF production 
(Fig. 5-17). Similarly, in infected cells from Vav-Atg7-/- mice, Mito-TEMPO 
reduced IL-1β but not TNF production and inhibited the production of 
activated caspase-1 (Fig. 5-18). Finally, we tested the effects of mito-
TEMPO on inflammasome activation in infected BMDMs in which 
autophagy was inhibited by knockdown of Atg5 with siRNA. Again, mito-
TEMPO inhibited the increase in IL-1β production and generation of 
activated caspase-1 that was seen when autophagy was prevented (Fig. 5-
19). 
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Figure 5.16; Increased inflammasome activation produced by gene silencing of  Lc3b 
is dependent on  ROS generation following P.aeruginosa PA103ΔUΔT infection. 
BMDMs were transfected with control siRNA and siRNA to Lc3b. then infected with 
PA103ΔUΔT at MOI of 25 for 4 hr ± Mito-TEMPO (µM), or ± NAC (mM). Figure shows 
Western blot analysis of Pro-caspase-1, caspase-1 p10 subunit, and mature IL-1β and 
level of IL-1β and TNF-α secretion. Columns are means of triplicate independent 
determinations; error bars are SEM. *** indicates significant differences between the 
levels in the presence and absence of mitochondrial inhibitors, p<0.001. Representative 
of two independent experiments. 
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Figure 5.17; Increased inflammasome activation produced by autophagy inhibitor 3-
MA is dependent on ROS following P. aeruginosa PA103ΔUΔT infection. 
 BMDMs cells were pre-treated in media with 3-MA (10 mM) then infected with 
PA103ΔUΔT at ( MOI of 25) for 4 hr ± Mito-TEMPO (µM) ,or ± NAC (mM). Figure shows 
Western blot analysis of Pro-caspase-1, caspase-1 p10 subunit, Pro-IL-1β, mature IL-1β 
and level of IL-1β and TNF-α secretion. Columns are means of triplicate independent 
determinations; error bars are SEM. *** indicate significant differences between the levels 
in the presence and absence of mitochondrial inhibitors, and 3-MA (10 mM), p<0.001. 
Representative of two independent experiments.   
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Figure 5.18; Increased inflammasome activation in the absence of  autophagic 
protein Atg7 induced  Inflammasome activation is dependent on ROS following 
P.aeruginosa PA103ΔUΔT infection.    
 Figure shows Western blot analysis of Pro-caspase, caspase-1 p10 subunit, mature IL-
1β p17 ± Mito-TEMPO and levels of IL-1β and TNF-α in BMDMs from WT or Vav-Atg7 -/- 
mice. Cells left uninfected (Basal), or infected with PA103ΔUΔT for 4hrs at a MOI of 25 ± 
Mito-TEMPO as indicated. Columns are means of triplicate independent determinations; 
error bars are SEM. *** indicate significant differences between WT animals and Vav-
Atg7 -/- mice ± Mito-TEMPO. p<0.001. n.s. not significant. Representative of two 
independent experiments.   
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Figure 5.19;  Increased inflammasome activation in the absence of  autophagic 
protein Atg5 induced  Inflammasome activation is dependent on ROS following 
P.aeruginosa PA103ΔUΔT infection.    
Figure shows Western blot analysis of Pro-caspase, caspase-1 p10 subunit, Pro-IL-1 β, 
mature IL-1 β and levels of IL-1β and TNF-α secretion. Cells left uninfected (Basal), or 
infected with PA103ΔUΔT for 4hrs at a MOI of 25 ± Mito-TEMPO as indicated. Columns 
are means of triplicate independent determinations; error bars are SEM.  **, and *** 
indicate significant differences between control siRNA and siRNA to Atg5 ± Mito-
TEMPO. p<0.001. Representative of two independent experiments.      
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5.2.3 P.aeruginosa produces release of Mitochondrial DNA that is 
essential for activation of the NLRC4 inflammasome  
One consequence of mitochondrial damage is release of 
mitochondrial DNA (Nakahira et al., 2011, Shimada et al., 2012). We 
hypothesised that the mitochondrial damage following P. aeruginosa 
infection would result in release of mitochondrial DNA that would be 
important in activating the NLRC4 inflammasome. First, we assayed for 
cytoplasmic mitochondrial DNA release following infection of BMDMs using 
quantitative PCR. Following infection with PA103ΔUΔT there was a marked 
increase in the relative amount of mitochondrial to nuclear cytoplasmic DNA 
(Fig. 5-20). This was further increased by inhibiting autophagy with 3-MA or 
by knockdown of Lc3b with siRNA (Fig. 5-20a). Inhibiting mitochondrial 
reactive oxygen production with Mito-TEMPO significantly inhibited 
mitochondrial DNA release (Fig. 5-20b). 
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Figure 5.20;  Mitochondrial DNA release following P.aeruginosa PA103ΔUΔT 
infection 
qPCR analysis of cytosolic mitochondrial DNA (mtDNA) relative to nuclear DNA in 
macrophages pre-treated a with Mito-TEMPO (500 µM) or 3-MA(10 mM) or control or 
Lc3b siRNA (b) and infected with PA103ΔUΔT (MOI 25) for 4 hours or uninfected (Basal) 
as shown. Columns show means of three independent determinations; error bars are 
SEM. * and *** indicate significant differences between groups ± 3-MA, or Mito- TEMPO. 
p<0.05, p<0.001 respectively. Representative of two independent experiments.      
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Further to establish the importance of mitochondria in the 
activation of the NLRC4 inflammasome by P. aeruginosa, we grew 
J774A.1 murine macrophages in ethidium bromide to generate cells 
that lack mitochondria (Hashiguchi and Zhang-Akiyama, 2009) 
(ρ0J774A.1). We confirmed that these cells had lost mitochondria by 
measuring cellular mitochondrial DNA content by quantitative PCR, 
Western blotting cell lysates for the mitochondrial protein ATPase 
inhibitory factor and flow cytometry of cells stained with the 
mitochondrial specific dye Mitotracker Green (Fig. 5-21a, b, and c). 
Infection of the ρ0J774A.1 cells with PA103ΔUΔT gave no increase in 
mitochondrial reactive oxygen production (Fig. 5-22a). Moreover, 
when infected with PA103ΔUΔT the ρ0J774A.1 cells lacking 
mitochondria failed to activate caspase-1 and produced significantly 
less IL-1β but similar amounts of TNF. Autophagy, as assayed by the 
formation of LC3 II and appearance of LC3 puncta, was maintained 
in ρ0J774A.1 cells compared to J774A.1 cells (Fig. 5-22b, c, and d), 
showing that loss of mitochondria had not inhibited this process. 
Thus, mitochondria are essential for P. aeruginosa to activate the 
inflammasome. 
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Figure 5.21; Depletion of Mitochondrial DNA following EtBr treatment 
a, Mitochondrial content of J774A.1 cells exposed to EtBr at the indicated concentration 
(ng/ml) measured by qPCR (normalised to untreated cells) and b immunoblot for the 
mitochondrial protein ATPIF1 at low and high exposure time; β-tubulin is show as a 
loading control. c, mitochondrial content of control of ethidium bromide treated J774A.1 
cells (ρJ774A.1) assayed by flow cytometry of MitoTracker stained cells. Representative 
of two independent experiments. 
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Figure 5.22; EtBr abolishes inflammasome activation following P.aeruginosa 
PA103ΔUΔT infection. 
a, Flow cytometry of J774A.1 and ρ˚J774A.1 cells left uninfected (Basal) or infected with 
PA103ΔUΔT (MOI 25) for 4hr and stained with MitoSox (2.5µM for 30 min at 37˚C). b, 
J774A.1 and ρ˚J774A.1 cells left untreated (basal) or infected with PA103ΔUΔT(MOI 25) 
for 4 hrs. The panels show Western blot of LC3 II, pro-caspase-1, the caspase-1 p10 
subunit, Pro-IL-1β, mature IL-1β and β-tubulin as a loading control. Graphs show IL-1β 
and TNF secretion. Columns show means of three independent determinations; error 
bars are SEM.  *** indicate significant differences between the levels in the presence and 
absence of the EtBr (500ng/ml), p < 0.001. c, Immunofluorescent staining of cells 
following infection as in panel b, Panels show staining for LC3 (green), ATPIF1 (red; 
Mito), colocalized red and green signal (Coloc) and merged res and green channels 
together with nuclei stained blue (Overlay). Scale bar is 5µm. All data representative from 
2-3 independent experiments.  
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5.2.4 Mitochondrial DNA directly activates the NLRC4 inflammasome  
Next, we explored the role of cytoplasmic mitochondrial DNA in 
activating the NLRC4 inflammasome following P. aeruginosa infection. We 
transfected BMDMs with DNAse-1, or with a control protein LDH or heat-
inactivated DNAse-1. We then determined the effect of these transfected 
proteins on the activation of the inflammasome. LDH or heat-inactivated 
DNAse-1 did not affect the production of activated capsase-1 or production 
of IL-1β following infection (Fig. 5-23). However, active DNAse-1 prevented 
caspase-1 activation and significantly reduced the production of mature IL-
1β following infection without affecting production of TNF (Fig. 5-23). 
DNAse-1 treatment reduced the presence of cytosolic mitochondrial DNA 
as expected (Fig. 5-23). Transfection of active DNAse-1 also reduced the 
inflammasome activation produced by infection of BMDMs with PAO1 strain 
without affecting TNF (Fig. 5-24). 
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Figure 5.23;  Cytosolic mtDNA is coactivator of  NLRC4 inflammasome activation 
following P. aeruginosa PA103ΔUΔT infection 
BMDMs were transfected with 3 µg DNAse-I, lactate dehydrogenase (LDH), or heat-
inactivated (HI) DNAse-I as shown and then infected with PA103ΔUΔT (MOI 25) for 4 
hrs. The panels show immunoblot of the indicated proteins and β-tubulin as a loading 
control. The graphs show IL-1β and TNF secretion and qPCR analysis of cytosolic 
mtDNA. Columns show means of three independent determinations; error bars are 
SEM. *** indicates significant difference from HI DNAse-I, p<0.001. Representative of 
two independent experiments. 
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Figure 5.24; mtDNA is required for inflammasome activation following P. aeruginosa 
PAO1 infection. 
BMDMs were transfected with 3 µg DNAse-I, lactate dehydrogenase (LDH), or heat-
inactivated (HI) DNAse-I as shown and then infected with PAO1 (MOI 25) for 4 hrs. The 
panels show IL-1β and TNF secretion. Columns show means of three independent 
determinations; error bars are SEM. ** indicates significant difference from HI DNAse-I, 
p<0.01.  
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Mitochondrial DNA may undergo oxidation on release and oxidised 
mitochondrial DNA has been shown to be important in activating the NLRP3 
inflammasome (Shimada et al., 2012). Thus, we set out to determine the 
role of native and oxidised mitochondrial DNA on activation of the NLRC4 
inflammasome in P. aeruginosa infection. Firstly, we transfected native and 
oxidised mitochondrial DNA into LPS primed BMDMs and showed that this 
increased IL-1β but not TNF release (Fig. 5-25a) as has been shown 
previously. Oxidised mitochondrial DNA produced a significantly greater 
amount of IL-1β (Fig. 5-25 a). Digestion of the DNA with DNAse-1 
abrogated the observed stimulation. We then repeated this experiment but 
infected the transfected BMDMs with PA103ΔUΔT. The transfected DNA 
significantly augmented the production of IL-1β in infected BMDMs without 
altering TNF secretion (Fig. 5-25 b). Again, oxidised DNA was more 
effective than native mitochondrial DNA. We repeated this experiment in 
BMDMs infected with PAO1 and found that transfection of mitochondrial 
DNA augmented inflammasome activation (Fig. 5-26). Taken together, 
these data support the conclusion that the release of mitochondrial DNA 
following infection with flagellated or non-flagellated P. aeruginosa is 
essential for subsequent activation of the NLRC4 inflammasome.  
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Figure 5.25; Cytosolic mtDNA is involved in NLRP3 and NLRC4 inflammasome 
activation  
a, IL-1β and TNF secretion from LPS primed BMDMs transfected for 6 hr with 2 µg 
mtDNA, 2 µg oxidised mtDNA, or DNA predigested by DNAse-I.as shown. Columns are 
means of triplicate independent determinations; error bars are SEM. *, ** and *** indicate 
significant difference at a level of p < 0.05, 0.01 or 0.001 respectively for the indicted 
comparison or from the result with oxidised DNA + LPS. b, as panel a but in BMDMs 
infected with PA103ΔUΔT (MOI 25) for 4 hrs as shown. Representative of two 
independent experiments.  
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Figure 5.26; mtDNA is involved in NLRC4 inflammasome activation following 
P.aeruginosa PAO1 infection. 
BMDMs were transfected with native or oxidised mDNA as shown and then infected with P. 
aeruginosa PAO1 (MOI: 25 for 4hrs). Upper panels show ELISA of IL-1β and TNF 
secretion. Columns are means of triplicate independent determinations; error bars are 
SEM. *, ** and *** indicate significant difference at a level of p < 0.05, 0.01 or 0.001 
respectively for the indicted comparison or from the result with oxidised DNA. Lower panel 
shows western blot of pro-IL-1β and mature secreted IL-1β.  
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A number of cytoplasmic DNA sensors might be responsible for 
these observed effects, including AIM2 as well as NLRP3 as previously 
described. We thus examined the effect of transfected mitochondrial DNA 
on IL-1β production in BMDMs from mice with a knockout of the Aim2 gene 
(Rathinam et al., 2010) (Aim2-/-). Compared to wild type macrophages 
(Aim2+/+), the transfected mitochondrial DNA produced less IL-1β in the 
Aim2-/- cells (Fig. 5-27). However, there was still a significant increase in IL-
1β production following transfection of mitochondrial DNA into LPS primed 
Aim2-/- BMDMs (Fig. 5-27a). Oxidised DNA was more effective than native, 
and TNF levels were unaffected. Thus, there is an AIM2 independent 
production of IL-1β stimulated by mitochondrial DNA, as has been 
previously observed and attributed to NLRP3. Similarly, in cells infected 
with PA103ΔUΔT, there was a reduction in amounts of IL-1β produced in 
Aim2 deficient cells, but this was still much greater than the output from 
uninfected cells (Fig. 5-27b). Again, even in the absence of AIM2, 
transfected mitochondrial DNA boosted IL-1β production in infected cells; 
oxidised DNA was more effective and TNF levels were unchanged (Fig. 5-
27b). 
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Figure 5.27; Mitochondrial DNA activates the inflammasome independently of Aim2.   
a, b, IL-1β and TNF secretion from LPS primed BMDMs from Aim2+/+ and Aim2-/-   
transfected for 6 hr with 2 µg mtDNA, 2 µg oxidised mtDNA, or DNA predigested by 
DNAse-I.as shown. Columns are means of triplicate independent determinations; error 
bars are SEM. *, ** and *** indicate significant difference at a level of p < 0.05, 0.01 or 
0.001 respectively for the indicted comparison or from the result with oxidised DNA + 
LPS. b, as panel a but in BMDMs infected with PA103ΔUΔT (MOI 25) for 4 hrs as shown. 
Representative of two independent experiments.  
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Unequivocally to show a role for NLRC4 in the detection of 
mitochondrial DNA, we repeated these experiments using BMDMs from 
mice with a knockout of the Nlrc4 gene (Nlrc4-/-). LPS primed cells were 
then transfected with mitochondrial DNA and inflammasome activation 
determined. Compared to wild type BMDMs (Nlrc4+/+), transfection of 
mitochondrial DNA into Nlrc4 knockout cells produced significantly reduced 
amounts of IL-1β and activated caspase-1 (Fig. 5-28). There was still some 
residual response to mitochondrial DNA in the Nlrc4-/- cells as would be 
expected from the remaining AIM2 and NLRP3, but it was substantially and 
significantly reduced. Therefore, NLRC4 independently can mediate 
activation of the inflammasome in response to transfected mitochondrial 
DNA. We then tested the effect of transfected DNA in infected cells from 
wild type and Nlrc4 knockout animals. Nlrc4-/- BMDMs showed no evidence 
of inflammasome activation following infection, as expected (Fig. 5-29). In 
Nlrc4-/- BMDMs transfected with mitochondrial DNA there was some 
residual stimulation of inflammasome activation after infection, but much 
less than seen in the infected and DNA transfected wild-type cells (Fig. 5-
29). Thus, there is a NLRC4 dependent response to mitochondrial DNA 
independent of other cytoplasmic DNA sensors. 
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Figure 5.28; Role of NLRC4 in activation of the inflammasome by mediated mtDNA.  
The panels show Western blot of pro-caspase-1, the caspase-1 p10 subunit, Pro-IL-1β, 
mature IL-1β in cells supernatant  and β-tubulin as a loading control in LPS primed 
Nlrc4+/+ and Nlrc4-/- BMDMs transfected for 6 hr with 2 µg mtDNA, or with  2 µg 
Oxd.mtDNA. Graphs show IL-1β and TNF secretion. Columns are means of triplicate 
independent determinations; error bars are SEM. *, ** and *** indicate significant 
difference at a level of p < 0.05, 0.01 or 0.001 respectively for the indicted comparison or 
from the result with oxidised DNA + LPS. Representative of two independent 
experiments. 
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Figure 5.29; Role of NLRC4 in activation of the inflammasome by mtDNA following P. 
aeruginosa PA103ΔUΔT infection. 
BMDMs from Nlrc4+/+ and Nlrc4-/- were transfected for 6 hr with 2 µg mtDNA, or with 2 µg 
Oxd.mtDNA and infected with PA103ΔUΔT (MOI 25) for 4 hrs. The panels show Western 
blot of pro-caspase-1, the caspase-1 p10 subunit, Pro-IL-1β, mature IL-1β in cells 
supernatant and β-tubulin as a loading control. Graphs show IL-1β and TNF secretion. 
Columns are means of triplicate independent determinations; error bars are SEM. *, ** 
and *** indicate significant difference at a level of p < 0.05, 0.01 or 0.001 respectively for 
the indicted comparison or from the result with oxidised DNA. Representative of two 
independent experiments. 
 
223 
 
5.2.5 NLRC4 Interacts with and is activated by Mitochondrial DNA  
We hypothesised that the activation of the NLRC4 inflammasome by 
mitochondrial DNA was mediated by binding to the NLRC4 protein. To test 
this, we grew cells in BrdU and prepared cell lysates before and after 
infection. NLRC4 was immunoprecipitated from the lysates and bound DNA 
in the immunoprecipitates detected by probing slot blots of the eluates with 
antibody to BrdU (Fig. 5-30). We added 3-MA to some of the cells prior to 
lysis to block autophagy and thus enhance the release of mitochondrial 
DNA. In lysates prepared from uninfected cells, no DNA was detected in the 
NLRC4 immunoprecipitates., even in the presence of 3-MA (Fig. 5-30a). 
Following infection, NLRC4, but not control, immunoprecipitates contained 
DNA; the amount was further increased in the presence of 3-MA (Fig. 5-
30a). We repeated this experiment, but probed the slot blot with an antibody 
to 8-OH deoxyguanosine, a modified deoxynuceloside found commonly in 
oxidised DNA (Fig. 5-30b) (Maki and Sekiguchi, 1992). NLRC4, but not 
control, immunoprecipitates contained material reacting with this antibody. 
Thus, following infection with P. aeruginosa, NLRC4 has a direct or indirect 
interaction with DNA, including DNA that has undergone oxidation. To 
demonstrate that this DNA is mitochondrial in origin, we performed NLRC4 
immunoprecipitation from both infected J774A.1 and ρ0J774A.1 that lack 
mitochondria. In lysates from infected cells lacking mitochondria, 
immunoprecipitates of NLRC4 did not contain DNA (Fig. 5-31). 
  
 
224 
 
 
                                                                                           
Figure 5.30; NLRC4 binds mtDNA following P.aeruginosa PA103ΔUΔT infection.   
a, BMDMs were grown in BrdU (10 mM) and infected for 4hr (MOI 25) with PA103ΔUΔT 
in the absence and prescence of 3-MA  as shown before lysates were 
immunoprecipitated with anti-NLRC4 or control rabbit serum as indicated. Bound material 
was slot-blotted to nitrocellulose and then blotted with anti-BrdU. b, as in a, but re-probed 
with antibody to 8OHdG. c, The panel shows separate immunoblot of eluted material 
from NLRC4 immunoprecipitates blotted for NLRC4. Representative of three independent 
experiments. 
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Figure 5.31; EtBr abolishes DNA binding to NLRC4 
a , J774A.1 and ρ˚J77A.1 cells  were grown in the presence of (10mM ) of BrdU to label 
DNA and then left uninfected or infected with PA103ΔUΔT(MOI 25) for 4 hr. Panel shows 
slot blot of elutes immunoprecipitated with anti-NLRC4 or control rabbit serum as 
indicated. b, as in a but re-probed with anti- 8OHdG. c, The panel shows separate 
immunoblot of eluted material from NLRC4 immunoprecipitates blotted for NLRC4. 
Representative of two independent experiments. 
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Next, we set out to determine if the interaction between NLRC4 and 
mitochondrial DNA was important in initiating inflammasome activation. To 
determine if mitochondrial DNA could directly activate NLRC4, we tested 
the effect of mitochondrial DNA on caspase-1 activation in a reconstituted 
cell based assay. This work was performed by Dr. Lee Hopkins in Professor 
Clare Bryant’s laboratory in Cambridge. This comprised of HEK cells 
transfected with expression plasmids encoding NLRC4 and NAIP. These 
cells were then transfected with mitochondrial DNA and activation of 
caspase-1 detected by a fluorescent probe, FLICACasp1. Using a variety of 
transfection reagents, we detected ‘spots’ of activated caspase-1 in cells 
following transfection of mitochondrial DNA, but not in control cells 
transfected without DNA (Fig. 5-32). Thus, mitochondrial DNA alone is 
sufficient in this assay to result in NLRC4 inflammasome activation. 
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Figure 5.32; Mitochondrial DNA activates NLRC4 in HEK cells. 
HEK cells transfected with NLRC4 and NAIP were transfected with and without mitochondrial DNA 
and active caspase-1 localised by immunofluorescent imaging using FLICACasp1. Panels show 
representative images of cells stained with FLICACasp1 (green) and nuclei stained with DAPI (blue) 
using the indicated transfection reagents. Arrows show ‘spots’ of active Caspase-1 formation.  
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5.2.6 Manipulation of autophagy alters inflammasome activation in 
vivo following P.areuginosa infection  
Given that autophagy attenuates the activation of the inflammasome 
by P. aeruginosa infection, we hypothesised that by drug manipulation of 
autophagy we could alter inflammasome activation in vivo. Firstly, we tested 
the effect of adding the known inducer of autophagy, rapamycin, to P. 
aeruginosa infected BMDMs as well as the macrophage lines J774A.1 and 
THP-1. We found that rapamycin augmented the degree of autophagy 
observed during infection, by assay of LC3 containing puncta, also LC3 II 
determination using a validated flow cytometric assay (Fig. 5-33a, b), and 
formation of the LC3 II isoform by Western blot assay (Fig. 5-34). In all cells 
studied, the addition of rapamycin significantly reduced the amount of IL-1β 
produced during infection (Fig. 5-34). Neither rapamycin nor 3-MA had any 
significant effect on the growth of P. aeruginosa in culture broth (data not 
shown).    
 Next, we tested the effect of altering autophagy on an in vivo model 
of P. aeruginosa infection in mice. Animals were infected with the microbe 
intraperitoneally and the effects of augmenting autophagy with rapamycin 
and inhibiting autophagy with 3-MA studied. These treatments boosted and 
inhibited respectively the degree of autophagy in cells recovered from the 
peritoneal cavity as assayed by levels of LC3 II and LC3 puncta per cell 
(Fig. 5-35). We found that rapamycin treatment significantly reduced the 
amount of IL-1β recovered from the peritoneal cavity after infection, but had 
no effect on levels of TNF (Fig. 5-36). Inhibiting autophagy with 3-MA 
significantly enhanced IL-1β levels, with no effect on TNF (Fig. 5-36). As an 
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indicator of disruption to the peritoneal barrier, we measured protein 
concentration in peritoneal fluid recovered after infection. Rapamycin 
significantly reduced the protein concentration while 3-MA enhanced it (Fig. 
5-37). We also measured the numbers of viable bacteria recovered from the 
peritoneal cavity following infection (Fig. 5-38). This showed that 
Rapamycin reduced the numbers of bacteria while 3-MA increased these 
numbers. Thus, increasing the degree of autophagy with rapamycin 
reduces the amount of inflammasome activation and resulting inflammatory 
response following infection in vivo. Inhibiting autophagy with 3-MA has the 
opposite effect. However, increasing the degree of autophagy with 
rapamycin results in lower numbers of bacteria remaining after infection; 
again inhibition of autophagy with 3-MA had the opposite effect.    
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Figure 5.33;  Rapamycin augments autophagy following  P.aeruginosa PA103ΔUΔT 
infection.    
a, representative immunofluorescence images of LC3 in THP-1, BMDM, and 
J774A.1cells. Cells left uninfected (Basal), treated with rapamycin (50µg/ml) for 4 h, or 
infected with PA103ΔUΔT or PA103ΔUΔT+rapamycin for 4hrs at a MOI of 25. Cells were 
stained with DAPI to visualize nuclei (blue), and LC3 staining is shown as green. Scale 
bar 10 µm. Representative of three independent experiments. b, FACS analysis for LC3 
protein following infection with PA103ΔUΔT (MOI 25 for 4h), in the presence and 
absence of rapamycin. Representative of two independent experiments.  
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Figure 5.34;  Induction of autophagy inhibits inflammasome activation in vitro. 
The panels show representative Western blot of LC3 isoforms, and β-tubulin as a loading 
control following infection and rapamycin treatment as indicated. Graphs are means (with 
SEM as error bars) of IL-1β secretion in the same experiment. THP-1, BMDM, and 
J774A.1cells were used as indicated.  *** indicate significant differences between the 
levels in the presence and absence of rapamycin during infection, p < 0.001. 
Representative of two independent experiments. 
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Figure 5.35; Pharmacological  manipulation  modulates  autophagy  following 
infection in vivo.  
Results from intraperitoneal infection of female C57/BL6 mice with PA103ΔUΔT treated 
with rapamycin (R), or 3-methyl adenine as indicated. Panel shows level of LC3 I and II in 
peritoneal cells recovered following infections and treatments as shown; lower panel 
shows mean (±SEM) numbers of LC3 containing puncta per cell. Representative of two 
independent experiments. 
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Figure 5.36; Induction of autophagy inhibits inflammasome activation in vivo following  
P. aeruginosa PA103ΔUΔT infection.   
Results from intraperitoneal infection of female C57/BL6 mice with PA103ΔUΔT treated 
with rapamycin (R), or 3-methyl adenine as indicated.  Graphs shows mean levels (n=3) 
of IL-1β and TNF (error bars are SEM) in the blood (a) and peritoneal washings (b) 
before and 6 hr after infection with the indicated treatments. *and ** and *** indicate 
significant differences from the levels in infected animals with no pre-treatment. 
Representative of two independent experiments. 
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Figure 5.37; Protein concentration following  intraperitoneal fluid infection.  
Protein concentration in peritoneal fluid following infection and treatments as in figure 5-
36. Representative of two independent experiments. 
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Figure 5.38; Autophagy contributes to bacterial killing in vivo following P. 
aeruginosa infection.  
Bacterial colony counts per ml of recovered fluid from the peritoneal cavity with 
treatments as shown. Columns are means of triplicate determinations; error bars SEM. 
Representative of two independent experiments. 
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5.3 Discussion      
We have shown here that mitochondria play an essential role in the 
activation of the NLRC4 inflammasome by the pathogen P. aeruginosa. 
Taken together, these data establish a novel pathway of NLRC4 activation 
dependent on mitochondrial sensing of infection. Flagellin (Miao et al., 2006) 
and components of the T3SS rod and needle complex have been reported 
to activate the NLRC4 inflammasome, utilising proteins of the NAIP family 
as adaptors (Miao et al., 2010, Zhao et al., 2011, Kofoed and Vance, 2011). 
We propose that these bacterial interactions with NAIP proteins are 
upstream of a subsequent initiation of mitochondrial damage and release of 
mitochondrial DNA. Given that NLRP3 activation has also been shown to be 
dependent on mitochondrial DNA release. The mechanism by which P. 
aeruginosa produces this mitochondrial damage is unclear. However, the 
initiation of inflammasome activation and pyroptosis has many similarities to 
apoptosis, in which mitochondria play a key role. For example, the Fas 
apoptosis pathway can results in cleavage of the protein Bid to a form that 
moves from the cytoplasm to mitochondria where it initiates damage and 
release of cytochrome c, amplifying the apoptotic signal (Billen et al., 2008). 
We speculate that in a similar fashion NAIP proteins may translocate to 
mitochondria after activation by flagellin or T3SS rod proteins. 
  The interaction of the T3SS of the microbe with its target cell results 
in mitochondrial production of reactive oxygen intermediates and the 
release of mitochondrial DNA. Through a number of independent 
approaches we have shown that this mitochondrial damage is essential to 
subsequent activation of the NLRC4 inflammasome by this pathogen and 
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that it can be attenuated by selective mitophagy, also triggered by the T3SS. 
We have shown that mitochondrial DNA is sufficient to activate the NLRC4 
inflammasome separately from other DNA sensors; oxidised DNA is more 
potent in this regard than the native form. NLRC4 complexes can bind 
mitochondrial DNA and results in inflammasome activation. Manipulation of 
the autophagocytic pathway in vivo can alter the activation of the 
inflammasome by P. aeruginosa infection and the subsequent inflammatory 
response.  
P. aeruginosa that lack a functional T3SS can activate the NLRP3 
inflammasome by a mechanism that requires a TRIF-dependent activation 
of caspase-11 (Rathinam et al., 2012, Kayagaki et al., 2011). This is a 
slower process than activation via the T3SS as it requires transcriptional 
activation of caspase-11, which typically takes some hours. All the work 
described here was with P. aeruginosa that has an active T3SS which 
produces rapid inflammasome activation that is independent of caspase-11 
and NLRP3 and is abolished in the absence of NLRC4 (Rathinam et al., 
2012, Arlehamn and Evans, 2011). Thus, the involvement of mitochondria 
in the activation of the inflammasome that we describe here is quite 
independent of caspase-11 and NLRP3 involvement. 
 Several groups have shown the importance of mitochondrial damage 
and sensing of released mitochondrial DNA in NLRP3 inflammasome 
activation (Nakahira et al., 2011, Shimada et al., 2012); removal of 
damaged mitochondria by selective autophagy (mitophagy) inhibits this 
activation. Thus, the question remains as to how specific NLRP3 or NLRC4 
inflammasome activation can be achieved through an identical signal. We 
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propose that additional proteins must be involved in triggering either a 
NLRC4 or NLRP3 response. These might be NAIP family members that in 
the context of binding to flagellin or T3SS rod/needle proteins direct a 
NLRC4 response over NLRP3 activation. As the original description of the 
inflammasome makes clear, an activating signal is required to bring 
together an inflammasome complex (Martinon et al., 2002). Thus, the 
presence of particular activated binding partners, such as NAIPs, may lead 
to assembly of the NLRC4 inflammasome, while different protein 
interactions may produce a NLRP3 inflammasome. For example, the 
guanylate binding protein GBP5 has been shown to be important for 
assembly of the NLRP3 inflammasome for some, but not all triggering 
stimuli (Shenoy et al., 2012). Indeed, different inflammasomes may 
assemble at different times during a triggering event such as an infection. A 
role for mitochondrial damage and sensing of mitochondrial DNA may 
therefore be a common factor that is required for the final activation of the 
assembled inflammasome.  
 We show here that immunoprecipitated NLRC4 contains bound 
mitochondrial DNA (Fig. 5-30). Similar results have been found for NLRP3. 
We do not know whether DNA is binding directly to the NLR proteins or if it 
binds to an associated protein. Direct binding to these different NLRs might 
suggest a role for the common central NOD domain of these proteins as 
DNA binding elements; equally, other interacting proteins may be involved. 
Further experiments to define the exact element that interacts with DNA are 
required. 
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 The results presented in this chapter show that autophagy regulates 
NLRC4 activation following P. aeruginosa infection, by selective removal of 
damaged mitochondria – mitophagy. The T3SS of the P. aeruginosa 
triggers a process that leads to the accumulation of full-length PINK-1 on 
the surface of mitochondria (Fig. 5-9) and their removal by mitophagy. This 
acts to abrogate the activation of the NLRC4 inflammasome. We have also 
found that there is a reciprocal effect of inflammasome activation on the 
process of autophagy, such that caspase-1 activation leads to proteolytic 
processing of the signalling intermediate TRIF and hence down-regulates 
autophagy (chapter 4). This is important to consider when evaluating the 
effects of interrupting NLRC4 activation on the production of mitochondrial 
reactive oxygen intermediates and release of mitochondrial DNA. Inhibiting 
NLRC4 activation results in attenuated caspase-1 activity and hence a 
reduction in TRIF processing and increased autophagy. This will lead to a 
reduction in mitochondrial reactive oxygen production and release of 
mitochondrial DNA. We suggest that this is the mechanism that accounts 
for the apparent dependence of mitochondrial damage on NLRP3 as 
reported by (Nakahira et al., 2011).  
 We show using an in vivo peritoneal infection model with P. 
aeruginosa that manipulation of the autophagocytic pathway with rapamycin 
and 3-MA can alter the degree of activation of the inflammasome and 
subsequent inflammation. This reinforces the physiological relevance of the 
mechanisms we have described in this work. Additionally, it suggests that 
manipulation of autophagy could be exploited therapeutically to modify the 
IL-1β response following infection. Clearly, IL-1β plays an important role in 
host defense, but excess production of inflammatory mediators is 
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deleterious as found in sepsis and septic shock. Down-regulating 
inflammasome activation by promoting autophagy in sepsis might therefore 
be a useful therapeutic strategy. Autophagy also has a role in clearance of 
P. aeruginosa; in our model of infection, augmenting or inhibiting autophagy 
decreased or increased respectively the numbers of bacteria recovered 
from peritoneal cavity (Fig. 5-38). 
 In conclusion, the work described here establishes a novel pathway 
by which infection activates the NLRC4 inflammasome, by inducing 
mitochondrial damage and release of mitochondrial DNA. This pathway is 
similar to that described for the activation of the NLRP3 inflammasome by 
LPS and ATP. Further work will be required to establish how each pathway 
operates independently. This study serves to underscore the importance of 
mitochondria in initiating an inflammatory response through activation of the 
inflammasome, and how control of mitochondrial quality through autophagy 
is central in limiting this response. 
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6    General discussion and Conclusions  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
242 
 
 It has been proved that mutation of autophagy genes increases 
susceptibility to infection by intracellular organisms in plants, flies worms, 
mice, and possibly to humans. It is suggested that autophagy pathway 
functions of autophagy proteins also have major role in controlling other 
aspects of immunity in multicellular organisms. The autophagy machinery is 
thought to have evolved as a stress response to allow eukaryotic organisms 
to survive in unfavourable conditions probably by regulating energy 
homeostasis and quality control of proteins and organelles. The autophagy 
machinery interacts with cellular stress response pathways (Kroemer et al., 
2010), including those responsible for controlling immune responses and 
the process of inflammation. There is direct   interaction between autophagy 
proteins and immune signalling molecules (Saitoh et al., 2009).  
 
To know whether autophagy is induced by P. aeruginosa, we studied 
this degradative mechanism in BMDMs, dendritic cells, the macrophage cell 
lines J774A.1, and RAW264.7, and the human cell line THP-1 cells. Our 
study revealed that autophagy is induced by P. aeruginosa in BMDMs 
through different pathways including Atg8 (LC3), Atg5 and Atg7. The results 
in chapter 3 and chapter 4 show that Pseudomonas aeruginosa induced 
autophagy and the PA103 pcrV mutant appears to show more autophagy 
than the PA103ΔUΔT strain, that was not dependent on functional T3SS 
but was dependent on TLR4 and the signaling molecule TRIF. PA infection 
also strongly induced activation of the inflammasome which was absolutely 
dependent on a functional T3SS. We found that inhibition of inflammasome 
activation increased autophagy, suggesting that the inflammasome normally 
inhibits this process. Further experiments showed that this inhibitory effect 
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was due to the proteolytic action of caspase-1 on the signaling molecule 
TRIF. Using a construct of TRIF with a mutation in the proteolytic cleavage 
site prevented caspase-1 cleavage and increased autophagy. TRIF is also 
involved in the production of interferon-β following infection. We also found 
that caspase-1 cleavage of TRIF down-regulated this pathway as well. 
Caspase-1 mediated inhibition of TRIF-mediated signaling is a novel 
pathway in the inflammatory response to infection. It is potentially amenable 
to therapeutic intervention. 
 Induction of autophagy following PA infection was determined using 
different methods: - electron microscopy, immunostaining of the 
autophagocytic marker, LC3 and post-translational conjugation of 
phosphatidyl-ethanoloamine (PE) to LC3 using Western blot, RT-PCR, and 
FACS for LC3 intracellular staining. We hypothesized the reciprocal link 
between autophagy and inflammasome activation. To test this hypothesis, 
we studied autophagy in the mouse BMDMs, dendritic cells, the 
macrophage cell lines J774A.1, and RAW264.7, and human cell line THP-1 
cells. Cells were infected with Pseudomonas aeruginosa PA103ΔUΔT, 
which has a fully functional T3SS but lacks translocated toxins and the 
PA103ΔpcrV strain which lacks a functional T3SS and is known not to 
activate the inflammasome. Incubations were conducted using different 
(MOI) and different time, and with Rapamycin 50µg/ml for 4 hours as 
positive control. This led to the redistribution of microtubule-associated 
protein 1 light chain (LC3) from diffuse to punctate staining, which is typical 
of autophagosome vacuoles (Ogawa et al., 2005); (Gutierrez et al., 2004). 
A well-recognised marker of activation of the autophagic mechanism within 
a cell is the conjugation of microtubule associated protein 1 light chain 3 
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(LC3-I) with phosphatidylethanolamine to generate LC3-II, which becomes 
bound to the membrane of the autophagosome (Kabeya et al., 2000). 
During the autophagy process, (LC3-I) undergoes processing to (LC3-II), 
and then the new form is targeted to autophagosomal membranes (Tanida 
et al., 2004).  LC3-I and LC3-II are separated by SDS-PAGE 12% due to a 
mobility shift, and the amount of LC3-II correlates with the number of 
autophagosome vesicles (Mizushima and Yoshimori, 2007).To further prove 
induction of autophagic vesicles in Pseudomonas aeruginosa infected cells, 
western blotting with an antibody against LC3 was done to monitor  
conversion of endogenous LC3-I to LC3-II. The conversion of the cystolic 
form of LC3-I to the lipid conjugated form of  LC3-II increased when BMDM 
were treated with 50 µg/ml Rapamycin for 4 h. Similarly, infection of BMDM 
with Pseudomonas aeruginosa wild-type PA103ΔUΔT and mutant strain 
PA103ΔpcrV also led to a rapid increase in cellular levels of LC3-II within 1 
hour compared to uninfected cells. Our data showed that conversion of 
LC3-I to LC3-II, number of autophagic vacuoles, and LC3 intracellular 
staining was increased when cells pre-treated with lysosomal inhibitors 
such as Pepstatin A, E64d, and Bafilomycin A which prevent loss of LC3-II 
during lysosomal degradation and recycling of the lipid conjugated form 
LC3-II to the cystolic form LC3-I after fusion of autophagosome with 
lysosomes. Therefore these inhibitors increase the autophagy marker (LC3 
protein) via blocking autophagy flux (Mizushima and Yoshimori, 2007).  
Numerous studies have demonstrated a role of potassium efflux in 
both NLRP3, and NLRC4 inflammasome activation (Sharp et al., 2009), 
(Hornung et al., 2008), (Gurcel et al., 2006) (Arlehamn et al., 2010). We 
found that treating of BMDMs, dendritic cells, J774A.1, and human cell line 
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THP-1cells with a high concentration of KCl 140mM/ml during infection with 
PA increased autophagy.  
The results in chapter 5 show the inhibition of autophagy by other 
means increases the activation of the inflammasome and production of the 
active IL-1β. Thus, autophagy acts normally to limit activation of the 
inflammasome and production of IL-1β. We also addressed another 
important question: How does autophagy limit inflammasome activation? 
Our hypothesis was the production of reactive oxygen intermediates (ROI) 
from mitochondria would be a force driving inflammasome activation, and 
that autophagy could remove sick mitochondria produced in infection and 
thus limit the production of ROI and hence inflammasome activation. We 
tested this hypothesis using specific inhibitors of mitochondrial ROS 
production. These did inhibit inflammasome activation, supporting our 
hypothesis. They were specific as they had no effect on cellular TNF 
production following bacterial infection. Activation of the NLRC4 
inflammasome by pathogenic bacteria is a central event in the innate 
immune response. We set out to determine the role of autophagy in 
controlling the activation of the NLRC4 by the pathogenic bacterium, 
Pseudomonas aeruginosa. We show that infection results in mitochondrial 
damage with increased production of reactive oxygen intermediates and 
release of mitochondrial DNA. This free cytoplasmic mitochondrial DNA 
activates the NLRC4 inflammasome. Autophagy attenuates this activation 
by removal of damaged mitochondria. NLRC4 immunoprecipitates bind 
mitochondrial DNA and transfection of mitochondrial DNA can activate a 
reconstituted NLRC4 inflammasome. Manipulation of autophagy alters the 
degree of inflammasome activation in an in vivo model of P. aeruginosa 
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infection, with modulation of the inflammatory response generated. These 
data demonstrate a novel mechanism by which the NLRC4 inflammasome 
can be activated, with similarities for mechanisms proposed for activation of 
the NLRP3 inflammasome. 
  The mechanism (s) by which the autophagy pathway inhibits 
inflammasome activation are not yet understood. One possibility includes 
direct interactions between autophagy proteins and inflammasome 
components, or indirect inhibition of inflammasome activity through 
autophagic suppression of mitochondrial ROS accumulation, or autophagic 
degradation of danger signals that activate the inflammasome. In line with 
the latter model, the autophagic degradation of amyotrophic-lateral-
sclerosis-linked mutant superoxide dismutase has been proposed to limit 
caspase 1 activation and IL-1β production (Meissner et al., 2010). 
3-MA inhibits autophagy by blocking autophagosome formation 
through the inhibition of type III Phosphatidylinositol 3-kinases PI3KIII which 
is required in the early stage of autophagy process for autophagosome 
generation (Petiot et al., 2000). Inhibition of PI3KIII by 3-methyladenine 
(3MA) or Wortmannin (Wm) has been shown to inhibit starvation-induced 
autophagy (Lum et al., 2005). Our results showed that 3MA (10 mM) is able 
to block Pseudomonas aeruginosa infection -induced autophagy.  A 
previous study showed that LPS plays a crucial role in inducing 
inflammasome activation and IL-1β secretion in embryonic liver 
macrophages from Atg16L -/- mice, suggesting a role for autophagy in 
dampening the inflammatory response to endotoxin (Saitoh et al., 2008). 
Autophagy has also been linked to augmenting and inhibiting inflammatory 
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responses. In inflammasome activation and induction of cell death by 
pyroptosis, autophagy has been shown to have a marked inhibitory effect 
(Saitoh et al., 2008).  
To demonstrate the crucial role of autophagic proteins during 
inflammasome activation following infection with PA, we isolated 
macrophages from mice with deletion of autophagy gene Vav-Atg7-/-, and 
infected the cells with PA103 ΔUΔT. First, we examined the effect of 
deficiency of the autophagic protein Atg7 on the activation of the 
inflammasome by measuring caspase-1 in BMDM WT, and Vav-Atg7-/- 
animals. Our results show the macrophages from mice lacking Atg7 had 
more of the active, cleaved form of caspase-1 in response to treatment with 
PA103 ΔUΔT than did wild-type macrophages. Additionally, the cleaved 
form of IL-1β, produced from the precursor pro-IL-1β through the action of 
activated caspase-1, was greater in abundance in the lysates and culture 
medium of Vav-Atg7-/- knockout macrophages. To prove induction of 
autophagic vesicles in Pseudomonas aeruginosa infected cells, 
immunofluorescence, western blotting, and FACS with an antibody against 
LC3 as well as RT-PCR was done in Vav-Atg7-/- compared with WT 
BMDMs. Similarly, knockdown of Atg5, and Lc3b mediated by small 
interfering RNA also enhanced IL-1β secretion and activation of caspase- 1 
in BMDM. In addition, secretion of tumour necrosis factor (TNF) in response 
to PA103 ΔUΔT was similar among the genotypes. Collectively these 
results demonstrate that depletion of autophagy proteins enhances 
caspase-1 activation and the secretion of IL-1β in BMDMs macrophages in 
response to PA103 ΔUΔT. Our results agree with the other studies (Castillo 
et al., 2012), their results showed M.tuberculosis infection of Atg5fl/fl LysM-
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Cre+ mice increased IL-1β levels. Other studies have shown inhibition of 
autophagy increases inflammasome activation by increase caspase-1, IL-
1α,β , and IL-18 secretion (Kleinnijenhuis et al., 2011) (Nakahira et al., 
2011). According to (Fujishima et al., 2011) the deletion of Atg7 in intestinal 
epithelium cells treated with LPS induces higher levels of IL-1β mRNA, 
compared to wild type mice. These results suggest that the autophagy 
pathway normally controls and regulates endogenous factors that would 
otherwise induce inflammasome assembly and activation (Harris, 2013).   
According to recent studies, there is a complex relation between 
autophagy and inflammasome activation. According to Newman etal. 2009, 
there is unclear information about the mechanism that accounts for 
autophagy producing inflammasome inhibition is not clear. In the study of 
(Harris et al., 2011) , autophagosomes were proposed to attack the 
inflammasome for the purpose of degradation. Though, since NLRP3 
inflammasome action is concealed by reactive oxygen species (ROS) 
obstruction and autophagy negatively controls ROS generation, it is likely 
that autophagic suppression of ROS restrains inflammasome activity 
indirectly (Okamoto and Kondo-Okamoto, 2012) . 
 
Another complexity in the relation between autophagy and 
inflammasome was put forward in a study by (Suzuki and Nunez, 2008). 
According to this study, inflammasome activation has a negative regulation 
on autophagy. This study found that caspase-1 deficiency promotes 
autophagy in macrophages infected with Shigella.  However, the report 
failed to provide complete information about the reciprocal nature of the 
relation between the two concepts.  
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According to (Shi et al., 2012), and (Harris et al., 2011), the induction 
of autophagy results in the reduction of IL-1β processing and secretion. 
According to Harris et al., 2011, the reduction was shown in cells that were 
treated with LPS or PAM3CysK4. They suggested that induction of 
autophagy is inducing degradation of pro-IL-1β, rather than processing and 
secretion of the mature (p17) form. Similarly, rapamycin abrogated IL-1 β 
secretion in response to treatment with LPS and ATP. The combination of 
rapamycin and LPS powerfully forced the formation of autophagosome in 
LC3-GFP iBMMs. These authors propose that autophagy acts to minimize 
the accessibility of pro-IL-1β under stimulated cells and represents a novel 
mechanism for self-regulation of inflammatory responses by macrophages 
and dendritic cells.  
 
Mitochondrial DNA has recently been emerged as the main element 
that can take active part in the establishment of inflammasome. A study of 
(Nakahira et al., 2011) showed that mitochondrial DNA has an involvement 
in NLRP3 inflammasome activation. Mitochondrial DNA directly induced 
NLRP3 inflammasome activation, because ρ˚ J774A.1cells lacking 
mitochondrial DNA after treatment with EtBr had severely attenuated IL-1β 
production, yet still underwent apoptosis. Thus, the data reveal that 
oxidized mitochondrial DNA released during programmed cell death causes 
activation of the NLRP3 inflammasome. These data supply or expand a 
missing link between apoptosis and inflammasome activation, through 
binding between cytosolic oxidized mitochondrial DNA and the NLRP3 
inflammasome (Shimada et al., 2012).  
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There could be an inverse relationship between the Atg proteins and 
immunity and inflammation and these proteins function both in induction 
and suppression of immune and inflammatory responses and similarly the 
immune and inflammatory signals function in both the induction and 
suppression of autophagy (Levine and Kroemer, 2008). The discovery of 
autophagy proteins and the relation between autophagy, immunity and 
Inflammation will reshape the understanding of immunity and disease. The 
autophagy proteins not only arrange the lysosomal degradation of 
unwanted cargo, but also help in the control of immunity and inflammation. 
Thus, the autophagy pathway and autophagy proteins may function as a 
balance between the beneficial and harmful effects of the host response to 
infection and immunological stimuli. Autophagy has been implicated in 
either the pathogenesis or response to a wide variety of diseases, chronic 
bacterial infections, viral infections, cancers, neurodegenerative diseases, 
and atherosclerosis (Kundu et al., 2008).   
 
Future work 
1- Further studies are necessary to determine how the immune responses 
are altered and specifically and interact with other critical innate and 
acquired immune responses (in vivo model). 
2- Investigate role of autophagy in Ag presentation following PA infection. 
Does blocking or enhancing the autophagy mechanism alter antigen 
presentation following PA infection? 
3- Further studies are needed to understand the molecular link between 
inflammasome activation, pyroptosis, and autophagy, as well as their 
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role in regulating host innate immune response against extracellular 
bacteria. 
4- Further studies are needed to understand how endogenous cytosolic 
mitochondrial DNA connects mitochondrial dysfunction to caspase-1 
activation following PA infection. 
5- Further studies are needed to understand how the pharmacological 
manipulation of the autophagy pathway could be of  therapeutic benefit 
in the treatment of PA infection in vivo. 
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